Solidion Technology (STI) S-1 2 Oct 24 IPO registration Financial data

Document And Entity Information

Document And Entity Information	6 Months Ended
	Jun. 30, 2024
Document Information Line Items
Entity Registrant Name	SOLIDION TECHNOLOGY, INC.
Document Type	S-1
Amendment Flag	false
Entity Central Index Key	0001881551
Entity Filer Category	Non-accelerated Filer
Entity Small Business	true
Entity Emerging Growth Company	false
Entity Incorporation, State or Country Code	DE

Condensed Consolidated and Comb

Condensed Consolidated and Combined Balance Sheets - USD ($)	Jun. 30, 2024	Dec. 31, 2023	Dec. 31, 2022
Current Assets:
Cash	$ 256,504	$ 780	$ 621,575
Accounts receivable	999	2,164
Other receivable	302,500	187,500
Inventory	24,430	22,730
Prepaid expenses	267,717	44,892
Other current assets	777,135
Total Current Assets	1,629,285	258,066
Property and Equipment, net of depreciation	2,193,641	2,319,152
Patents, net of amortization	1,938,690	1,852,649
Other assets	778,167
Total Assets	6,539,783	4,429,867
Current Liabilities:
Accounts payable and accrued expenses	3,401,885	144,923
Income taxes payable	89,267
Excise tax payable	890,385
Funds allocated for share redemption		17,834,235
Derivative liabilities	16,844,750
Convertible notes	527,500
Short-term notes payable	2,858,769
Total liabilities	24,700,429	1,017,408
Stockholders’ Deficit:
Preferred stock value
Common stock value	8,709	6,980
Additional paid-in capital	79,610,239	28,850,985
Stock subscription receivable	(80,241)
Accumulated deficit	(97,699,353)	(25,445,506)
Total Stockholders’ Equity (Deficit)	(18,160,646)	(28,533,250)	(3,894,774)
Total Liabilities and Stockholders’ Equity (Deficit)	6,539,783	4,429,867
Related Party
Current Liabilities:
Due to related party	87,873	872,485
Previously Reported
Current Assets:
Cash		19,979	545,655
Prepaid expenses		85,538	215,628
Derivative asset		28,245,500
Total Current Assets		28,351,017	761,283
Cash and investments held in the Trust Account		42,994,274	127,782,882
Other assets			35,870
Total Assets		71,345,291	128,580,035
Current Liabilities:
Accounts payable and accrued expenses		2,131,019	439,086
Income taxes payable		906,563	339,899
Excise tax payable		890,385
Accrued offering costs			5,000
Funds allocated for share redemption		17,834,235
Derivative liabilities		46,728,596
Advances from Target		187,500
Convertible notes		1,297,500	125,341
Total Current Liabilities		71,213,298	909,326
Deferred underwriting commission		4,322,500	4,322,500
Total liabilities		75,535,798	5,231,826
Commitments and contingencies (Note 8)
Class A common stock subject to possible redemption; 2,293,741 and 12,350,000 shares (at redemption value)		24,342,743	127,242,983
Stockholders’ Deficit:
Preferred stock value
Additional paid-in capital
Accumulated deficit		(28,533,570)	(3,895,094)
Total Stockholders’ Equity (Deficit)		3,412,459	5,983,426
Total Liabilities and Stockholders’ Equity (Deficit)		71,345,291	128,580,035
Previously Reported | Related Party
Current Liabilities:
Advances from Related Party		332,500
Due to related party		905,000
Previously Reported
Current Liabilities:
Advances from Target		187,500
Previously Reported | Previously Reported
Stockholders’ Deficit:
Total Stockholders’ Equity (Deficit)		(28,533,250)	(3,894,774)
After Retroactive Application of Recapitalization
Stockholders’ Deficit:
Total Stockholders’ Equity (Deficit)	$ (18,160,646)	3,412,459
Class A Common Stock | Previously Reported
Stockholders’ Deficit:
Common stock value		12	12
Class B Common Stock | Previously Reported
Stockholders’ Deficit:
Common stock value		$ 308	$ 308

Condensed Consolidated and Co_2

Condensed Consolidated and Combined Balance Sheets (Parentheticals) - $ / shares	Jun. 30, 2024	Dec. 31, 2023	Dec. 31, 2022
Preferred stock, par value (in Dollars per share)	$ 0.0001	$ 0.0001
Preferred stock, shares authorized	2,000,000	2,000,000
Preferred stock, shares issued
Preferred stock, shares outstanding
Common stock, par value (in Dollars per share)	$ 0.0001	$ 0.0001
Common stock, shares authorized	300,000,000	300,000,000
Common stock, shares issued	87,100,341	69,800,000
Common stock, shares outstanding	87,100,341	69,800,000
Previously Reported
Preferred stock, par value (in Dollars per share)		$ 0.0001	$ 0.0001
Preferred stock, shares authorized		1,000,000	1,000,000
Preferred stock, shares issued
Preferred stock, shares outstanding
Previously Reported | Class A Common Stock
Common stock subject to possible redemption		2,293,741	12,350,000
Common stock, par value (in Dollars per share)		$ 0.0001	$ 0.0001
Common stock, shares authorized		100,000,000	100,000,000
Common stock, shares issued		123,500	123,500
Common stock, shares outstanding		123,500	123,500
Previously Reported | Class B Common Stock
Common stock, par value (in Dollars per share)		$ 0.0001	$ 0.0001
Common stock, shares authorized		10,000,000	10,000,000
Common stock, shares issued		3,087,500	3,087,500
Common stock, shares outstanding		3,087,500	3,087,500

Condensed Consolidated and Co_3

Condensed Consolidated and Combined Statements of Operations (Unaudited) - USD ($)	3 Months Ended		6 Months Ended		12 Months Ended
	Jun. 30, 2024	Jun. 30, 2023	Jun. 30, 2024	Jun. 30, 2023	Dec. 31, 2023	Dec. 31, 2022
EXPENSES
Administrative fee – related party					$ 125,000	$ 95,000
Research and development	$ 400,658	$ 681,646	$ 1,129,772	$ 1,442,131
Selling, general and administrative	2,532,651	351,330	5,562,873	1,332,962	3,384,621	809,193
Total operating expenses	2,933,309	1,032,976	6,692,645	2,775,093	3,509,621	904,193
Operating loss	(2,933,309)	(1,032,976)	(6,692,645)	(2,774,793)
OTHER (EXPENSE) INCOME
Change in fair value of derivative liabilities	24,966,700		16,784,200		(18,483,096)
Issuance of common stock and warrants			(17,820,998)
Income earned on Investments held in Trust Account					3,788,143	1,812,882
Interest income	171		482		8,580	5,683
Interest expense	(19,184)		(22,923)
Other income (expense)	4,038	391	4,037	666
Change in fair value of over-allotment liability						19,432
Total other income (expense)	24,951,725	391	(1,055,202)	666	(14,686,373)	1,837,996
Net (loss) income before provision for income taxes					(18,195,994)	933,804
Provision for income taxes					1,579,608	339,899
Net Income (loss)	$ 22,018,416	$ (1,032,585)	$ (7,747,847)	$ (2,774,127)	$ (19,775,602)	$ 593,905
Weighted average number of shares basic (in Shares)	86,913,581	69,800,000	82,556,000	69,800,000
Basic net (loss) income per share (in Dollars per share)	$ 0.25	$ (0.01)	$ (0.09)	$ (0.04)
Weighted average number of shares diluted (in Shares)	96,159,497	69,800,000	82,556,000	69,800,000
Diluted net (loss) income per share (in Dollars per share)	$ 0.23	$ (0.01)	$ (0.09)	$ (0.04)
Net sales				$ 300
Cost of goods sold
Gross profit				$ 300
Class A Redeemable Common Stock
OTHER (EXPENSE) INCOME
Weighted average number of shares basic (in Shares)					7,654,886	9,846,164
Basic net (loss) income per share (in Dollars per share)					$ (1.82)	$ 0.05
Weighted average number of shares diluted (in Shares)					7,654,886	9,846,164
Diluted net (loss) income per share (in Dollars per share)					$ (1.82)	$ 0.05
Class A and B Non-Redeemable Common Stock
OTHER (EXPENSE) INCOME
Weighted average number of shares basic (in Shares)					3,211,000	3,117,537
Basic net (loss) income per share (in Dollars per share)					$ (1.82)	$ 0.05
Weighted average number of shares diluted (in Shares)					3,211,000	3,185,962
Diluted net (loss) income per share (in Dollars per share)					$ (1.82)	$ 0.05

Condensed Consolidated and Co_4

Condensed Consolidated and Combined Statements of Changes in Stockholders’ (Deficit) Equity (Unaudited) - USD ($)	Common Stock Class A	Common Stock Class B	Common Stock Previously Reported	Common Stock Retroactive application of recapitalization	Common Stock Adjusted	Common Stock	Additional Paid-in Capital Previously Reported	Additional Paid-in Capital Retroactive application of recapitalization	Additional Paid-in Capital Adjusted	Additional Paid-in Capital	Accumulated Deficit Previously Reported	Accumulated Deficit Retroactive application of recapitalization	Accumulated Deficit Adjusted	Accumulated Deficit	Stock Subscription Receivable Previously Reported	Stock Subscription Receivable Retroactive application of recapitalization	Stock Subscription Receivable Adjusted	Stock Subscription Receivable	Previously Reported	Retroactive application of recapitalization	Adjusted	Total
Balance beginning at Dec. 31, 2021		$ 316								$ 24,684				$ (1,430)								$ 23,570
Balance beginning (in Shares) at Dec. 31, 2021		3,162,500
Proceeds Allocated to Public Warrants										3,755,675												3,755,675
Proceeds from Private Warrants										5,405,000												5,405,000
Value of transaction costs allocated to the fair value of equity instruments										(234,654)												(234,654)
Class A common stock issued to Representative	$ 12									776,803												776,815
Class A common stock issued to Representative (in Shares)	123,500
Class A Common Stock Redeemable Remeasurement Adjustment at Initial Public Offering										(9,727,508)				(3,214,594)								(12,942,102)
Class A Common Stock Redeemable Remeasurement Adjustment														(1,272,983)								(1,272,983)
Forfeiture of Class B Common Stock		$ (8)												8
Forfeiture of Class B Common Stock (in Shares)		(75,000)
Net income (loss)														593,905								593,905
Balance ending at Dec. 31, 2022	$ 12	$ 308		$ 6,980	$ 6,980		$ 26,104,307	$ (6,980)	$ 26,097,327		$ (20,120,881)		$ (20,120,881)	(3,895,094)					$ 5,983,426		$ 5,983,426	(3,894,774)
Balance ending (in Shares) at Dec. 31, 2022	123,500	3,087,500		69,800,000	69,800,000
Contributions and net transfers with related parties									442,368												442,368
Net income (loss)													(1,741,542)								(1,741,542)
Balance ending at Mar. 31, 2023					$ 6,980				26,539,695				(21,862,423)								4,684,252
Balance ending (in Shares) at Mar. 31, 2023					69,800,000
Balance beginning at Dec. 31, 2022	$ 12	$ 308		$ 6,980	$ 6,980		26,104,307	(6,980)	26,097,327		(20,120,881)		(20,120,881)	(3,895,094)					5,983,426		5,983,426	(3,894,774)
Balance beginning (in Shares) at Dec. 31, 2022	123,500	3,087,500		69,800,000	69,800,000
Class A common stock issued to Representative																						$ 776,815
Class A common stock issued to Representative (in Shares)																						123,500
Class A Common Stock Redeemable Remeasurement Adjustment														(3,972,489)								$ (3,972,489)
Excise tax on redemption of Class A Common Stock														(890,385)								(890,385)
Net income (loss)														(19,775,602)								(19,775,602)
Balance ending at Dec. 31, 2023	$ 12	$ 308		$ 6,980	$ 6,980		28,857,965	(6,980)	28,850,985		(25,445,506)		(25,445,506)	(28,533,570)					3,412,459		3,412,459	(28,533,250)
Balance ending (in Shares) at Dec. 31, 2023	123,500	3,087,500		69,800,000	69,800,000
Balance beginning at Mar. 31, 2023					$ 6,980				26,539,695				(21,862,423)								4,684,252
Balance beginning (in Shares) at Mar. 31, 2023					69,800,000
Contributions and net transfers with related parties										185,865												185,865
Net income (loss)														(1,032,585)								(1,032,585)
Balance ending at Jun. 30, 2023						$ 6,980				26,732,540				(22,895,008)								3,837,532
Balance ending (in Shares) at Jun. 30, 2023						69,800,000
Balance beginning at Dec. 31, 2023	$ 12	$ 308		$ 6,980	$ 6,980		28,857,965	(6,980)	28,850,985		(25,445,506)		(25,445,506)	(28,533,570)					3,412,459		3,412,459	(28,533,250)
Balance beginning (in Shares) at Dec. 31, 2023	123,500	3,087,500		69,800,000	69,800,000
Capital contributions from related party									487,273												487,273
Issuance of common stock upon consummation of the Merger					$ 600				(27,888,519)												(27,887,919)
Issuance of common stock upon consummation of the Merger (in Shares)					6,004,741
Conversion of convertible notes into common stock upon consummation of the Merger					$ 596				3,174,404												3,175,000
Conversion of convertible notes into common stock upon consummation of the Merger (in Shares)					5,962,325
Stock subscription receivable																	(80,241)				(80,241)
Earnout Arrangement									63,600,000				(63,600,000)
Contingent consideration									906,000				(906,000)
Private Placement					$ 513				8,931,484												8,931,997
Private Placement (in Shares)					5,133,332
Issuance costs in connection with the Private Placement									(262,064)												(262,064)
Stock-based compensation									1,359,000												1,359,000
Net income (loss)													(29,766,263)								(29,766,263)
Balance ending at Mar. 31, 2024					$ 8,689				79,158,563				(119,717,769)				(80,241)				(40,630,758)
Balance ending (in Shares) at Mar. 31, 2024					86,900,398
Balance beginning at Dec. 31, 2023	$ 12	$ 308		$ 6,980	$ 6,980		$ 28,857,965	$ (6,980)	28,850,985		$ (25,445,506)		(25,445,506)	(28,533,570)					$ 3,412,459		3,412,459	$ (28,533,250)
Balance beginning (in Shares) at Dec. 31, 2023	123,500	3,087,500		69,800,000	69,800,000
Shares issued from exercise of Series D Warrants (in Shares)																						199,943
Class A common stock issued to Representative																						$ 1,081,011
Balance ending at Jun. 30, 2024						$ 8,709				79,610,239				(97,699,353)				$ (80,241)				(18,160,646)
Balance ending (in Shares) at Jun. 30, 2024						87,100,341
Balance beginning at Mar. 31, 2024					$ 8,689				$ 79,158,563				$ (119,717,769)				$ (80,241)				$ (40,630,758)
Balance beginning (in Shares) at Mar. 31, 2024					86,900,398
Shares issued from exercise of Series D Warrants						$ 20				14												34
Shares issued from exercise of Series D Warrants (in Shares)						199,943
Stock-based compensation										451,662												451,662
Net income (loss)														22,018,416								22,018,416
Balance ending at Jun. 30, 2024						$ 8,709				$ 79,610,239				$ (97,699,353)				$ (80,241)				$ (18,160,646)
Balance ending (in Shares) at Jun. 30, 2024						87,100,341

Condensed Consolidated and Co_5

Condensed Consolidated and Combined Statements of Cash Flows (Unaudited) - USD ($)	6 Months Ended		12 Months Ended
	Jun. 30, 2024	Jun. 30, 2023	Dec. 31, 2023	Dec. 31, 2022
Cash Flows From Operating Activities:
Net income (loss)	$ (7,747,847)	$ (2,774,127)	$ (19,775,602)	$ 593,905
Adjustments to reconcile net income (loss) to net cash used in operating activities:
Depreciation and amortization	197,303	182,179
Stock based compensation	1,810,662
Change in fair value of derivative liabilities	(16,784,200)		18,483,096
Issuance of common stock and warrants	17,820,998
Change in fair value of over-allotment liability				(19,432)
Derivative asset/liabilities	(17,820,998)
Changes in operating assets and liabilities:
Accounts receivable	1,164	40
Other receivable	(115,000)
Inventory	(1,700)
Prepaid expenses	(57,418)	(11,700)
Prepaid expenses and other current assets	(777,135)
Other non-current assets	(778,167)
Accounts payable and accrued expenses	2,889,968	9,135
Due to related party		444,076
Net Cash Used In Operating Activities	(3,541,372)	(2,150,397)
Cash Flows From Investing Activities:
Capitalized patent costs	(157,834)	(62,235)
Net Cash Used In Investing Activities	(157,834)	(62,235)
Cash Flows From Financing Activities:
Capital contributions from related party	487,273	1,592,095
Cash received from NUBI Trust	25,160,047
Discount payment related to Non Redemption Agreement	(13,937,997)
Payment for reimbursement of consideration shares related to the Forward Purchase Agreement	(2,193,800)
Payment for reimbursement of Recycled Shares related to Forward Purchase Agreement	(80,241)
Payment of transaction expenses in connection with the Merger	(8,948,009)
Inflow from Merger	17,555
Proceeds from convertible notes	527,500
Proceeds from short-term notes	670,000
Repayment of short-term notes	(424,277)
Proceeds from issuance of common stock and warrants in connection with the Private Placement	3,850,000
Proceeds from issuance of common stock from exercise of warrants	34
Issuance costs in connection with the Private Placement	(262,064)
Payment of related party payable	(911,091)
Net Cash Provided By Financing Activities	3,954,930	1,592,095
Net change in cash	255,724	(620,537)
Cash at beginning of period	780	621,575	621,575
Cash at end of period	256,504	1,038	780	621,575
Supplemental disclosure
Cash paid for interest expense	89,012
Supplemental disclosure of non-cash financing activities:
Issuance of Common Stock upon the closing of the Merger	1,216
Previously Reported [Member]
Cash Flows From Operating Activities:
Net income (loss)			(19,775,602)	593,905
Adjustments to reconcile net income (loss) to net cash used in operating activities:
Income earned on Investments held in Trust Account			(3,788,143)	(1,812,882)
Change in fair value of over-allotment liability				(19,432)
Derivative asset/liabilities			18,483,096
Changes in operating assets and liabilities:
Prepaid expenses and other current assets			130,090	(215,628)
Other assets			35,870	(35,870)
Accrued formation and offering costs			(5,000)
Income tax payable			566,664	339,899
Accounts payable and accrued expenses			1,691,932	424,906
Net Cash Used In Operating Activities			(2,661,093)	(725,102)
Cash Flows From Investing Activities:
Cash withdrawn for taxes			1,523,258
Cash withdrawn for redemptions of Class Common Stock			89,038,494
Cash deposited into Trust Account			(1,985,000)	(125,970,000)
Net Cash Used In Investing Activities			88,576,752	(125,970,000)
Cash Flows From Financing Activities:
Proceeds from convertible note – Sponsor			1,172,159
Proceeds from convertible notes			905,000
Advances from Related Party			332,500
Advances from Target			187,500
Payments for redemption of Class A Common Stock			(89,038,494)
Sale of Units in the Initial Public Offering, net of underwriting discount				123,500,000
Issuance costs in connection with the Private Placement				5,405,000
Payment of underwriter fees				(1,235,000)
Payment of offering costs				(429,243)
Net Cash Provided By Financing Activities			(86,441,335)	127,240,757
Net change in cash			(525,676)	545,655
Cash at beginning of period	$ 19,979	$ 545,655	545,655
Cash at end of period			19,979	545,655
Supplemental disclosure
Cash paid for income taxes			1,012,944
Supplemental disclosure of non-cash financing activities:
Deferred offering costs included in accrued offering costs				25,000
Deferred offering costs included in related party payable				939
Deferred underwriters’ compensation charged to temporary equity in connection with the Public Offering				4,322,500
Class A redeemable Common Stock measurement adjustment at Initial Public Offering				12,942,102
Fair value of representative shares				776,815
Issuance of Common Stock upon the closing of the Merger				19,432
Excise tax on redemption of Class A Common Stock			890,385
Class A Common Stock Redeemable Current Period Remeasurement Adjustment			3,972,489	1,272,983
Reclassification of redeemed Class A ordinary shares			$ 17,834,235

Description of Organization, Bu

Description of Organization, Business Operations and Going Concern	6 Months Ended	12 Months Ended
	Jun. 30, 2024	Dec. 31, 2023
Description of Organization, Business Operations and Going Concern [Abstract]
DESCRIPTION OF ORGANIZATION, BUSINESS OPERATIONS AND GOING CONCERN	NOTE 1 — DESCRIPTION OF ORGANIZATION, BUSINESS OPERATIONS AND GOING CONCERN Solidion Technology, Inc (the “Company”, “Solidion” or “Solidion Technology”), formerly known as Nubia Brand International Corp. prior to February 2, 2024, was incorporated in Delaware on June 14, 2021 and is an advanced battery technology company focused on the development and commercialization of battery materials, components, cells, and selected module/pack technologies. Solidion’s headquarters is in Dallas, Texas. Research and development and manufacturing operations are located in Dayton, Ohio. On February 2, 2024, Nubia Brand International Corp., a Delaware corporation (“Nubia” and after the Transactions described herein, the “Company”, “Solidion” or “Solidion Technology, Inc.”), consummated the previously announced merger (the “Closing”) pursuant to a Merger Agreement, dated February 16, 2023 (as amended on August 25, 2023, the “Merger Agreement”), by and among Nubia, Honeycomb Battery Company, an Ohio corporation (“HBC”), and Nubia Merger Sub, Inc., an Ohio corporation and wholly -owned In accordance with the Merger Agreement the Company issued to the HBC stockholders aggregate consideration of 70,000,000 (i) (ii) -two (iii) If, prior to the expiration of the earn out periods set forth in (i)-(iii) above, there occurs any transaction resulting in a change in control, and the corresponding valuation of Solidion’s Class A common stock, calculated inclusive of the Earnout Shares to be issued under the Earnout Arrangement, is greater than or equal to the amount set forth in (i)-(iii), as applicable, then, immediately prior to the consummation of such change in control, the event set forth in (i)-(iii), as applicable, if not previously satisfied, shall be deemed to have occurred, subject to the terms provided in the Merger Agreement. As of June 30, 2024, none of the Earnout Shares had been earned by G3. The Merger was accounted for as a common control transaction with respect to HBC which is akin to a reverse recapitalization. This conclusion was based on the fact that G3 had a controlling financial interest in HBC prior to the Merger and has a controlling financial interest in Solidion (which includes HBC as a wholly owned subsidiary). Net assets of Nubia will be stated at their historical carrying amounts with no goodwill or intangible assets recognized in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”). The Merger with respect to HBC will not be treated as a change in control due primarily to G3 receiving the controlling voting stake in Solidion and G3’s ability to nominate a majority of the board of directors of Solidion. Under the guidance in ASC 805 for transactions between entities under common control, the assets and liabilities of HBC and Nubia are recognized at their carrying amounts on the date of the Merger. Under a reverse recapitalization, Nubia will be treated as the “acquired” company for financial reporting purposes. Accordingly, for accounting purposes, the Merger will be treated as the equivalent of HBC issuing stock for the net liabilities of Nubia, accompanied by a recapitalization. Going Concern The Company’s financial statements have been prepared under the assumption that the Company will continue as a going concern, which contemplates the realization of assets and satisfaction of liabilities in the normal course of business for the foreseeable future. Since the Company’s inception, it has experienced recurring net losses and net cash used in operating activities and has generated minimal sales. For the six months ended June 30, 2024, the Company recorded a net loss of $7,747,847, which included a gain of $16,784,200 due to the change in the fair value of derivative liabilities and a $17,820,998 loss due to the issuance of common stock and warrants, net cash used in operating activities of $3,541,372 and as of June 30, 2024, had cash and cash equivalents of $256,504. For the year ended December 31, 2023, the Company recorded a net loss of $5,324,624 and net cash used in operating activities of $4,068,302. Additionally, as of the balance sheet date and up to the date that the financial statements were issued, the Company does not have availability under any debt agreements. The Company also expects to continue to incur net losses and net cash used in operating activities in accordance with its operating plan and expects that expenditures will increase significantly in connection with its ongoing activities. Given the Company’s projected operating requirements and its existing cash and cash equivalents, the Company is projecting insufficient liquidity to sustain its operations and meet its obligations through one year following the date that the financial statements were issued. These events and conditions raise substantial doubt about the Company’s ability to continue as a going concern. As an early -stage The financial statements do not include any adjustments that might result from the outcome of this uncertainty. Risks and Uncertainties The Company’s current business activities consist of development and commercialization of battery materials, components, cells, and selected module/pack technologies. The Company faces inherent risks associated with its operations, such as the ongoing development of its technology, marketing, and distribution channels, as well as the enhancement of its supply chain and manufacturing capabilities. Additionally, the need to recruit additional management and key personnel is vital. The success of the Company’s development initiatives and the achievement of profitability hinge on various factors, including its ability to enter potential markets and secure sustainable financing in the future. The Company’s future results of operations involve a number of risks and uncertainties. Factors that could affect the Company’s future operating results and cause actual results to vary materially from expectations include, but are not limited to, rapid technological change, competition from substitute products and larger companies, protection of proprietary technology, ability to maintain distributor relationships and dependence on key individuals.	NOTE 1 — DESCRIPTION OF ORGANIZATION, BUSINESS OPERATIONS AND GOING CONCERN Solidion Technology, Inc, formerly known as Nubia Brand International Corp. prior to February 2, 2024 (the “Closing Date”) was incorporated in Delaware on June 14, 2021 and Nubia Merger Sub, Inc., an Ohio corporation, (collectively, the Company”) was formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses (the “Business Combination”). The Company is not limited to a particular industry or sector for purposes of consummating a Business Combination. The Company is an early stage and emerging growth company and, as such, the Company is subject to all of the risks associated with early stage and emerging growth companies. As of December 31, 2023, the Company had not commenced any operations. All activity for the period from June 14, 2021 (inception) through December 31, 2023 relates to the Company’s formation and the initial public offering (“Initial Public Offering” or “IPO”), which is described below. The Company will not generate any operating revenues until after the completion of its initial Business Combination, at the earliest. The Company will generate non -operating On February 16, 2023, the Company entered into a Merger Agreement (the “Merger Agreement”) by and among Honeycomb Battery Company, an Ohio corporation (the “Honeycomb”), the Company, and Nubia Merger Sub, Inc., an Ohio corporation (“Merger Sub”) and wholly -owned -owned The Merger Agreement provides that the Company will issue to the Honeycomb stockholders aggregate consideration of 70,000,000 (i) (ii) -two (iii) The Merger Agreement contains customary representations and warranties of the parties. The Merger is accounted for as a reverse recapitalization with Honeycomb as the accounting acquirer. On February 2, 2024 (the “Closing Date”), the Company consummated the business combination (the “Closing”) pursuant to a Merger Agreement, dated February 16, 2023 (as amended on August 25, 2023, the “Merger Agreement”) with HBC surviving such merger as a wholly owned subsidiary of Nubia, which was renamed “Solidion Technology, Inc.” upon Closing. Business Prior to the Business Combination The registration statement for the Company’s Initial Public Offering was declared effective on March 10, 2022. On March 15, 2022, the Company consummated the Initial Public Offering of 11,000,000 units (“Units” and, with respect to the shares of common stock included in the Units being offered, the “Public Shares”), generating gross proceeds of $110,000,000, which is described in Note 3. Simultaneously with the closing of the Initial Public Offering, the Company consummated the private sale (the “Private Placement”) of an aggregate of 5,000,000 warrants (the “Private Placement Warrants”) to Mach FM Acquisitions LLC (the “Sponsor”) at a purchase price of $1.00 per Private Placement Warrant, generating gross proceeds to the Company in the amount of $5,000,000. On March 15, 2022, the underwriters purchased an additional 1,350,000 Units pursuant to the partial exercise of the over -allotment -allotment The Company’s ability to commence operations is contingent upon obtaining adequate financial resources through its Initial Public Offering of 12,350,000 Units (including a partial exercise of the underwriters’ over -allotment -allotment The Company’s management has broad discretion with respect to the specific application of the net proceeds of the Initial Public Offering and the sale of Private Placement Warrants, although substantially all of the net proceeds are intended to be applied generally toward consummating a Business Combination. There is no assurance that the Company will be able to complete a Business Combination successfully. The Company must complete one or more initial Business Combinations with one or more operating businesses or assets with a fair market value equal to at least 80% of the net assets held in the Trust Account (as defined below) (excluding the deferred underwriting commissions and taxes payable on the interest earned on the Trust Account). The Company will only complete a Business Combination if the post -transaction -ended -7 -interest The holders of the Founder Shares have agreed (a) to waive their redemption rights with respect to the Founder Shares and Public Shares held by them in connection with the completion of a Business Combination and (b) not to propose an amendment to the Certificate of Incorporation (i) to modify the substance or timing of the Company’s obligation to allow redemptions in connection with a Business Combination or to redeem 100% of its Public Shares if the Company does not complete a Business Combination within the Combination Period (as defined below) or (ii) with respect to any other provision relating to stockholders’ rights or pre -business On March 13, 2023, in accordance with the current certificate of incorporation, the Company contributed an aggregate of $1,235,000 (or $0.10 per share for each outstanding public share) to the trust account and extended the time to complete a business combination from March 15, 2023 to June 15, 2023. On June 14, 2023, the Company held a special meeting of stockholders (the “Special Meeting”). At the Special Meeting, stockholders approved to amend the Company’s Amended and Restated Certificate of Incorporation to allow the Company to extend the date by which the Company must consummate a business combination (the “Extension”) on a monthly basis up to six times from June 15, 2023 (the date that is 15 months from the closing date of the Company’s initial public offering of units) to December 15, 2023 (the date that is 21 months from the closing date of the IPO). The Company contributed an additional $125,000 per month from June through November 2023 for a total of $750,000 related to the Special Meeting Extension. Stockholders elected to redeem an aggregate 8,430,383 or shares of Common Stock in connection with the Special Meeting. As such, $89,038,494 was withdrawn from the Trust. In connection with the redemption, the Company recorded an excise tax liability and equity adjustment of $0.9 million. On December 14, 2023, the Company held another special meeting of stockholders (the “Second Special Meeting”). At the Second Special Meeting, stockholders approved the business combination. Stockholders elected to redeem an aggregate 1,625,876 Excise tax, if any, related to the redemption will be accrued on the date the funds are paid to the stockholders. Going Concern Consideration On February 2, 2024 (the “Closing Date”), the Company consummated the business combination (the “Closing”) pursuant to a Merger Agreement, dated February 16, 2023 (as amended on August 25, 2023, the “Merger Agreement”) with HBC surviving such merger as a wholly owned subsidiary of Nubia, which was renamed “Solidion Technology, Inc.” upon Closing. Since Solidion’s inception, the Company has experienced recurring net losses and has generated minimal sales. For the year ended December 31, 2023, Solidion recorded net losses of approximately $5,300,000, net cash used in operating activities of approximately $4,100,000 and, as of December 31, 2023, had cash and cash equivalents on hand of approximately $1,000, which factors raise substantial doubt about the Company’s ability to continue as a going concern. The Company plans to finance its operations with proceeds from the sale of equity securities or debt; however, there is no assurance that management’s plans to obtain additional debt or equity financing will be successfully implemented or implemented on terms favorable to the Company. The balance sheets do not include any adjustments that might result from the outcome of this uncertainty. The accompanying financial statements have been prepared in conformity with generally accepted accounting principles in the United States of America (“US GAAP”), which contemplate continuation of the Company as a going concern. Risks and Uncertainties The IR Act imposes a 1% excise tax on the fair market value of stock repurchases made by covered corporations after December 31, 2022. The total taxable value of shares repurchased is reduced by the fair market value of and newly issued shares during the taxable year. Redemption rights are ubiquitous to nearly all SPACs. Stockholders have the ability to require the SPAC to repurchase their shares prior to the merger in what is known as a redemption right, essentially getting their money back. The Company recorded an excise tax liability and equity adjustment of $0.9 million for the ended December 31, 2023 in connection with Second Special Meeting redemptions. In February 2022, the Russian Federation and Belarus commenced a military action with the country of Ukraine. As a result of this action, various nations, including the United States, have instituted economic sanctions against the Russian Federation and Belarus. Further, the impact of this action, related sanctions on the world economy and the ongoing hostilities in the Middle East are not determinable as of the date of these financial statements. The specific impact on the Company’s financial condition, results of operations, and cash flows is also not determinable as of the date of these financial statements.

Summary of Significant Accounti

Summary of Significant Accounting Policies	6 Months Ended	12 Months Ended
	Jun. 30, 2024	Dec. 31, 2023
Summary of Significant Accounting Policies [Abstract]
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES	NOTE 3 — SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Basis of Presentation and Principles of Consolidation The accompanying unaudited condensed consolidated and combined financial statements (the “financial statements”) are presented in conformity with US GAAP -1 Throughout the period covered till the Closing date of the Merger, the Company operated as part of G3. Consequently, stand -alone -alone However, the financial statements included herein may not be indicative of the financial position, results of operations, and cash flows of the Company in the future or if the Company had been a separate, stand -alone In the opinion of management, the Company has made all adjustments necessary to present fairly its financial statements for the periods presented. Such adjustments are of a normal, recurring nature. The Company’s financial statements have been prepared under the assumption that the Company will continue as a going concern, which contemplates the realization of assets and discharge of liabilities in the normal course of business for the foreseeable future. The financial statements include the Company entities. All intercompany transactions have been eliminated for consolidation purposes. Emerging Growth Company The Company is an “emerging growth company,” as defined in Section 2(a) of the Securities Act of 1933, as amended (the “Securities Act”), as modified by the Jumpstart Our Business Startups Act of 2012, as amended (the “JOBS Act”), and it may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies including, but not limited to, not being required to comply with the independent registered public accounting firm attestation requirements of Section 404 of the Sarbanes -Oxley Further, Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that a company can elect to opt out of the extended transition period and comply with the requirements that apply to non -emerging Use of Estimates The preparation of financial statements in conformity with US GAAP requires the Company’s management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of expenses during the reporting period. Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the balance sheet which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. Accordingly, the actual results could differ significantly from those estimates. Segment Reporting The Company has determined that the Chief Executive Officer is its Chief Operating Decision Maker (the “CODM”). Operating segments are defined as components of an entity for which separate financial information is available and that is regularly reviewed by the CODM in deciding how to allocate resources to an individual segment and in assessing performance. The Company has determined that it operates in one operating segment and one reportable segment, as the CODM reviews financial information presented on a consolidated basis for purposes of making operating decisions, allocating resources, and evaluating financial performance. Cash and cash equivalents The Company considers all short -term Accounts Receivable, net of Allowance for Credit Losses Accounts receivables are stated at the amount the Company expects to collect. The Company recognizes an allowance for credit losses to ensure accounts receivables are not overstated due to un -collectability -time Other Receivable As of December 31, 2023, the Company held an other receivable balance of $187,500 from Nubia. This balance originated from cash advances made by G3 on behalf of The Battery Group of G3, in connection with Nubia’s funding requirements for extensions of time in closing the Merger. Pursuant to the Merger Agreement, G3’s Battery Group was responsible for funding 50% of this additional trust funding requirement. As of June 30, 2024, following the elimination of an intercompany amount upon the closing of the Merger, the Company no longer had a balance related to the trust funding requirement. During the first quarter, the Company advanced $302,500 to G3 for transaction costs incurred during the Merger. The outstanding balance of other receivables amounted to $302,500 as of June 30, 2024. Inventory Inventories are stated at the lower of first -in -out -down Property and Equipment, net Property and equipment are recorded at cost less accumulated depreciation and amortization. Expenditures for maintenance and repairs, which do not extend the economic useful life of the related assets, are charged to operations as incurred, and expenditures, which extend the economic life, are capitalized. When assets are retired, or otherwise disposed of, the costs and related accumulated depreciation or amortization are removed from the accounts and any gain or loss on disposal is recognized. The Company assesses the carrying value of its property and equipment for impairment each year and when indicators exist that there could be an impairment. Based on its assessments, the Company did not incur any impairment charges for the three and six months ended June 30, 2024 and 2023. The Company depreciates its property and equipment for financial reporting purposes using the straight -line Building 40 years Leasehold improvements 15 years Machinery & equipment 5 years Depreciation expense of property and equipment was $68,416, $125,510, $64,515 and $156,871 for the three and six months ended June 30, 2024 and 2023, respectively. Patents The Company capitalizes external costs, such as filing fees and associated attorney fees, incurred to obtain issued patents. The Company’s intangible assets consist of capitalized costs for unissued patents and issued patents. Issued patents are carried at cost less accumulated amortization. Successful patent efforts are amortized over the life of the patent, and unsuccessful efforts are expensed. The issued patents are being amortized over a useful life of 20 years. Amortization of the patent costs commences upon patent issuance. Net unissued and issued patents were $1,081,011 and $857,680 as of June 30, 2024, respectively; and $1,103,792 and $748,857 as of December 31, 2023, respectively. The Company assesses the carrying value of its intangible assets for impairment each year and when indicators exist that there could be an impairment. Based on its assessments, the Company did not incur any impairment charges for the three and six months ended June 30, 2024 and 2023. Amortization expense of patents was $34,495, $71,793, $11,992 and $25,308 for the three and six months ended June 30, 2024 and 2023, respectively. Translation of Foreign Currencies The functional currency of Solidion’s Taiwan subsidiary is the New Taiwan Dollar. In accordance with Financial Accounting Standards Board (FASB) Accounting Standards Codification (ASC) 830, Foreign Currency Matters Revenue Recognition Revenue is recognized when a performance obligation has been satisfied by transferring control of promised products or services to customers in an amount that reflects the consideration the Company expects to receive in exchange for those products. Revenues are recognized at a point in time when control transfers to customers, which is generally determined when title, ownership and risk of loss pass to the customer. Research and Development All research and development costs are expensed as incurred. Selling, General and Administrative Expenses Selling, general and administrative expenses represent costs incurred by the Company in managing the business, including salary, benefits, stock -based -research Stock-Based Compensation The Company has an incentive equity plan, (“2023 Equity Incentive Plan”). Under the terms of the plan, Solidion’s employees, consultants and directors, and employees and consultants of its affiliates, may be eligible to receive awards in the form of incentive stock options (“ISOs”) to employees and for the grant of non -statutory The number of stocks of common stock initially reserved for issuance under the incentive plan will be 9,500,000. Stocks subject to stock awards granted under the incentive plan that expire or terminate without being exercised in full, or that are paid out in cash rather than in stocks, will not reduce the number of stocks available for issuance under the incentive plan. The incentive plan also includes an evergreen provision that provides for an automatic annual increase to the number of stocks of common stock available for issuance under the incentive plan on the first day of each fiscal year beginning with the 2024 fiscal year, equal to the least of (i) 9,500,000 stocks of common stock, (ii) 5% of the total number of stocks of common stock outstanding as of the last day of our immediately preceding fiscal year, or (iii) such lesser amount determined by the plan administrator. The Company measures stock options and restricted stock unit awards granted to employees, non -employees Generally, the Company issues stock options and restricted stock units with only service -based -line -based -based The fair value of each stock option grant is estimated on the date of grant using the Black -Scholes -pricing -specific The expected term of all of the Company’s stock options has been determined utilizing the “simplified” method. The risk -free Income Taxes Income taxes are recorded in accordance with ASC 740, Income Taxes (“ASC 740”), which provides for deferred taxes using an asset and liability approach. The Company recognizes deferred tax assets and liabilities for the expected future tax consequences of events that have been included in the financial statements or tax returns. Deferred tax assets and liabilities are determined based on the difference between the financial statement and tax basis of assets and liabilities using enacted tax rates in effect for the year in which the differences are expected to reverse. Valuation allowances are provided, if based upon the weight of available evidence, it is more likely than not that some or all of the deferred tax assets will not be realized. The Company accounts for uncertain tax positions in accordance with the provisions of ASC 740. When uncertain tax positions exist, the Company recognizes the tax benefit of tax positions to the extent that the benefit would more likely than not be realized assuming examination by the taxing authority. The determination as to whether the tax benefit will more likely than not be realized is based upon the technical merits of the tax position as well as consideration of the available facts and circumstances. The Company recognizes any interest and penalties accrued related to unrecognized tax benefits as income tax expense. Net Income (Loss) per Common Stock The Company complies with accounting and disclosure requirements of FASB ASC Topic 260, “ Earnings Per Share. The calculation of diluted income (loss) per share of common stock does not include potentially dilutive common stock equivalents if their include would be anti -dilutive The following table presents potentially dilutive common stock equivalents that have been excluded from the calculation of dilutive loss per share as their inclusion would be anti -dilutive June 30, 2024 December 31, 2023 HBC Holdback Shares 200,000 — Warrants – Public 6,175,000 — Warrants – Private 5,405,000 — Warrants – Series A 22,141,701 — Warrants – Series B 5,549,655 — Stock-based compensation – equity awards 300,000 — Forward Purchase Agreement – Additional Shares 8,038,537 — Convertible notes 3,396,261 — HBC Earnout Shares 22,500,000 — Total common stock equivalents excluded from dilutive loss per share 73,706,154 — The following table presents potentially dilutive common stock equivalents that have been included in the calculation of dilutive income per share for the three months ended June 30, 2024, as their inclusion would be dilutive. June 30, 2024 Warrants – Series B 5,549,655 Stock-based compensation – equity awards 300,000 Convertible notes 3,396,261 Total common stock equivalents included in dilutive income per share 9,245,916 Concentration of Credit Risk Financial instruments that potentially subject the Company to concentrations of credit risk consist of cash accounts in financial institutions, which, at times, may exceed the Federal Depository Insurance Coverage of $250,000. The Company has not experienced losses on these accounts. Fair Value of Financial Instruments Fair value is defined as the price that would be received for sale of an asset or paid to transfer of a liability, in an orderly transaction between market participants at the measurement date. US GAAP establishes a three -tier Warrants The Company accounts for warrants as either equity -classified -classified For issued or modified warrants that meet all of the criteria for equity classification, the warrants are required to be recorded as a component of additional paid -in -classified -classified -to-fixed Forward Purchase Agreement The Company accounts for the forward purchase agreement (“FPA”) as either equity -classified -classified For issued or modified FPA that meets all of the criteria for equity classification, the FPA is required to be recorded as a component of additional paid -in -classified Other Current Assets The composition of other current assets was: June 30, 2024 December 31, 2023 Directors & Officers Insurance 777,135 — Total other assets 777,135 — Other Assets The composition of other assets was: June 30, 2024 December 31, 2023 Directors & Officers Insurance 778,167 — Total other assets 778,167 — Recent Accounting Standards In December 2023, the FASB issued ASU 2023 -09 -09 -09 -09 In November 2023, the FASB issued Accounting Standards Update (ASU) 2023 -07 Management does not believe that any recently issued, but not yet effective, accounting standards, if currently adopted, would have a material effect on the Company’s financial statements.	NOTE 2 — SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Basis of Presentation and Principles of Consolidation The accompanying consolidated financial statements have been prepared in accordance with U.S. GAAP and pursuant to the rules and regulations of the Securities and Exchange Commission (“SEC”). The consolidated financial statements include the accounts of the Company and its subsidiaries. All intercompany transactions and balances have been eliminated. Emerging Growth Company The Company is an “emerging growth company,” as defined in Section 2(a) of the Securities Act of 1933, as amended (the “Securities Act”), as modified by the Jumpstart Our Business Startups Act of 2012, as amended (the “JOBS Act”), and it may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies including, but not limited to, not being required to comply with the independent registered public accounting firm attestation requirements of Section 404 of the Sarbanes -Oxley Further, Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that a company can elect to opt out of the extended transition period and comply with the requirements that apply to non -emerging Use of Estimates The preparation of financial statements in conformity with US GAAP requires the Company’s management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of expenses during the reporting period. Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the balance sheet which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. Accordingly, the actual results could differ significantly from those estimates. Cash and cash equivalents The Company considers all short -term Cash and investments held in Trust Account The funds held in Trust are invested only in U.S. government securities, within the meaning set forth in Section 2(a)(16) of the Investment Company Act, with a maturity of 185 days or less or in any open -ended -7 -interest Offering Costs associated with an Initial Public Offering The Company complies with the requirements of the Financial Accounting Standards Board (“FASB”) ASC 340 -10-S99-1 Expenses of Offering.” -allotment Class A ordinary shares subject to possible redemption The Company accounts for its Class A common stock subject to possible redemption in accordance with the guidance enumerated in ASC 480 “ Distinguishing Liabilities from Equity The Company recognizes changes in redemption value immediately as they occur and adjusts the carrying value of redeemable Class A common stock to equal the redemption value at the end of each reporting period. Immediately upon the closing of the Initial Public Offering, the Company recognized a measurement adjustment from initial book value to redemption amount value. The change in the carrying value of redeemable Class A ordinary shares resulted in charges against additional paid -in At December 31, 2023 and December 31, 2022, the Class A common stock subject to possible redemption reflected in the balance sheet is reconciled in the following table: Gross proceeds $ 123,500,000 Less: Proceeds allocated to Public Warrants (3,755,675 ) Class A common stock issuance costs (6,716,427 ) (10,472,102 ) Plus: Class A Common Stock Redeemable Remeasurement Adjustment at IPO 12,942,102 Remeasurement adjustment for the year ended December 31, 2022 1,272,983 Class A common stock subject to possible redemption as of December 31, 2022 127,242,983 Transfer to funds payable to redeemed Class A stockholders (17,834,235 ) Redemptions (89,038,494 ) Remeasurement adjustment for the year ended December 31, 2023 3,972,489 Class A common stock subject to possible redemption as of December 31, 2023 $ 24,342,743 Funds payable to redeemed Class A stockholders On December 14, 2023, the Company held a second special meeting of stockholders (the “Second Special Meeting”). In connection with the Second Special Meeting, stockholders elected to redeem an aggregate 1,625,876 Excise tax, if any, related to the redemption will be accrued on the date the funds are paid to the stockholders. Income Taxes The Company follows the asset and liability method of accounting for income taxes under ASC 740, “ Income Taxes ASC 740 prescribes a recognition threshold and a measurement attribute for the financial statement recognition and measurement of tax positions taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more likely than not to be sustained upon examination by taxing authorities. The Company recognizes accrued interest and penalties related to unrecognized tax benefits as income tax expense. There were no unrecognized tax benefits and no amounts accrued for interest and penalties as of December 31, 2023 and 2022. The Company is currently not aware of any issues under review that could result in significant payments, accruals or material deviation from its position. The Company is subject to income tax examinations by major taxing authorities since inception. The Company has identified the United States as its only “major” tax jurisdiction. The Company is subject to income taxation by major taxing authorities since inception. These examinations may include questioning the timing and amount of deductions, the nexus of income among various tax jurisdictions and compliance with federal and state tax laws. The Company’s management does not expect that the total amount of unrecognized tax benefits will materially change over the next twelve months. The IR Act imposes a 1% excise tax on the fair market value of stock repurchases made by covered corporations after December 31, 2022. The total taxable value of shares repurchased is reduced by the fair market value of and newly issued shares during the taxable year. Redemption rights are ubiquitous to nearly all SPACs. Stockholders have the ability to require the SPAC to repurchase their shares prior to the merger in what is known as a redemption right, essentially getting their money back. There are two possible scenarios in which redemption rights come into play. First, they can be exercised by the stockholders themselves because they are exiting the transaction, or second, they can be triggered because the SPAC did not find a target with which to merge. In connection with shareholder redemptions in 2023, the Company recorded an excise tax liability and equity adjustment of $0.9 Net Income (Loss) per Common Stock The Company complies with accounting and disclosure requirements of FASB ASC Topic 260, “ Earnings Per Share. -class The calculation of diluted income (loss) per share of common stock does not consider the effect of the warrants issued in connection with the (i) Initial Public Offering and (ii) the Private Placement since the exercise of the warrants is contingent upon the occurrence of future events. As of December 31, 2023 and 2022, the warrants are exercisable to purchase 11,580,000 Stockholders elected to redeem an aggregate 1,625,876 The following tables reflects the calculation of basic and diluted net income (loss) per common share (in dollars, except per share amounts): For the Class A Redeemable Common Stock Numerator: Income allocable to Class A Redeemable Common Stock $ 448,713 Denominator: Diluted weighted average shares outstanding 9,846,164 Diluted net income per share, Class A Redeemable Common Stock $ 0.05 Class A and Class B Non-Redeemable Common Stock Numerator: Income allocable to Class A and Class B Non-Redeemable Common Stock $ 145,192 Denominator: Diluted weighted average shares outstanding 3,185,962 Diluted net income per share, Class A and Class B Non-Redeemable Common Stock $ 0.05 Year ended Class A Redeemable Common Stock Numerator: Loss allocable to Class A Redeemable Common Stock $ (13,931,674 ) Denominator: Basic and diluted weighted average shares outstanding 7,654,886 Basic and diluted net loss per share, Class A Redeemable Common Stock $ (1.82 ) Class A and Class B Non-redeemable Common Stock Numerator: Loss allocable to Class A and Class B Non-Redeemable Common Stock $ (5,843,928 ) Denominator: Basic and diluted weighted average shares outstanding 3,211,000 Basic and diluted net loss per share, Class A and Class B Non-Redeemable Common Stock $ (1.82 ) Concentration of Credit Risk Financial instruments that potentially subject the Company to concentrations of credit risk consist of a cash account in a financial institution, which, at times, may exceed the Federal Depository Insurance Coverage of $250,000. The Company has not experienced losses on this account. Fair Value of Financial Instruments Fair value is defined as the price that would be received for sale of an asset or paid to transfer of a liability, in an orderly transaction between market participants at the measurement date. US GAAP establishes a three -tier Convertible Notes The Company accounts for convertible notes as either equity -classified -classified whether the convertible notes meet all of the requirements for equity classification under ASC 815, including whether the conversion feature are indexed to the Company’s own common shares. The Company has concluded that the convertible notes qualify for equity treatment. Warrants The Company accounts for warrants as either equity -classified -classified For issued or modified warrants that meet all of the criteria for equity classification, the warrants are required to be recorded as a component of additional paid -in -classified Forward Purchase Agreement and Non-Redemption Agreement The Company accounts for forward purchase agreement and non -redemption -classified -classified For issued or modified FPA and NRAs that meet all of the criteria for equity classification, the FPA and NRA are required to be recorded as a component of additional paid -in -classified Recent Accounting Standards In December 2023, the FASB issued ASU 2023 -09 -09 -09 -09 Management does not believe that any recently issued, but not yet effective, accounting standards, if currently adopted, would have a material effect on the Company’s financial statements.

Initial Public Offering

Initial Public Offering	12 Months Ended
	Dec. 31, 2023
Initial Public Offering [Abstract]
INITIAL PUBLIC OFFERING	NOTE 3 — INITIAL PUBLIC OFFERING Pursuant to the Initial Public Offering, the Company sold 11,000,000 Units at a price of $10.00 per Unit. Each Unit consists of one share of Class A common stock and one -half On March 15, 2022, the underwriters purchased an additional 1,350,000 Units pursuant to the partial exercise of the over -allotment

Private Placements

Private Placements	12 Months Ended
	Dec. 31, 2023
Private Placements [Line Items]
PRIVATE PLACEMENTS	NOTE 4 — PRIVATE PLACEMENTS The Sponsor purchased an aggregate of 5,000,000 Private Placement Warrants at a price of $1.00 per Private Placement Warrant, generating gross proceeds of $5,000,000, from the Company in private placements that occurred simultaneously with the closing of the Initial Public Offering. Each Private Placement Warrant is exercisable to purchase one share of Common stock at a price of $11.50 per share, subject to adjustment (see Note 7). The proceeds from the sale of the Private Placement Warrants were added to the net proceeds from the Initial Public Offering held in the Trust Account. If the Company does not complete a Business Combination within the Combination Period, the proceeds from the sale of the Private Placement Warrants held in the Trust Account will be used to fund the redemption of the Public Shares (subject to the requirements of applicable law) and the Private Placement Warrants will expire worthless. The Private Placement Warrants (including the Common stock issuable upon exercise of the Private Placement Warrants) will not be transferable, assignable or saleable until 30 days after the completion of an Initial Business Combination, subject to certain exceptions. On March 15, 2022, in connection with the exercise of the over -allotment

Related Parties

Related Parties	6 Months Ended	12 Months Ended
	Jun. 30, 2024	Dec. 31, 2023
Related Parties [Abstract]
RELATED PARTIES	NOTE 7 — RELATED PARTIES Capital Contributions from Global Graphene Group (“G3”) G3, a significant shareholder of the Company, infused capital resources into the business to cover operating expenses incurred prior to the close of the merger. The capital contributions from G3 included allocations for payroll, rent and facility costs, and professional services. The total capital contribution from G3 amounted to $487,273 and $1,592,095 for the period ended June 30, 2024 and 2023, respectively. Other Receivable As of December 31, 2023, the Company held an other receivable balance of $187,500 from Nubia. This balance originated from cash advances made by Global Graphene Group (“G3”) on behalf of the Battery Group, in connection with Nubia’s funding requirements for extensions of time in closing the Merger. Pursuant to the Merger Agreement, the Battery Group was responsible for funding 50% of this additional trust funding requirement. As of June 30, 2024, following the elimination of an intercompany amount upon the closing of the Merger, the Company no longer had a balance related to the trust funding requirement. During the first quarter, the Company advanced $302,500 to G3 for transaction costs incurred during the Merger. The outstanding balance of other receivables amounted to $302,500 as of June 30, 2024. Shared Services Agreement Effective February 2, 2024, the Company entered into a shared services agreement (the “SSA”) with G3, under which G3 agreed to provide certain services, including employees, office space and use of equipment, and the Company agreed to pay for such services on a monthly basis. The SSA is subject to typical conditions and may be terminated by either party upon written notice. The management and board continues to monitor the SSA and all other related party transactions to uphold transparency and protect shareholder interests. Expenses incurred related to the SSA were $76,521 for the period of February 2, 2024 to June 30, 2024. Amounts outstanding as of June 30, 2024 were $13,000. Due to Related Party During the merger closing process, G3 incurred certain transaction expenses that were due to be reimbursed by the Company after the Closing Date, as per the Business Combination Agreement. These expenses included legal, advisory and audit fees directly associated with facilitating the merger. The total amount due to G3 was $879,985 as of the Closing Date. Additionally, at the time of the merger close, the Company had an outstanding payable related to the monthly administrative services support fees due to Mach FM Corp, an affiliate of Mach FM Acquisitions LLC, the sponsor of Nubia. This fee covered office space, utilities, and secretarial and administrative support provided by Mach FM to support Nubia’s operating activities. The outstanding balance payable to Mach FM amounted to $88,979 as of the Closing Date. On April 29, 2024, the Company made a payment of $669,985 to reimburse G3 for Merger -related Contingent Consideration At Closing, the G3 Tax Lien has not been settled by G3 and as of June 30, 2024, the 200,000 Holdback Shares have not been issued. The contingent consideration represents a potential obligation that would become released only upon G3 settling its G3 Tax Lien. See Notes 4 and 8 for further discussion regarding Holdback Shares related to the G3 Tax Lien. As of the Closing Date, the Company recorded a fair value of $906,000 for the 200,000 Holdback Shares, which was accounted for as an equity transaction.	NOTE 5 — RELATED PARTIES Founder Shares On August 17, 2021, the Sponsor received 2,875,000 of the Company’s Class B common stock (the “Founder Shares”) for $25,000 paid for Company deferred offering costs. On March 10, 2022, the Company effectuated a 1.1 -for-1 -allotment -converted -allotment The holders of the Founder Shares have agreed, subject to limited exceptions, not to transfer, assign or sell any of the Founder Shares until the earlier to occur of: (A) one year after the completion of a Business Combination and (B) subsequent to a Business Combination, (x) if the last reported sale price of the Class A common stock equals or exceeds $12.00 per share (as adjusted for stock splits, stock capitalizations, reorganizations, recapitalizations and the like) for any 20 trading days within any 30 -trading Promissory Note — Sponsor On July 27, 2021, the Sponsor issued an unsecured promissory note to the Company (the “Promissory Note”), pursuant to which the Company may borrow up to an aggregate principal amount of $300,000. The Promissory Note is non -interest -interest As of December 31, 2023 and December 31, 2022, there was $1,297,500, and $125,341, respectively, outstanding under the Promissory Note. On January 29, 2024, the Promissory Notes with the Sponsor was amended such that the Promissory Note any or all of the unpaid principal upon consummation of the Company’s initial business combination was convertible into common shares at a conversion price of $1.00 per share. Convertible Note — Related party At various dates in the third and fourth quarters of 2023, the Company issued Convertible notes to related parties of $905,000 to meet our working capital requirements. As of December 31, 2023 and December 31, 2022, there was $905,000 and $0 in Convertible Notes from Related Parties outstanding. The convertible notes with related parties bear similar conditions to the promissory note — sponsor. Advances from Target On June 15, 2023, Honeycomb Battery Company advanced to the Company $62,500. On July 14, 2023, Honeycomb Battery Company advanced an additional $62,500. On August 15, 2023, Honeycomb Battery Company advanced an additional $62,500. As of December 31, 2023 and December 31, 2022, there was $187,500 and $0 Advances from Related Parties From time to time, affiliates of the Sponsor advance funds to the Company or pay expenses on behalf of the Company for formation and operating costs. These advances are due on demand and are non -interest $0 Letter Agreement between Nubia and Mach FM Acquisitions LLC On December 13, 2023, Nubia and the Sponsor entered into an agreement (the “Agreement”) wherein Nubia shall make a cash payment to the Sponsor in the amount of $7,250,000. In consideration for such payment, the Sponsor agreed to assume certain fees and expenses accrued by Nubia in connection with the transactions contemplated by the Merger Agreement. The payment is due at closing of the Merger Agreement and relates to the deferred underwriting commission of $4,322,500, which is included in the balance sheet as of December General and Administrative Services Commencing on the date of the Initial Public Offering, the Company has agreed to pay the Sponsor a total of $10,000 per month for office space, utilities and secretarial and administrative support. Upon completion of the Initial Business Combination or the Company’s liquidation, the Company will cease paying these monthly fees. During the year ended December 31, 2023 and December 31, 2022, the Company recorded $125,000 and $95,000, respectively, of expenses related to the agreement, respectively. As of December 31, 2023 and December 31, 2022, there was an outstanding balance of $79,481 and $0, respectively. Related Party Loans In order to finance transaction costs in connection with a Business Combination, the Sponsor or an affiliate of the Sponsor, or certain of the Company’s officers and directors may, but are not obligated to, loan the Company funds as may be required (“Working Capital Loans”). Such Working Capital Loans would be evidenced by promissory notes. The notes may be repaid upon completion of a Business Combination, without interest, or, at the lender’s discretion, up to $1,500,000 of the notes may be converted upon completion of a Business Combination into Warrants at a price of $1.00 per Warrant. Such Units would be identical to the Private Placement Warrants. In the event that a Business Combination does not close, the Company may use a portion of proceeds held outside the Trust Account to repay the Working Capital Loans but no proceeds held in the Trust Account would be used to repay the Working Capital Loans. As of December 31, 2023 and December 31, 2022, there were no amounts outstanding under the Working Capital Loans.

Commitments and Contingencies

Commitments and Contingencies	6 Months Ended	12 Months Ended
	Jun. 30, 2024	Dec. 31, 2023
Commitments and Contingencies [Abstract]
COMMITMENTS AND CONTINGENCIES	NOTE 8 — COMMITMENTS AND CONTINGENCIES From time to time, we may be involved in lawsuits, claims or legal proceedings that arise in the ordinary course of business. We accrue a contingent liability when it is probable that a liability has been incurred and the amount of loss can be reasonably estimated. Management believes that there are no claims against us for which the outcome is expected to have a material effect on our financial position, results of operations or cash flows. G3 Tax Lien The Internal Revenue Service has placed a federal tax lien on all the property and rights to property belonging to G3 which would include any proceeds from sale of property assets included in the financial statements of the Company. The lien relates to unpaid federal income taxes for 2017. Inclusive of interest, the balance owed is approximately $1,950,000 as of August 2024. As disclosed in Note 3, the Company and G3 included a provision in the Merger Agreement that adjusts the aggregate share consideration to be paid to the shareholders of HBC if the G3 Tax Lien is not released prior to closing. Specifically, 200,000 The G3 Tax Lien represents a potential obligation that would become payable only upon the sale of the building. As the timing and likelihood of such a sale are uncertain and there are no immediate plans to sell, the Company has not recorded a liability on the balance sheet for this contingent obligation. Should the Company decide to sell the building in the future, this lien may need to be settled from the proceeds of the sale, which could impact the net cash inflow from such a transaction. The Company will continue to monitor the situation and will recognize a liability in the financial statements if and when it becomes probable that the building will be sold and the lien will need to be satisfied. HBC Earnout Arrangement As noted in Note 1, in connection with the Merger, HBC shareholders are entitled to up to 22,500,000 -merger See Notes 4 and 8 for further discussion regarding the earnout related to the reverse capitalization transaction and HBC Holdback Shares related to the federal tax lien.	NOTE 6 — COMMITMENTS AND CONTINGENCIES Registration Rights The holders of the Founder Shares, Private Placement Warrants that may be issued upon conversion of Working Capital Loans (and any shares of common stock issuable upon the exercise of the Private Placement Warrants or warrants issued upon conversion of the Working Capital Loans and upon conversion of the Founder Shares) are entitled to registration rights pursuant to a registration rights agreement to be signed prior to or on the effective date of Initial Public Offering requiring the Company to register such securities for resale (in the case of the Founder Shares, only after conversion to shares of Class A common stock). The holders of these securities are entitled to make up to three demands, excluding short form registration demands, that the Company register such securities. In addition, the holders have certain “piggy -back -up Underwriting Agreement The Company granted the underwriters a 45 -day -allotments The underwriters were paid a cash underwriting discount of $0.10 per Unit, or $1,235,000 upon the closing of the Initial Public Offering. EF Hutton, division of Benchmark Investments, LLC, which is the representative of the underwriters in the Initial Public Offering, also received 123,500 -allotment On March 15, 2022, the underwriters purchased an additional 1,350,000 Units pursuant to the partial exercise of the over -allotment -allotment -50 -allotment -Scholes -allotment The Representative Shares have been deemed compensation by FINRA and are therefore subject to a lock -up

Stockholders_ Equity (Deficit)

Stockholders’ Equity (Deficit)	6 Months Ended	12 Months Ended
	Jun. 30, 2024	Dec. 31, 2023
Stockholders’ Equity (Deficit) [Abstract]
STOCKHOLDERS’ EQUITY (DEFICIT)	NOTE 9 — STOCKHOLDERS’ EQUITY (DEFICIT) Preferred Stock The Company is authorized to issue 2,000,000 no Common Stock The Company is authorized to issue 300,000,000 Equity Financing On March 13, 2024, Solidion entered into a private placement transaction (the “Private Placement”), pursuant to a Securities Purchase Agreement (the “Subscription Agreement”) with certain institutional investors (the “Purchasers”) for aggregate gross proceeds of $3,850,000. The issuance costs associated with the Private Placement, including fees to the placement agent and other expenses, totaled $522,867, of which $262,064 was allocated to the issuance of Private Placement common stock and 260,803 was allocated to the issuance of series A and B warrants. The Private Placement closed on March 15, 2024. As part of the Private Placement, the Company issued an aggregate of 5,133,332 units and pre -funded -funded	NOTE 7 — STOCKHOLDERS’ EQUITY (DEFICIT) Preferred Stock no Class A Common Stock Class B Common Stock -allotment -allotment -allotment Only holders of the Class B common stock will have the right to vote on the election of directors prior to the Business Combination. Holders of Class A common stock and holders of Class B common stock will vote together as a single class on all matters submitted to a vote of our stockholders except as otherwise required by law. In connection with our initial business combination, we may enter into a stockholders agreement or other arrangements with the stockholders of the target or other investors to provide for voting or other corporate governance arrangements that differ from those in effect upon completion of this offering. The shares of Class B common stock will automatically convert into Class A common stock at the time of a Business Combination, or earlier at the option of the holder, on a one -for-one -linked -outstanding -linked -linked Warrants five The Company will not be obligated to deliver any shares of Class A common stock pursuant to the exercise of a warrant and will have no obligation to settle such warrant exercise unless a registration statement under the Securities Act covering the issuance of the shares of Class A common stock issuable upon exercise of the warrants is then effective and a current prospectus relating to those shares of Class A common stock is available, subject to the Company satisfying its obligations with respect to registration, or a valid exemption from registration is available. No warrant will be exercisable for cash or on a cashless basis, and the Company will not be obligated to issue any shares to holders seeking to exercise their warrants, unless the issuance of the shares upon such exercise is registered or qualified under the securities laws of the state of residence of the exercising holder, or an exemption from registration is available. The Company has agreed that as soon as practicable after the closing of a Business Combination the Company will use its commercially reasonable efforts to file, and within 90 days following a Business Combination to have declared effective, a registration statement covering the issuance of the shares of Class A common stock issuable upon exercise of the warrants and to maintain a current prospectus relating to those shares of Class A common stock until the warrants expire or are redeemed. Notwithstanding the above, if the Class A common stock is at the time of any exercise of a warrant not listed on a national securities exchange such that it satisfies the definition of a “covered security” under Section 18(b)(1) of the Securities Act, the Company may, at its option, require holders of Public Warrants who exercise their warrants to do so on a “cashless basis” in accordance with Section 3(a) (9) of the Securities Act and, in the event the Company so elects, the Company will not be required to file or maintain in effect a registration statement, but will use its commercially reasonable efforts to register or qualify the shares under applicable blue sky laws to the extent an exemption is not available. Redemption of Warrants When the Price per Share of Class A Common Stock Equals or Exceeds $18.00 • • • -day • -trading If and when the warrants become redeemable by the Company, the Company may exercise its redemption right even if it is unable to register or qualify the underlying securities for sale under all applicable state securities laws. If the Company calls the Public Warrants for redemption, as described above, its management will have the option to require any holder that wishes to exercise the Public Warrants to do so on a “cashless basis,” as described in the warrant agreement. The exercise price and number of common stock issuable upon exercise of the Public Warrants may be adjusted in certain circumstances including in the event of a stock dividend, extraordinary dividend or recapitalization, reorganization, merger or consolidation. However, except as described below, the Public Warrants will not be adjusted for issuances of common stock at a price below its exercise price. Additionally, in no event will the Company be required to net cash settle the Public Warrants. If the Company is unable to complete a Business Combination within the Combination Period and the Company liquidates the funds held in the Trust Account, holders of Public Warrants will not receive any of such funds with respect to their Public Warrants, nor will they receive any distribution from the Company’s assets held outside of the Trust Account with respect to such Public Warrants. Accordingly, the Public Warrants may expire worthless. The Private Placement Warrants are identical to the Public Warrants underlying the Units being sold in the Initial Public Offering.

Forward Purchase Agreement and

Forward Purchase Agreement and Non Redemption Agreement	6 Months Ended	12 Months Ended
	Jun. 30, 2024	Dec. 31, 2023
Forward Purchase Agreement and Non Redemption Agreement [Abstract]
FORWARD PURCHASE AGREEMENT AND NON REDEMPTION AGREEMENT	NOTE 11 — FORWARD PURCHASE AGREEMENT, NON REDEMPTION AGREEMENT AND PRIVATE PLACEMENT FINANCING Forward Purchase Agreement On December 13, 2023, Nubia entered into an agreement with (i) Meteora Capital Partners, LP (“MCP”), (ii) Meteora Select Trading Opportunities Master, LP (“MSTO”), and (iii) Meteora Strategic Capital, LLC (“MSC” and, collectively with MCP and MSTO, “Seller” or “Forward Purchase Investors”) (the “Forward Purchase Agreement”). For purposes of the Forward Purchase Agreement, NUBI is referred to as the “Counterparty” prior to the consummation of the Merger, while Solidion Technology, Inc. (“Pubco”) is referred to as the “Counterparty” after the consummation of the Merger. Capitalized terms used herein but not otherwise defined shall have the meanings ascribed to such terms in the Forward Purchase Agreement. Pursuant to the terms of the Forward Purchase Agreement, Seller intends, but is not obligated, to, concurrently with the Closing pursuant to Seller’s FPA Funding Amount PIPE Subscription Agreement, purchase up to 9.9% of the total Class A ordinary shares, par value $0.0001 per share, of NUBI (“NUBI Shares”) outstanding following the closing of the Merger, as calculated by Seller (the “Purchased Amount”), less the number of NUBI Shares purchased by Seller separately from third parties through a broker in the open market (“Recycled Shares”). Seller will not be required to purchase an amount of NUBI Shares such that, following such purchase, that Seller’s ownership would exceed 9.9% of the total NUBI Shares outstanding immediately after giving effect to such purchase, unless Seller, at its sole discretion, waives such 9.9% ownership limitation. The Number of Shares subject to the Forward Purchase Agreement is subject to reduction following a termination of the Forward Purchase Agreement with respect to such shares as described under “Optional Early Termination” in the Forward Purchase Agreement. The Forward Purchase Agreement provides for a prepayment shortfall in an amount in U.S. dollars equal to 0.50% of the product of the Recycled Shares and the Initial Price (as defined below). As described below in Shortfall Sales, Seller in its sole discretion may sell Recycled Shares at any time following the Trade Date at any sales price without payment by Seller of any Early Termination Obligation until such time as the proceeds from such sales equal 100% of the Prepayment Shortfall (as set forth under Shortfall Sales below) (such sales, “Shortfall Sales,” and such Shares, “Shortfall Sale Shares”). A sale of Shares is only (a) a “Shortfall Sale,” subject to the terms and conditions herein applicable to Shortfall Sale Shares, when a Shortfall Sale Notice is delivered under the Forward Purchase Agreement, and (b) an Optional Early Termination, subject to the terms and conditions of the Forward Purchase Agreement applicable to Terminated Shares, when an OET Notice is delivered under the Forward Purchase Agreement, in each case with the delivery of such notice being in the sole discretion of Seller (as further described in the “Optional Early Termination” and “Shortfall Sales” sections in the Forward Purchase Agreement). The Forward Purchase Agreement provides that Seller will be paid directly an aggregate cash amount (the “Prepayment Amount”) equal to (a) the sum of (i) the Number of Shares as set forth in a Pricing Date Notice, plus (ii) number of Recycled Shares multiplied by the redemption price per share (the “Initial Price”) as defined in Section 9.2(b) of NUBI’s Certificate of Incorporation, effective as of March 10, 2023, and as amended from time to time (the “Certificate of Incorporation”), less (b) the Prepayment Shortfall. The Counterparty will pay to Seller the Prepayment Amount required under the Forward Purchase Agreement directly from the Counterparty’s Trust Account maintained by Continental Stock Transfer and Trust Company holding the net proceeds of the sale of the units in the Counterparty’s initial public offering and the sale of private placement warrants (the “Trust Account”), no later than the earlier of (a) one Local Business Day after the Closing Date and (b) the date any assets from the Trust Account are disbursed in connection with the Merger; except that to the extent that the Prepayment Amount is to be paid from the purchase of Additional Shares by Seller, such amount will be netted against such proceeds, with Seller being able to reduce the purchase price for the Additional Shares by the Prepayment Amount. For the avoidance of doubt, any Additional Shares purchased by Seller will be included in the Number of Shares under the Forward Purchase Agreement for all purposes, including for determining the Prepayment Amount. In addition to the Prepayment Amount, Counterparty shall pay directly from the Trust Account, on the Prepayment Date, an amount equal to the product of (x) up to 200,000 (with such final amount to be determined by Seller in its sole discretion via written notice to Counterparty) and (y) the Initial Price. Following the Closing, the reset price (the “Reset Price”) will initially be the Initial Price. The Reset Price will be subject to reset on a bi -weekly From time to time and on any date following the Trade Date (any such date, an “OET Date”) and subject to the terms and conditions in the Forward Purchase Agreement, Seller may, in its absolute discretion, terminate the Transaction in whole or in part by providing written notice to the Counterparty (the “OET Notice”), by the later of (a) the fifth Local Business Day following the OET Date and (b) the next Payment Date following the OET Date (which shall specify the quantity by which the Number of Shares shall be reduced (such quantity, the “Terminated Shares”)). The effect of an OET Notice shall be to reduce the Number of Shares by the number of Terminated Shares specified in such OET Notice with effect as of the related OET Date. As of each OET Date, the Counterparty shall be entitled to an amount from Seller, and Seller shall pay to the Counterparty an amount, equal to the product of (x) the number of Terminated Shares and (y) the Reset Price in respect of such OET Date. The payment date may be changed within a quarter at the mutual agreement of the parties. The valuation date will be the earliest to occur of (a) the date that is three (3) years after the date of the closing of the Merger (the date of the closing of the Merger, the “Closing Date”) pursuant to the Merger Agreement, (b) the date specified by Seller in a written notice to be delivered to Counterparty at Seller’s discretion (which Valuation Date shall not be earlier than the day such notice is effective) after the occurrence of any of (v) a Shortfall Variance Registration Failure, (w) a VWAP Trigger Event, (x) a Delisting Event, (y) a Registration Failure or (z) unless otherwise specified therein, any Additional Termination Event, and (c) the date specified by Seller in a written notice to be delivered to the Counterparty at Seller’s sole discretion (which Valuation Date shall not be earlier than the day such notice is effective). The Valuation Date notice will become effective immediately upon its delivery from Seller to the Counterparty in accordance with the Forward Purchase Agreement. In the event the Valuation Date is determined pursuant to clause (c), the Settlement Amount Adjustment will not apply to the calculation of the Settlement Amount. On the Cash Settlement Payment Date, which is the tenth Local Business Day immediately following the last day of the Valuation Period, Seller will remit to the Counterparty an amount equal to the Settlement Amount and will not otherwise be required to return to the Counterparty any of the Prepayment Amount and the Counterparty shall remit to Seller the Settlement Amount Adjustment; provided that, if the Settlement Amount less the Settlement Amount Adjustment is a negative number, then neither Seller nor the Counterparty shall be liable to the other party for any payment under the “Cash Settlement Payment” Date section of the Forward Purchase Agreement. Under certain circumstances, the Company would be required to settle in shares or cash at the discretion of the Company. Seller has agreed to waive any redemption rights with respect to the Recycled Shares in connection with the Merger as well as any redemption rights under NUBI’s Certificate of Incorporation that would require redemption by NUBI of the NUBI Shares. Such waiver may reduce the number of NUBI Shares redeemed in connection with the Merger, and such reduction could alter the perception of the potential strength of the Merger. The Forward Purchase Agreement has been structured, and all activity in connection with such agreement has been undertaken, to comply with the requirements of all tender offer regulations applicable to the Merger, including Rule 14e -5 On February 2, 2024, upon consummation of the Merger, NUBI made a payment to each Forward Purchase Investor in respect of their respective Recycled Shares. This payment totaled 7,352 On January 17, 2024, the Company received a Pricing Date Notice from the Forward Purchase Investors specifying 5,838,537 Additional Shares. On March 22, 2024, the Company received an amended Pricing Date Notice revising the total number of Additional Shares to 8,038,537. On June 11, 2024 the Company received an amended Pricing Date Notice revising the total number of Additional Shares to 9,543,002. As of June 30, 2024, the Additional Shares had not been issued to the Forward Purchase Investors. On July 17, 2024, plaintiffs Meteora Capital Partners LP, Meteora Select Trading Opportunities Master LP and Meteora Strategic Capital LLC brought a lawsuit against Solidion in Delaware Chancery Court seeking specific performance and monetary damages related to the Forward Purchase Agreement. As a result of the ongoing legal proceedings, the Company expects to receive an amended Pricing Date Notice, which will revise the total number of Additional Shares to 8,996,779. This anticipated revision has been considered in the fair valuation of the related financial instrument. For further details, refer to Note 16 — Subsequent Events. Additionally, the fair value measurement of this instrument, reflecting the anticipated outcome, is discussed in Note 15 — Fair Value Measurements. The Company used a Monte Carlo analysis to determine the fair value of the FPA, assuming a total number of Additional Shares of 8,996,779. The model measured the total present value of the Company’s proceeds at approximately $216,967 and the total present value of the Company’s liability at approximately $5,032,777, resulting in a net liability of approximately $4,815,800 as of June 30, 2024. In the event the total number of Additional Shares is 9,543,002, as contemplated in the Pricing Date Notice dated June 11, 2024, the total present value of the Company’s proceeds would change to $245,051, and the total present value of the Company’s liability would change to $5,403,534, resulting in a net liability of approximately $5,158,483. Non-Redemption Agreement On December 13, 2023, NUBI entered into a non -redemption -Redemption -Redemption -Redemption outstanding NUBI Shares, and shall not elect to redeem or otherwise tender or submit for redemption any of such Backstop Shares in connection with the second special meeting of NUBI stockholders to be held for the purpose of approving the Merger (the “Second Special Meeting”); provided, however, that in the event Backstop Investor has previously elected to redeem, tender or submit any Backstop Shares for redemption, Backstop Investor shall rescind or reverse such redemption request prior to Closing and NUBI shall accept such request(s) promptly once submitted by Backstop Investor. On February 2, 2024, upon consummation of the Merger, NUBI paid to each Backstop Investor a payment in respect of its respective Backstop Shares a payment in cash released from the Trust Account in an amount equal to the product of (x) the number of Backstop Shares and (y) the Redemption Price, less $4.00. The total cash payment paid to Backstop Investors was $13,937,997 released from the trust account. Private Placement Financing On March 13, 2024, the Company entered into a private placement transaction (the “Private Placement”), pursuant to a Securities Purchase Agreement (the “Subscription Agreement”) with certain institutional investors (the “PIPE Investors”) for aggregate gross proceeds of approximately $3.85 million, before deducting fees to the placement agent and other expenses payable by the Company in connection with the Private Placement. The Company intends to use the net proceeds from the Private Placement for working capital and general corporate purposes. EF Hutton, LLC, acted as the exclusive placement agent for the Private Placement. The Private Placement closed on March 15, 2024. As part of the Private Placement, the Company issued an aggregate of 5,133,332 units and pre -funded -funded -funded -Funded -Funded The Pre -Funded -dilution th th In connection with the Private Placement, the Company entered into a registration rights agreement with the PIPE Investors, dated as of March 13, 2024 (the “Registration Rights Agreement”), pursuant to which the Company agreed to file a registration statement with the SEC covering the resale of the shares of common stock issued pursuant to the Securities Purchase Agreement and the common stock issuable upon exercise of the Warrants. The Company filed a registration statement with the SEC pursuant to the Registration Rights Agreement on April 15, 2024. The registration statement has been declared effective by the SEC on June 17, 2024. Reset Period The reset period ended on July 2, 2024 (the “Reset Date”), with the lowest 10 -day	NOTE 8 — FORWARD PURCHASE AGREEMENT AND NON REDEMPTION AGREEMENT Forward Purchase Agreement On December 13, 2023, Nubia entered into an agreement with (i) Meteora Capital Partners, LP (“MCP”), (ii) Meteora Select Trading Opportunities Master, LP (“MSTO”), and (iii) Meteora Strategic Capital, LLC (“MSC” and, collectively with MCP and MSTO, “Seller” or “Forward Purchase Investors”) (the “Forward Purchase Agreement”). For purposes of the Forward Purchase Agreement, NUBI is referred to as the “Counterparty” prior to the consummation of the Business Combination, while Solidion Technology, Inc. (“Pubco”) is referred to as the “Counterparty” after the consummation of the Business Combination. Capitalized terms used herein but not otherwise defined shall have the meanings ascribed to such terms in the Forward Purchase Agreement. Pursuant to the terms of the Forward Purchase Agreement, Seller intends, but is not obligated, to, concurrently with the Closing pursuant to Seller’s FPA Funding Amount PIPE Subscription Agreement, purchase up to 9.9% of the total Class A ordinary shares, par value $0.0001 per share, of NUBI (“NUBI Shares”) outstanding following the closing of the Business Combination, as calculated by Seller (the “Purchased Amount”), less the number of NUBI Shares purchased by Seller separately from third parties through a broker in the open market (“Recycled Shares”). Seller will not be required to purchase an amount of NUBI Shares such that, following such purchase, that Seller’s ownership would exceed 9.9% of the total NUBI Shares outstanding immediately after giving effect to such purchase, unless Seller, at its sole discretion, waives such 9.9% ownership limitation. The Number of Shares subject to the Forward Purchase Agreement is subject to reduction following a termination of the Forward Purchase Agreement with respect to such shares as described under “Optional Early Termination” in the Forward Purchase Agreement. The Forward Purchase Agreement provides for a prepayment shortfall in an amount in U.S. dollars equal to 0.50% of the product of the Recycled Shares and the Initial Price (as defined below). As described below in Shortfall Sales, Seller in its sole discretion may sell Recycled Shares at any time following the Trade Date at any sales price without payment by Seller of any Early Termination Obligation until such time as the proceeds from such sales equal 100% of the Prepayment Shortfall (as set forth under Shortfall Sales below) (such sales, “Shortfall Sales,” and such Shares, “Shortfall Sale Shares”). A sale of Shares is only (a) a “Shortfall Sale,” subject to the terms and conditions herein applicable to Shortfall Sale Shares, when a Shortfall Sale Notice is delivered under the Forward Purchase Agreement, and (b) an Optional Early Termination, subject to the terms and conditions of the Forward Purchase Agreement applicable to Terminated Shares, when an OET Notice is delivered under the Forward Purchase Agreement, in each case with the delivery of such notice being in the sole discretion of Seller (as further described in the “Optional Early Termination” and “Shortfall Sales” sections in the Forward Purchase Agreement). The Forward Purchase Agreement provides that Seller will be paid directly an aggregate cash amount (the “Prepayment Amount”) equal to (a) the sum of (i) the Number of Shares as set forth in a Pricing Date Notice, plus (ii) number of Recycled Shares multiplied by the redemption price per share (the “Initial Price”) as defined in Section 9.2(b) of NUBI’s Certificate of Incorporation, effective as of March 10, 2023, and as amended from time to time (the “Certificate of Incorporation”), less (b) the Prepayment Shortfall. The Counterparty will pay to Seller the Prepayment Amount required under the Forward Purchase Agreement directly from the Counterparty’s Trust Account maintained by Continental Stock Transfer and Trust Company holding the net proceeds of the sale of the units in the Counterparty’s initial public offering and the sale of private placement warrants (the “Trust Account”), no later than the earlier of (a) one Local Business Day after the Closing Date and (b) the date any assets from the Trust Account are disbursed in connection with the Business Combination; except that to the extent that the Prepayment Amount is to be paid from the purchase of Additional Shares by Seller, such amount will be netted against such proceeds, with Seller being able to reduce the purchase price for the Additional Shares by the Prepayment Amount. For the avoidance of doubt, any Additional Shares purchased by Seller will be included in the Number of Shares under the Forward Purchase Agreement for all purposes, including for determining the Prepayment Amount. In addition to the Prepayment Amount, Counterparty shall pay directly from the Trust Account, on the Prepayment Date, an amount equal to the product of (x) up to 200,000 (with such final amount to be determined by Seller in its sole discretion via written notice to Counterparty) and (y) the Initial Price. Following the Closing, the reset price (the “Reset Price”) will initially be the Initial Price. The Reset Price will be subject to reset on a bi -weekly From time to time and on any date following the Trade Date (any such date, an “OET Date”) and subject to the terms and conditions in the Forward Purchase Agreement, Seller may, in its absolute discretion, terminate the Transaction in whole or in part by providing written notice to the Counterparty (the “OET Notice”), by the later of (a) the fifth Local Business Day following the OET Date and (b) the next Payment Date following the OET Date (which shall specify the quantity by which the Number of Shares shall be reduced (such quantity, the “Terminated Shares”)). The effect of an OET Notice shall be to reduce the Number of Shares by the number of Terminated Shares specified in such OET Notice with effect as of the related OET Date. As of each OET Date, the Counterparty shall be entitled to an amount from Seller, and Seller shall pay to the Counterparty an amount, equal to the product of (x) the number of Terminated Shares and (y) the Reset Price in respect of such OET Date. The payment date may be changed within a quarter at the mutual agreement of the parties. The valuation date will be the earliest to occur of (a) the date that is three (3) years after the date of the closing of the Business Combination (the date of the closing of the Business Combination, the “Closing Date”) pursuant to the Merger Agreement, (b) the date specified by Seller in a written notice to be delivered to Counterparty at Seller’s discretion (which Valuation Date shall not be earlier than the day such notice is effective) after the occurrence of any of (v) a Shortfall Variance Registration Failure, (w) a VWAP Trigger Event, (x) a Delisting Event, (y) a Registration Failure or (z) unless otherwise specified therein, any Additional Termination Event, and (c) the date specified by Seller in a written notice to be delivered to the Counterparty at Seller’s sole discretion (which Valuation Date shall not be earlier than the day such notice is effective). The Valuation Date notice will become effective immediately upon its delivery from Seller to the Counterparty in accordance with the Forward Purchase Agreement. In the event the Valuation Date is determined pursuant to clause (c), the Settlement Amount Adjustment will not apply to the calculation of the Settlement Amount. On the Cash Settlement Payment Date, which is the tenth Local Business Day immediately following the last day of the Valuation Period, Seller will remit to the Counterparty an amount equal to the Settlement Amount and will not otherwise be required to return to the Counterparty any of the Prepayment Amount and the Counterparty shall remit to Seller the Settlement Amount Adjustment; provided that, if the Settlement Amount less the Settlement Amount Adjustment is a negative number, then neither Seller nor the Counterparty shall be liable to the other party for any payment under the “Cash Settlement Payment” Date section of the Forward Purchase Agreement. Seller has agreed to waive any redemption rights with respect to any Recycled Shares in connection with the Business Combination, as well as any redemption rights under NUBI’s Certificate of Incorporation that would require redemption by NUBI of the NUBI Shares. Such waiver may reduce the number of NUBI Shares redeemed in connection with the Business Combination, and such reduction could alter the perception of the potential strength of the Business Combination. The Forward Purchase Agreement has been structured, and all activity in connection with such agreement has been undertaken, to comply with the requirements of all tender offer regulations applicable to the Business Combination, including Rule 14e -5 The derivative liabilities includes the FPA and NRA of $35,576,596 and $11,152,000, respectively at December 31, 2023. The derivative asset relates to the FPA at December Non-Redemption Agreement On December 13, 2023, NUBI entered into a non -redemption -Redemption -Redemption -Redemption Upon consummation of the business combination, NUBI shall pay or cause to be paid to each Backstop Investor a payment in respect of its respective Backstop Shares a payment in respect of Backstop Shares in cash released from the Trust Account in an amount equal to the product of (x) the number of Backstop Shares and (y) the Redemption Price, less $4.00.

Fair Value Measurements

Fair Value Measurements	6 Months Ended	12 Months Ended
	Jun. 30, 2024	Dec. 31, 2023
Fair Value Measurements [Abstract]
FAIR VALUE MEASUREMENTS	NOTE 15 — FAIR VALUE MEASUREMENTS The Company follows the guidance in ASC 820 for its financial assets and liabilities that are re -measured -financial -measured The fair value of the Company’s financial assets and liabilities reflects management’s estimate of amounts that the Company would have received in connection with the sale of the assets or paid in connection with the transfer of the liabilities in an orderly transaction between market participants at the measurement date. In connection with measuring the fair value of its assets and liabilities, the Company seeks to maximize the use of observable inputs (market data obtained from independent sources) and to minimize the use of unobservable inputs (internal assumptions about how market participants would price assets and liabilities). The following fair value hierarchy is used to classify assets and liabilities based on the observable inputs and unobservable inputs used in order to value the assets and liabilities: Level 1 — quoted prices in active markets for identical assets or liabilities. An active market for an asset or liability is a market in which transactions for the asset or liability occur with sufficient frequency and volume to provide pricing information on an ongoing basis. Level 2 observable inputs other than Level 1 inputs. Examples of Level 2 inputs include quoted prices in active markets for similar assets or liabilities and quoted prices for identical assets or liabilities in markets that are not active. Level 3 unobservable inputs based on our assessment of the assumptions that market participants would use in pricing the asset or liability. The following table presents information about the Company’s liabilities that are measured at fair value at June 30, 2024 and December 31, 2023, and indicates the fair value hierarchy of the valuation inputs the Company utilized to determine such fair value: Description: Level June 30, December 31, Derivative Liabilities: Forward purchase agreement 3 $ 4,815,800 $ — Warrants – Series A and B 3 $ 12,028,950 $ — Forward purchase agreement The Company used a Monte Carlo analysis to determine the fair value of the FPA, assuming a total number of Additional Shares of 8,996,779. The model measured the total present value of the Company’s proceeds at approximately $216,967 and the total present value of the Company’s liability at approximately $5,032,777, resulting in a net liability of approximately $4,815,800 as of June 30, 2024. The fair value measurement of the FPA at February 2, 2024 and June 30, 2024, was calculated using the following range of weighted average assumptions: June 30, February 2, Risk-free interest rate 4.60 % 4.14 % Stock price $ 0.55 $ 4.53 Expected life 2.4 years 2.8 years Expected volatility of underlying stock 100 % 70.0 % Dividends 0 % 0 % In the event the total number of Additional Shares is 9,543,002, as contemplated in the Pricing Date Notice dated June 11, 2024, the total present value of the Company’s proceeds would change to $245,051, and the total present value of the Company’s liability would change to $5,403,534, resulting in a net liability of approximately $5,158,483. See Note 11 for further discussion on Additional Shares on the FPA instrument. Warrants — Series A and B The Company utilized a Monte Carlo simulation analysis to determine the fair value of the Series C Warrants and Series D Warrants at the date of issuance (March 15, 2024), which included the following assumptions: Series A Warrants Series B Warrants Expected term (in years) 5.7 years 5.7 years Stock price $ 1.74 $ 1.74 Risk free rate 4.2 % 4.2 % Expected volatility 82.5 % 82.5 % Expected dividend rate $ 0.00 $ 0.00 Exercise Price $ 0.75 $ 0.0001 The Company utilized a Monte Carlo simulation analysis to determine the fair value of the Series C Warrants and Series D Warrants at June 30, 2024, which included the following assumptions: Series A Warrants Series B Warrants Expected term (in years) 5.4 years 5.4 years Stock price $ 0.55 $ 0.55 Risk free rate 4.2 % 4.2 % Expected volatility 110 % 110 % Expected dividend rate $ 0.00 $ 0.00 Exercise Price $ 0.348 $ 0.0001 The fair value of the Series C Warrants and Series D Warrants as of June 30, 2024, was $9,139,200 and $2,889,750, respectively. This resulted in a gain (loss) from the change in fair value of derivatives and issuance of warrants of $9,141,900, $710,050, $0, and $(17,820,998) for the three and six months ended June 30, 2024, respectively. As of June 30, 2024, investors received 0 and 199,943 common shares from exercise of Series A and Series D Warrants, respectively. The table below provides a summary of the changes in fair value, including net transfers in and/or out, of all financial assets and liabilities measured at fair value on a recurring basis using significant unobservable inputs (Level 3) during the six months ended June 30, 2024. Forward purchase agreement Fair Value Balance, December 31, 2023 $ — Initial measurement, February 2, 2024 20,889,950 Change in fair value (249,350 ) Balance, March 31, 2024 20,640,600 Change in fair value (15,824,800 ) Balance, June 30, 2024 4,815,800 Warrants — Series A and B Fair Value Balance, December 31, 2023 $ — Initial measurement, March 15, 2024 12,739,000 Change in fair value 8,431,850 Balance, March 31, 2024 21,170,850 Change in fair value (9,141,900 ) Balance, June 30, 2024 12,028,950 HBC earnout shares The Company utilized a Monte Carlo simulation analysis to determine the fair value of the Earnout Shares at the date of the Merger, which included the following assumptions: stock price of $4.53, risk free rate of 3.98%, volatility of 85%, dividends yield of 0% and duration of 4 years.	NOTE 9 — FAIR VALUE MEASUREMENTS The Company follows the guidance in ASC 820 for its financial assets and liabilities that are re -measured -financial -measured The fair value of the Company’s financial assets and liabilities reflects management’s estimate of amounts that the Company would have received in connection with the sale of the assets or paid in connection with the transfer of the liabilities in an orderly transaction between market participants at the measurement date. In connection with measuring the fair value of its assets and liabilities, the Company seeks to maximize the use of observable inputs (market data obtained from independent sources) and to minimize the use of unobservable inputs (internal assumptions about how market participants would price assets and liabilities). The following fair value hierarchy is used to classify assets and liabilities based on the observable inputs and unobservable inputs used in order to value the assets and liabilities: Level 1 quoted prices in active markets for identical assets or liabilities. An active market for an asset or liability is a market in which transactions for the asset or liability occur with sufficient frequency and volume to provide pricing information on an ongoing basis. Level 2 observable inputs other than Level 1 inputs. Examples of Level 2 inputs include quoted prices in active markets for similar assets or liabilities and quoted prices for identical assets or liabilities in markets that are not active. Level 3 unobservable inputs based on our assessment of the assumptions that market participants would use in pricing the asset or liability. The following table presents information about the Company’s assets and liabilities that are measured at fair value at December 31, 2023 and December 31, 2022, and indicates the fair value hierarchy of the valuation inputs the Company utilized to determine such fair value: Description: Level December 31, December 31, Assets: Cash and investments held in Trust Account 1 $ 42,994,274 $ 127,782,882 Derivative asset 3 $ 28,245,500 $ — Derivative liabilities 3 $ 46,728,596 $ — The derivative liabilities includes the FPA and NRA of $35,576,596 and $11,152,000, respectively at December The Company used a Monte Carlo analysis to determine the fair value of the FPA and NRA. The fair value measurement of the FPA and the NRA liability at December 31, 2023, was calculated using the following range of weighted average assumptions: December 31, Risk-free interest rate (FPA) 3.85 % Expected life of over-allotment option (FPA) 5.4 years Expected volatility of underlying stock (FPA) 75 % Dividends (FPA) 0 % Probability of merger closing (FPA and NRA) 80 % The 123,500 Representative Shares have a grant date fair value of $6.29 per share or an aggregate of $776,815. The Company measured the fair value of the Representative Shares on the grant date of the award utilizing a valuation model which considers certain assumptions. These assumptions include the offering price, the marketability of the Company and the probability of initial business combination, which were considered Level 3 inputs. Upon the Initial Public Offering, such amounts were allocated to offering costs within stockholders’ equity (deficit).

Income Taxes

Income Taxes	6 Months Ended	12 Months Ended
	Jun. 30, 2024	Dec. 31, 2023
Income Taxes [Abstract]
INCOME TAXES	NOTE 13 — INCOME TAXES The Company provides for income taxes using the asset and liability approach. Deferred tax assets and liabilities are recorded based on the differences between the financial statement and tax bases of assets and liabilities and the tax rates in effect when these differences are expected to reverse. Deferred tax assets are reduced by a valuation allowance if, based on the weight of available evidence, it is more likely than not that some or all of the deferred tax assets will not be realized. As of June 30, 2024, and December 31, 2023, the Company had a full valuation allowance against its deferred tax assets. For the three and six months ended June 30, 2024 and 2023, the Company utilized the annualized effective tax rate method and recorded zero zero No -tax -tax	NOTE 10 — INCOME TAXES The Company’s deferred tax assets are as follows at December 31, 2023 and 2022: December 31, December 31, Deferred tax asset Net operating loss $ — $ — Startup/organizational costs 369,290 147,881 Total deferred tax asset 369,290 147,881 Valuation allowance (369,290 ) (147,881 ) Deferred tax asset, net of allowance $ — $ — The income tax provision (benefit) consists of the following for the year December 31, 2023 and December 31, 2022: December 31, December 31, Federal Current $ 1,579,608 $ 339,899 Deferred — — State and Local Current — — Deferred — — Income tax provision/(benefit) $ 1,579,608 $ 339,899 In assessing the realization of the deferred tax assets, management considers whether it is more likely than not that some portion of all of the deferred tax assets will not be realized. The ultimate realization of deferred tax assets is dependent upon the generation of future taxable income during the periods in which temporary differences representing net future deductible amounts become deductible. Management considers the scheduled reversal of deferred tax liabilities, projected future taxable income and tax planning strategies in making this assessment. After consideration of all of the information available, management believes that significant uncertainty exists with respect to future realization of the deferred tax assets and has therefore established a full valuation allowance. For the year ended December 31, 2023 and 2022, the change in the valuation allowance was $221,409 and $147,481, respectively. A reconciliation of the statutory tax rate to the Company’s effective tax rates for the year ended December 31, 2023 and 2022: Year Ended Year Ended Statutory federal income tax rate 21.00 % 21.00 % State taxes, net of federal tax benefit — — Merger costs (2.60 ) — Derivatives (8.46 ) Other (0.04 ) (0.44 ) Change in valuation allowance (1.22 ) 15.84 Income tax provision (benefit) 8.68 % 36.40 %

Subsequent Events

Subsequent Events	6 Months Ended	12 Months Ended
	Jun. 30, 2024	Dec. 31, 2023
Subsequent Events [Abstract]
SUBSEQUENT EVENTS	NOTE 16 — SUBSEQUENT EVENTS The Company evaluated subsequent events and transactions that occurred after the balance sheet date up to the date that the financial statements were issued. The Company did not identify any subsequent events, except as noted below, that would have required adjustment or disclosure in the financial statements. Meteora Legal Proceedings On July 17, 2024, plaintiffs Meteora Capital Partners LP, Meteora Select Trading Opportunities Master LP and Meteora Strategic Capital LLC brought a lawsuit against Solidion in Delaware Chancery Court seeking specific performance and monetary damages related to the Forward Purchase Agreement. Solidion disagrees with the Plaintiff’s interpretation of the agreement and plans to vigorously defend itself. See Note 11 for further discussion on the Forward Purchase Agreement instrument.	NOTE 11 — SUBSEQUENT EVENTS The Company evaluated subsequent events and transactions that occurred after the balance sheet date up to the date that the financial statements were issued. The Company did not identify any subsequent events, except as noted below, that would have required adjustment or disclosure in the financial statements. On February 2, 2024 (the “Closing Date”), the Company consummated the business combination (the “Closing”) pursuant to a Merger Agreement, dated February 16, 2023 (as amended on August 25, 2023, the “Merger Agreement”) with HBC surviving such merger as a wholly owned subsidiary of Nubia, which was renamed “Solidion Technology, Inc.” upon Closing. On February 5, 2024, our Common Stock continued trading on the Nasdaq Global Market under the symbol “STI”. Furthermore, on the same date, the Company’s Public Warrants, previously listed under ticker “NUBIW”, were delisted from the Nasdaq. Stockholders elected to redeem an aggregate 1,625,876 or shares of Common Stock in connection with the Second Special Meeting held on December 14, 2023. The funds of $17,834,235 are due and payable to the redeeming stockholders on the earlier of the closing of the business combination or the liquidation date. The funds were transferred to the stockholders upon closing of the business combination on February 2, 2024. On January 29, 2024, the Promissory Notes with the Sponsor was amended such that the Promissory Note any or all of the unpaid principal upon consummation of the Company’s initial business combination was convertible into common shares at a conversion price of $1.00 per share. On February 1, 2024, the Company executed a promissory note with EF Hutton, totaling $2,200,000, to cover underwriters’ fees associated with the closure of the business combination with Honeycomb. The principal amount of this Note is payable on designated dates, with $183,333 due on April 1, 2024, and subsequent payments of the same amount scheduled on the first business day of each following month until the final payment on March 1, 2025. On March 13, 2024, Solidion entered into a private placement transaction (the “Private Placement”), pursuant to a Securities Purchase Agreement (the “Subscription Agreement”) with certain institutional investors (the “Purchasers”) for aggregate gross proceeds of approximately $3.85 million, before deducting fees to the placement agent and other expenses payable by the Company in connection with the Private Placement. The Company intends to use the net proceeds from the Private Placement for working capital and general corporate purposes. The Private Placement closed on March 15, 2024. As part of the Private Placement, the Company issued an aggregate of 5,133,332 units and pre -funded -funded -funded

Restatement of Previously Issue

Restatement of Previously Issued Financial Statements	6 Months Ended
	Jun. 30, 2024
Restatement of Previously Issued Financial Statements [Abstract]
RESTATEMENT OF PREVIOUSLY ISSUED FINANCIAL STATEMENTS	NOTE 2 — RESTATEMENT OF PREVIOUSLY ISSUED FINANCIAL STATEMENTS Subsequent to the issuance of the financial statements as of and for the three and six months ended June 30, 2023 for the Battery Group of Global Graphene Group, Inc. (also known as the energy solutions division of Global Graphene Group, Inc.), the Company determined that it had incorrectly accounted for operating expenses in the previously issued unaudited interim financial statements for the three and six months ended June 30, 2023. Specifically, the Company had not timely accrued operating expenses in the three and six month periods ended June 30, 2023, resulting in an understatement of operating expenses and payable to parent liability for those periods. In addition, the Company had incorrectly excluded certain patents contributed to the Battery Group of Global Graphene Group, Inc. by its parent. This resulted in an understatement of patents, net of amortization and contributions and net transfers with related parties. The amortization expense associated with these patents was also understated. As a result, the financial statements as of and for the three and six month periods ended June 30, 2023, have been restated. In accordance with SEC Staff Accounting Bulletin (SAB) No. The following tables summarize the effect of the restatement on each financial statement line item as of the dates, and for the periods, indicated: As Previously Reported Adjustments As Restated Condensed Consolidated and Combined Statement of Operations for the three months ended June 30, 2023 Operating expenses Selling, general and administrative 308,245 43,085 351,330 Total operating expenses 989,891 43,085 1,032,976 Operating loss (989,891 ) (43,085 ) (1,032,976 ) Net Income (loss) $ (989,500 ) $ (43,085 ) $ (1,032,585 ) Condensed Consolidated and Combined Statement of Operations for the six months ended June 30, 2023 Operating expenses Selling, general and administrative 951,386 381,576 1,332,962 Total operating expenses 2,393,517 381,576 2,775,093 Operating loss (2,393,217 ) (381,576 ) (2,774,793 ) Net Income (loss) (2,392,551 ) (381,576 ) (2,774,127 ) Basic and diluted net income (loss) per share of common stock $ (0.03 ) $ (0.01 ) $ (0.04 ) As Previously Reported Adjustments As Restated Condensed Consolidated and Combined Statement of Cash Flows for the six months ended June 30, 2023 Cash Flows From Operating Activities: Net loss $ (2,392,551 ) $ (381,576 ) $ (2,774,127 ) Adjustments to reconcile net income (loss) to net cash used in operating activities: Changes in operating assets and liabilities: Due to related party — 444,076 444,076 Net Cash Used In Operating Activities (2,212,897 ) 62,500 (2,150,397 ) Cash Flows From Investing Activities: Capitalized patent costs (32,065 ) (30,170 ) (62,235 ) Net Cash Used In Investing Activities (32,065 ) (30,170 ) (62,235 ) Cash Flows From Financing Activities: Capital contributions from related party 1,624,425 (32,330 ) 1,592,095 Net Cash Provided By Financing Activities 1,624,425 (32,330 ) 1,592,095 Net change in cash $ (620,537 ) $ — $ (620,537 ) Condensed Consolidated and Combined Statement of Changes in Stockholders’ (Deficit) Equity for the three months ended June 30, 2023 Contributions and net transfers with related parties 226,698 (40,833 ) 185,865 Net loss (989,500 ) (43,085 ) (1,032,585 ) Stockholders’ Equity (Deficit), Balance at June 30, 2023 $ 3,865,588 $ (28,056 ) $ 3,837,532

Recapitalization

Recapitalization	6 Months Ended
	Jun. 30, 2024
Recapitalization [Abstract]
RECAPITALIZATION	NOTE 4 — RECAPITALIZATION As discussed in Note 1, the Merger was accounted for as a common control transaction with respect to HBC which is akin to a reverse recapitalization. Transaction Proceeds Upon the Closing, the Company received net proceeds of $17,555 after deducting transaction costs. The following table reconciles the elements of the Merger to the condensed consolidated and combined statements of cash flows and the condensed consolidated and combined statements of changes in stockholders’ equity (deficit) for the period ended June 30, 2024: Cash received from NUBI Trust 25,160,047 Less: discount payment related to Non Redemption Agreement (13,937,997 ) Less: reimbursement for consideration shares related to the FPA (2,193,800 ) Less: reimbursement for Recycled Shares related to the FPA (80,241 ) Less: transaction expenses paid in connection with the Merger (8,948,009 ) Net cash received from NUBI Trust — Add: cash from NUBI operating account 17,555 Add: prepaid expenses 165,407 Less: derivative liabilities (20,889,950 ) Less: other liabilities (4,086,172 ) Reverse recapitalization, net (24,793,160 ) The number of shares of common stock issued immediately following the consummation of the Merger were: Nubia common stock, outstanding prior to the closing of the Merger 6,004,741 Shares issued to Nubia convertible noteholders 5,962,325 Predecessor HBC Shares 69,800,000 Common stock immediately after the closing of the Merger 81,767,066 The number of Predecessor HBC shares was determined as follows: Predecessor HBC Shares Shares issued to shareholders of Predecessor HBC Common stock 1,000 69,800,000 IPO warrants In connection with the Nubia’s initial public offering in 2022, 6,175,000 public warrants were issued and 5,405,000 warrants were issued in a private placement, all of which warrants remained outstanding and became warrants for the Common Stock in the Company. HBC Holdback Shares The Company and G3 included a provision in the Merger Agreement that adjusts the aggregate share consideration to be paid to the shareholders of HBC if the G3 Tax Lien is not released prior to closing. Specifically, 200,000 HBC Earnout Arrangement As noted in Note 1, in connection with the Merger, HBC shareholders are entitled to up to 22,500,000 The accounting for the Earnout Arrangement was first evaluated under FASB ASC 718, “Compensation — Stock Compensation” (“ASC 718”) to determine if the arrangement represents a share -based Next, the Company determined that the Earnout Arrangement represent a freestanding equity -linked -40 The Company next considered and concluded that the contract was indexed to the Company’s own stock as per ASC 815 -40-15 -40-25 As the merger has been accounted for as a reverse recapitalization, the fair value of the Earnout Arrangement has been accounted for as an equity transaction as of the Closing Date of the Merger. The Company utilized a Monte Carlo simulation analysis to determine the fair value of the Earnout Arrangement at the date of the merger, which included the following assumptions: stock price of $4.53, risk free rate of 3.98%, volatility of 85%, dividends yield of 0% and duration of 4 years. As of June 30, 2024, none of the Earnout Shares had been earned by G3.

Patents

Patents	6 Months Ended
	Jun. 30, 2024
Patents [Abstract]
PATENTS	NOTE 5 — PATENTS Issued patents are recognized on the balance sheets net of accumulated amortization of $1,938,690 and $1,852,649 as of June 30, 2024 and December 31, 2023, respectively. Amortization expense for the patents included in these financial statements was $34,495, $71,793, $11,992 and $25,308 for the three and six months ended June 30, 2024 and 2023, respectively. Future amortization expense for the patents over the next five years is anticipated to be approximately $148,000 per year.

Foreign Operations

Foreign Operations	6 Months Ended
	Jun. 30, 2024
Foreign Operations [Abstract]
FOREIGN OPERATIONS	NOTE 6 — FOREIGN OPERATIONS The foreign subsidiary of the Company represented $34,057 and $24,132 of total assets, and $21,268 and $62,753 of total liabilities as of June 30, 2024 and December 31, 2023, respectively. Of the total assets, property and equipment totaled $10,250 and $14,500 as of June 30, 2024 and December 31, 2023, respectively. There were no

Warrants

Warrants	6 Months Ended
	Jun. 30, 2024
Warrants [Abstract]
WARRANTS	NOTE 10 — WARRANTS IPO Warrants The warrants issued in connection with the Company’s IPO (the “public warrants”) entitle the holder of each public warrant to purchase one share of common stock at a price of $11.50 per share, subject to adjustment. Pursuant to the warrant agreement, a warrant holder may exercise its warrants only for a whole number of shares of common stock. This means that only a whole warrant may be exercised at any given time by a warrant holder. No fractional warrants will be issued upon separation of the units and only whole warrants will trade. Accordingly, unless you purchase at least two units, you will not be able to receive or trade a whole warrant. The warrants will expire five The Company is not be obligated to deliver any shares of common stock pursuant to the exercise of a warrant and has no obligation to settle such warrant exercise unless a registration statement under the Securities Act with respect to the shares of common stock underlying the warrants is then effective and a prospectus relating thereto is current, subject to the Company satisfying its obligations described below with respect to registration. No warrant will be exercisable and the Company will not be obligated to issue shares of common stock upon exercise of a warrant unless common stock issuable upon such warrant exercise has been registered, qualified or deemed to be exempt under the securities laws of the state of residence of the registered holder of the warrants. In the event that the conditions in the two immediately preceding sentences are not satisfied with respect to a warrant, the holder of such warrant will not be entitled to exercise such warrant and such warrant may have no value and expire worthless. In no event will the Company be required to net cash settle any warrant. In the event that a registration statement is not effective for the exercised warrants, the purchaser of a unit containing such warrant will have paid the full purchase price for the unit solely for the share of common stock underlying such unit. However, the Company has agreed that as soon as practicable after the closing of the Company’s initial business combination, the Company will use its best efforts to file with the SEC a registration statement covering the shares of common stock issuable upon exercise of the warrants, to cause such registration statement to become effective and to maintain a current prospectus relating to those shares of common stock until the warrants expire or are redeemed, as specified in the warrant agreement. If a registration statement covering the shares of common stock issuable upon exercise of the warrants is not effective by the 90 th provided by Section 3(a)(9) of the Securities Act of 1933, as amended, or the Securities Act, provided that such exemption is available. If that exemption, or another exemption, is not available, holders will not be able to exercise their warrants on a cashless basis. Once the warrants become exercisable, the Company may call the warrants for redemption: • • • -day • -trading If and when the warrants become redeemable by us, the Company may not exercise the Company’s redemption right if the issuance of shares of common stock upon exercise of the warrants is not exempt from registration or qualification under applicable state blue sky laws or we are unable to effect such registration or qualification. The Company will use its best efforts to register or qualify such shares of common stock under the blue sky laws of the state of residence in those states in which the warrants were offered by us in the Company’s initial public offering. The Company has established the last of the redemption criterion discussed above to prevent a redemption call unless there is at the time of the call a significant premium to the warrant exercise price. If the foregoing conditions are satisfied and we issue a notice of redemption of the warrants, each warrant holder will be entitled to exercise its warrant prior to the scheduled redemption date. However, the price of the common stock may fall below the $18.00 redemption trigger price (as adjusted for stock splits, stock dividends, reorganizations, recapitalizations and the like) as well as the $11.50 warrant exercise price after the redemption notice is issued. If the Company calls the warrants for redemption as described above, the Company’s management will have the option to require any holder that wishes to exercise its warrant to do so on a “cashless basis.” In determining whether to require all holders to exercise their warrants on a “cashless basis,” the Company’s management will consider, among other factors, the Company’s cash position, the number of warrants that are outstanding and the dilutive effect on the Company’s stockholders of issuing the maximum number of shares of common stock issuable upon the exercise of the Company’s warrants. If the Company’s management takes advantage of this option, all holders of warrants would pay the exercise price by surrendering their warrants for that number of shares of common stock equal to the quotient obtained by dividing (x) the product of the number of shares of common stock underlying the warrants, multiplied by the difference between the exercise price of the warrants and the “fair market value” (defined below) by (y) the fair market value. The “fair market value” for this purpose shall mean the average reported last sale price of the common stock for the 10 trading days ending on the third trading day prior to the date on which the notice of redemption is sent to the holders of warrants. If the Company’s management takes advantage of this option, the notice of redemption will contain the information necessary to calculate the number of shares of common stock to be received upon exercise of the warrants, including the “fair market value” in such case. Requiring a cashless exercise in this manner will reduce the number of shares to be issued and thereby lessen the dilutive effect of a warrant redemption. We believe this feature is an attractive option to us if we do not need the cash from the exercise of the warrants after the Company’s initial business combination. If the Company calls its warrants for redemption and the Company’s management does not take advantage of this option, the Company’s sponsor and its permitted transferees would still be entitled to exercise their placement warrants for cash or on a cashless basis using the same formula described above that other warrant holders would have been required to use had all warrant holders been required to exercise their warrants on a cashless basis, as described in more detail below. A holder of a warrant may notify us in writing in the event it elects to be subject to a requirement that such holder will not have the right to exercise such warrant, to the extent that after giving effect to such exercise, such person (together with such person’s affiliates), to the warrant agent’s actual knowledge, would beneficially own in excess of 4.9% or 9.8% (or such other amount as a holder may specify) of the shares of common stock outstanding immediately after giving effect to such exercise. If the number of outstanding shares of common stock is increased by a stock dividend payable in shares of common stock, or by a split -up -up In addition, if we, at any time while the warrants are outstanding and unexpired, pay a dividend or make a distribution in cash, securities or other assets to the holders of common stock on account of such shares of common stock (or other shares of the Company’s capital stock into which the warrants are convertible), other than (a) as described above, (b) certain ordinary cash dividends, (c) to satisfy the redemption rights of the holders of common stock in connection with a proposed initial business combination, (d) to satisfy the redemption rights of the holders of common stock in connection with a stockholder vote to amend the Company’s amended and restated certificate of incorporation (i) to modify the substance or timing of its obligation to allow redemption in connection with the Company’s initial business combination or certain amendments to the Company’s charter prior thereto or to redeem 100% of the Company’s common stock if we do not complete the Company’s initial business combination within 12 months (or up to 18 months if the Company’s time to complete a business combination is extended as described herein) from the closing of the Company’s initial public offering or (ii) with respect to any other provision relating to stockholders’ rights or pre -initial If the number of outstanding shares of the Company’s common stock is decreased by a consolidation, combination, reverse stock split or reclassification of shares of common stock or other similar event, then, on the effective date of such consolidation, combination, reverse stock split, reclassification or similar event, the number of shares of common stock issuable on exercise of each warrant will be decreased in proportion to such decrease in outstanding shares of common stock. Whenever the number of shares of common stock purchasable upon the exercise of the warrants is adjusted, as described above, the warrant exercise price will be adjusted by multiplying the warrant exercise price immediately prior to such adjustment by a fraction (x) the numerator of which will be the number of shares of common stock purchasable upon the exercise of the warrants immediately prior to such adjustment, and (y) the denominator of which will be the number of shares of common stock so purchasable immediately thereafter. In case of any reclassification or reorganization of the outstanding shares of common stock (other than those described above or that solely affects the par value of such shares of common stock), or in the case of any merger or consolidation of us with or into another corporation (other than a consolidation or merger in which we are the continuing corporation and that does not result in any reclassification or reorganization of the Company’s outstanding shares of common stock), or in the case of any sale or conveyance to another corporation or entity of the assets or other property of us as an entirety or substantially as an entirety in connection with which we are dissolved, the holders of the warrants will thereafter have the right to purchase and receive, upon the basis and upon the terms and conditions specified in the warrants and in lieu of the shares of the Company’s common stock immediately theretofore purchasable and receivable upon the exercise of the rights represented thereby, the kind and amount of shares of stock or other securities or property (including cash) receivable upon such reclassification, reorganization, merger or consolidation, or upon a dissolution following any such sale or transfer, that the holder of the warrants would have received if such holder had exercised their warrants immediately prior to such event. However, if less than 70% of the consideration receivable by the holders of common stock in such a transaction is payable in the form of common stock in the successor entity that is listed for trading on a national securities exchange or is quoted in an established over -the-counter -Scholes -Scholes The warrants will be issued in registered form under a warrant agreement between Continental Stock Transfer & Trust Company, as warrant agent, and us. You should review a copy of the warrant agreement, which we filed as an exhibit to the registration statement of which this prospectus forms a part, for a complete description of the terms and conditions applicable to the warrants. The warrant agreement provides that the terms of the warrants may be amended without the consent of any holder to cure any ambiguity or correct any mistake, but requires the approval by the holders of at least a majority of the then outstanding public warrants to make any change that adversely affects the interests of the registered holders of public warrants. In addition, if (x) we issue additional shares of common stock or equity -linked The warrants may be exercised upon surrender of the warrant certificate on or prior to the expiration date at the offices of the warrant agent, with the exercise form on the reverse side of the warrant certificate completed and executed as indicated, accompanied by full payment of the exercise price (or on a cashless basis, if applicable), by certified or official bank check payable to us, for the number of warrants being exercised. The warrant holders do not have the rights or privileges of holders of common stock and any voting rights until they exercise their warrants and receive shares of common stock. After the issuance of shares of common stock upon exercise of the warrants, each holder will be entitled to one (1) vote for each share held of record on all matters to be voted on by stockholders. No fractional shares will be issued upon exercise of the warrants. If, upon exercise of the warrants, a holder would be entitled to receive a fractional interest in a share, the Company will, upon exercise, round down to the nearest whole number of shares of common stock to be issued to the warrant holder. The Company has agreed that, subject to applicable law, any action, proceeding or claim against us arising out of or relating in any way to the warrant agreement will be brought and enforced in the courts of the State of New York or the United States District Court for the Southern District of New York, and we irrevocably submit to such jurisdiction, which jurisdiction will be the exclusive forum for any such action, proceeding or claim. This provision applies to claims under the Securities Act but does not apply to claims under the Exchange Act or any claim for which the federal district courts of the United States of America are the sole and exclusive forum. Private Warrants Except as described below, the private warrants have terms and provisions that are identical to those of the public warrants, including as to exercise price, exercisability and exercise period. The private warrants (including the common stock issuable upon exercise of the private warrants) will not be transferable, assignable or saleable until 30 days after the completion of the Company’s initial business combination (except to the Company’s officers and directors and other persons or entities affiliated with the holders of the private warrants). They will also be exercisable on a cashless basis and will not be redeemable by us so long as they are held by the holders of the private warrants or their permitted transferees. The holders of the private warrants or their permitted transferees have the option to exercise the private warrants on a cashless basis. If the private warrants are held by holders other than the holders of the private warrants and their permitted transferees, the private warrants will be redeemable by us and exercisable by the holders on the same basis as the warrants included in the units being sold in the Company’s initial public offering. If holders of the private warrants elect to exercise them on a cashless basis, they would pay the exercise price by surrendering their warrants for that number of shares of common stock equal to the quotient obtained by dividing (x) the product of the number of shares of common stock underlying the warrants, multiplied by the difference between the exercise price of the warrants and the “fair market value” (defined below) by (y) the fair market value. The “fair market value” for this purpose shall mean the average reported last sale price of the common stock for the 10 trading days ending on the third trading day prior to the date on which the notice of warrant exercise is sent to the warrant agent. The reason that we have agreed that these warrants will be exercisable on a cashless basis so long as they are held by the holders of the private warrants and their permitted transferees is because it is not known at this time whether they will be affiliated with us following an initial business combination. If they remain affiliated with us, their ability to sell the Company’s securities in the open market will be significantly limited. We have policies in place that prohibit insiders from selling the Company’s securities except during specific periods of time. Even during such periods of time when insiders will be permitted to sell the Company’s securities, an insider cannot trade in the Company’s securities if he or she is in possession of material non -public In addition, holders of the Company’s private warrants are entitled to certain registration rights. The holders of the private warrants have agreed not to transfer, assign or sell any of the private warrants (including the common stock issuable upon exercise of any of these warrants) until the date that is 30 days after the date we complete the Company’s initial business combination, except to the Company’s officers and directors and other persons or entities affiliated with the holders of the private warrants. Series A and Series D Warrants In accordance with ASC 815, the Series C Warrants and Series D Warrants were determined to be liability classified at the issuance date and subject to periodic remeasurement. As such, on the date of issuance the Company allocated the proceeds between the common stock, Series C Warrants and Series D Warrants first to the fair value of the Series C Warrants and Series D Warrants, which were recorded as a liability. The total fair value of the Series C Warrants and Series D Warrants measured at issuance was $12,656,550 and $82,450, respectively, which exceeded the total gross proceeds from the Private Placement of $3,850,000. As the fair value of the derivative liability exceeded the proceeds on the day of issuance, the difference was recorded as a loss from issuance of stock and warrants of $17,820,998. The fair value of the Series C Warrants and Series D Warrants as of June 30, 2024 was $9,139,200 and $2,889,750, respectively, resulting in a gain of $9,141,900 and $710,050 during the three and six months ended June 30, 2024. The number of Series C Warrants and Series D Warrants exercised as of June 30, 2024, was 0 and 333,333, respectively, resulting in the issuance of 199,943 common shares.

Debt

Debt	6 Months Ended
	Jun. 30, 2024
Debt [Abstract]
DEBT	NOTE 12 — DEBT Convertible Notes At various dates during the first quarter of 2024, the Company issued Convertible Notes of $527,500 to meet our working capital requirements. The Notes convert to approximately 3.3 million common shares. The outstanding balance on Convertible Notes amounted to $527,500 and $0 as of June 30, 2024 and December 31, 2023, respectively. Short-term Notes Payable EF Hutton LLC On February 1, 2024, the Company executed a Promissory Note with EF Hutton, totaling $2,200,000, to cover underwriters’ fees associated with the closure of the Company’s Merger with HBC. In the case of an event of default, this Note shall bear interest at a rate of 24% per annum until such event of default is cured. The principal amount of this Note is payable on designated dates, with $183,333 scheduled on the first business day of each month until the final payment on March 1, 2025. Loeb and Loeb LLP On February 1, 2024, the Company executed a Promissory Note with Loeb and Loeb, totaling $540,000 for legal services provided to the Company in connection with the Company’s Merger with HBC. The principal and interest amount of this Note is payable in 12 equal monthly installments beginning on March 1, 2024. The Note bears implied interest of 23.5% per annum, resulting in total interest payments of approximately $127,000 over the term of the Note. The monthly installments include both principal and interest payments. Benesch Friedlander Coplan & Aronoff LLP On April 29, 2024, the Company executed a Promissory Note with Benesch Friedlander Coplan & Aronoff in the amount of $670,000. The interest rate is 7% per annum, with maturity date of November 1, 2024. The outstanding balance on Short -term $

Stock-Based Compensation

Stock-Based Compensation	6 Months Ended
	Jun. 30, 2024
Stock-Based Compensation [Abstract]
STOCK-BASED COMPENSATION	NOTE 14 — STOCK-BASED COMPENSATION Unrestricted Common Stock Awards During the period ended June 30, 2024, the Company granted unrestricted common shares to certain executives in connection with the terms of their individual employment agreements. As these awards were fully -vested Selling, general, and administrative expenses Restricted Stock Units and Stock Options There were no restricted stock units or stock options granted during the six -month Awards with Market-Based Conditions In connection with the aforementioned executive employment agreements, certain executives are eligible to receive unrestricted shares of common stock if certain stock price targets are met during the term of the respective employment agreements. A stock price target will be satisfied if the 120 -day six Awards with Performance Conditions In connection with the aforementioned executive employment agreements, certain executives are eligible to receive cash incentive payments in connection with the Company achieving certain capital raise targets. In addition, these executives can also receive a cash bonus equal to 2.5% of the equity value of the Company (up to $10 million for each executive, totaling $20 million) in an applicable sale of the Company as defined by the terms of the employment agreements. Through June 30, 2024, it was not considered probable that either performance condition would be achieved, and therefore no expense was recorded related to these awards.

Accounting Policies, by Policy

Accounting Policies, by Policy (Policies)	6 Months Ended	12 Months Ended
	Jun. 30, 2024	Dec. 31, 2023
Summary of Significant Accounting Policies [Abstract]
Basis of Presentation and Principles of Consolidation	Basis of Presentation and Principles of Consolidation The accompanying unaudited condensed consolidated and combined financial statements (the “financial statements”) are presented in conformity with US GAAP -1 Throughout the period covered till the Closing date of the Merger, the Company operated as part of G3. Consequently, stand -alone -alone However, the financial statements included herein may not be indicative of the financial position, results of operations, and cash flows of the Company in the future or if the Company had been a separate, stand -alone In the opinion of management, the Company has made all adjustments necessary to present fairly its financial statements for the periods presented. Such adjustments are of a normal, recurring nature. The Company’s financial statements have been prepared under the assumption that the Company will continue as a going concern, which contemplates the realization of assets and discharge of liabilities in the normal course of business for the foreseeable future. The financial statements include the Company entities. All intercompany transactions have been eliminated for consolidation purposes.	Basis of Presentation and Principles of Consolidation The accompanying consolidated financial statements have been prepared in accordance with U.S. GAAP and pursuant to the rules and regulations of the Securities and Exchange Commission (“SEC”). The consolidated financial statements include the accounts of the Company and its subsidiaries. All intercompany transactions and balances have been eliminated.
Emerging Growth Company	Emerging Growth Company The Company is an “emerging growth company,” as defined in Section 2(a) of the Securities Act of 1933, as amended (the “Securities Act”), as modified by the Jumpstart Our Business Startups Act of 2012, as amended (the “JOBS Act”), and it may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies including, but not limited to, not being required to comply with the independent registered public accounting firm attestation requirements of Section 404 of the Sarbanes -Oxley Further, Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that a company can elect to opt out of the extended transition period and comply with the requirements that apply to non -emerging	Emerging Growth Company The Company is an “emerging growth company,” as defined in Section 2(a) of the Securities Act of 1933, as amended (the “Securities Act”), as modified by the Jumpstart Our Business Startups Act of 2012, as amended (the “JOBS Act”), and it may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies including, but not limited to, not being required to comply with the independent registered public accounting firm attestation requirements of Section 404 of the Sarbanes -Oxley Further, Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that a company can elect to opt out of the extended transition period and comply with the requirements that apply to non -emerging
Use of Estimates	Use of Estimates The preparation of financial statements in conformity with US GAAP requires the Company’s management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of expenses during the reporting period. Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the balance sheet which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. Accordingly, the actual results could differ significantly from those estimates.	Use of Estimates The preparation of financial statements in conformity with US GAAP requires the Company’s management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of expenses during the reporting period. Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the balance sheet which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. Accordingly, the actual results could differ significantly from those estimates.
Cash and cash equivalents	Cash and cash equivalents The Company considers all short -term	Cash and cash equivalents The Company considers all short -term
Cash and investments held in Trust Account		Cash and investments held in Trust Account The funds held in Trust are invested only in U.S. government securities, within the meaning set forth in Section 2(a)(16) of the Investment Company Act, with a maturity of 185 days or less or in any open -ended -7 -interest
Offering Costs associated with an Initial Public Offering		Offering Costs associated with an Initial Public Offering The Company complies with the requirements of the Financial Accounting Standards Board (“FASB”) ASC 340 -10-S99-1 Expenses of Offering.” -allotment
Class A ordinary shares subject to possible redemption		Class A ordinary shares subject to possible redemption The Company accounts for its Class A common stock subject to possible redemption in accordance with the guidance enumerated in ASC 480 “ Distinguishing Liabilities from Equity The Company recognizes changes in redemption value immediately as they occur and adjusts the carrying value of redeemable Class A common stock to equal the redemption value at the end of each reporting period. Immediately upon the closing of the Initial Public Offering, the Company recognized a measurement adjustment from initial book value to redemption amount value. The change in the carrying value of redeemable Class A ordinary shares resulted in charges against additional paid -in At December 31, 2023 and December 31, 2022, the Class A common stock subject to possible redemption reflected in the balance sheet is reconciled in the following table: Gross proceeds $ 123,500,000 Less: Proceeds allocated to Public Warrants (3,755,675 ) Class A common stock issuance costs (6,716,427 ) (10,472,102 ) Plus: Class A Common Stock Redeemable Remeasurement Adjustment at IPO 12,942,102 Remeasurement adjustment for the year ended December 31, 2022 1,272,983 Class A common stock subject to possible redemption as of December 31, 2022 127,242,983 Transfer to funds payable to redeemed Class A stockholders (17,834,235 ) Redemptions (89,038,494 ) Remeasurement adjustment for the year ended December 31, 2023 3,972,489 Class A common stock subject to possible redemption as of December 31, 2023 $ 24,342,743
Funds payable to redeemed Class A stockholders		Funds payable to redeemed Class A stockholders On December 14, 2023, the Company held a second special meeting of stockholders (the “Second Special Meeting”). In connection with the Second Special Meeting, stockholders elected to redeem an aggregate 1,625,876 Excise tax, if any, related to the redemption will be accrued on the date the funds are paid to the stockholders.
Income Taxes	Income Taxes Income taxes are recorded in accordance with ASC 740, Income Taxes (“ASC 740”), which provides for deferred taxes using an asset and liability approach. The Company recognizes deferred tax assets and liabilities for the expected future tax consequences of events that have been included in the financial statements or tax returns. Deferred tax assets and liabilities are determined based on the difference between the financial statement and tax basis of assets and liabilities using enacted tax rates in effect for the year in which the differences are expected to reverse. Valuation allowances are provided, if based upon the weight of available evidence, it is more likely than not that some or all of the deferred tax assets will not be realized. The Company accounts for uncertain tax positions in accordance with the provisions of ASC 740. When uncertain tax positions exist, the Company recognizes the tax benefit of tax positions to the extent that the benefit would more likely than not be realized assuming examination by the taxing authority. The determination as to whether the tax benefit will more likely than not be realized is based upon the technical merits of the tax position as well as consideration of the available facts and circumstances. The Company recognizes any interest and penalties accrued related to unrecognized tax benefits as income tax expense.	Income Taxes The Company follows the asset and liability method of accounting for income taxes under ASC 740, “ Income Taxes ASC 740 prescribes a recognition threshold and a measurement attribute for the financial statement recognition and measurement of tax positions taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more likely than not to be sustained upon examination by taxing authorities. The Company recognizes accrued interest and penalties related to unrecognized tax benefits as income tax expense. There were no unrecognized tax benefits and no amounts accrued for interest and penalties as of December 31, 2023 and 2022. The Company is currently not aware of any issues under review that could result in significant payments, accruals or material deviation from its position. The Company is subject to income tax examinations by major taxing authorities since inception. The Company has identified the United States as its only “major” tax jurisdiction. The Company is subject to income taxation by major taxing authorities since inception. These examinations may include questioning the timing and amount of deductions, the nexus of income among various tax jurisdictions and compliance with federal and state tax laws. The Company’s management does not expect that the total amount of unrecognized tax benefits will materially change over the next twelve months. The IR Act imposes a 1% excise tax on the fair market value of stock repurchases made by covered corporations after December 31, 2022. The total taxable value of shares repurchased is reduced by the fair market value of and newly issued shares during the taxable year. Redemption rights are ubiquitous to nearly all SPACs. Stockholders have the ability to require the SPAC to repurchase their shares prior to the merger in what is known as a redemption right, essentially getting their money back. There are two possible scenarios in which redemption rights come into play. First, they can be exercised by the stockholders themselves because they are exiting the transaction, or second, they can be triggered because the SPAC did not find a target with which to merge. In connection with shareholder redemptions in 2023, the Company recorded an excise tax liability and equity adjustment of $0.9
Net Income (Loss) per Common Stock	Net Income (Loss) per Common Stock The Company complies with accounting and disclosure requirements of FASB ASC Topic 260, “ Earnings Per Share. The calculation of diluted income (loss) per share of common stock does not include potentially dilutive common stock equivalents if their include would be anti -dilutive The following table presents potentially dilutive common stock equivalents that have been excluded from the calculation of dilutive loss per share as their inclusion would be anti -dilutive June 30, 2024 December 31, 2023 HBC Holdback Shares 200,000 — Warrants – Public 6,175,000 — Warrants – Private 5,405,000 — Warrants – Series A 22,141,701 — Warrants – Series B 5,549,655 — Stock-based compensation – equity awards 300,000 — Forward Purchase Agreement – Additional Shares 8,038,537 — Convertible notes 3,396,261 — HBC Earnout Shares 22,500,000 — Total common stock equivalents excluded from dilutive loss per share 73,706,154 — The following table presents potentially dilutive common stock equivalents that have been included in the calculation of dilutive income per share for the three months ended June 30, 2024, as their inclusion would be dilutive. June 30, 2024 Warrants – Series B 5,549,655 Stock-based compensation – equity awards 300,000 Convertible notes 3,396,261 Total common stock equivalents included in dilutive income per share 9,245,916	Net Income (Loss) per Common Stock The Company complies with accounting and disclosure requirements of FASB ASC Topic 260, “ Earnings Per Share. -class The calculation of diluted income (loss) per share of common stock does not consider the effect of the warrants issued in connection with the (i) Initial Public Offering and (ii) the Private Placement since the exercise of the warrants is contingent upon the occurrence of future events. As of December 31, 2023 and 2022, the warrants are exercisable to purchase 11,580,000 Stockholders elected to redeem an aggregate 1,625,876 The following tables reflects the calculation of basic and diluted net income (loss) per common share (in dollars, except per share amounts): For the Class A Redeemable Common Stock Numerator: Income allocable to Class A Redeemable Common Stock $ 448,713 Denominator: Diluted weighted average shares outstanding 9,846,164 Diluted net income per share, Class A Redeemable Common Stock $ 0.05 Class A and Class B Non-Redeemable Common Stock Numerator: Income allocable to Class A and Class B Non-Redeemable Common Stock $ 145,192 Denominator: Diluted weighted average shares outstanding 3,185,962 Diluted net income per share, Class A and Class B Non-Redeemable Common Stock $ 0.05 Year ended Class A Redeemable Common Stock Numerator: Loss allocable to Class A Redeemable Common Stock $ (13,931,674 ) Denominator: Basic and diluted weighted average shares outstanding 7,654,886 Basic and diluted net loss per share, Class A Redeemable Common Stock $ (1.82 ) Class A and Class B Non-redeemable Common Stock Numerator: Loss allocable to Class A and Class B Non-Redeemable Common Stock $ (5,843,928 ) Denominator: Basic and diluted weighted average shares outstanding 3,211,000 Basic and diluted net loss per share, Class A and Class B Non-Redeemable Common Stock $ (1.82 )
Concentration of Credit Risk	Concentration of Credit Risk Financial instruments that potentially subject the Company to concentrations of credit risk consist of cash accounts in financial institutions, which, at times, may exceed the Federal Depository Insurance Coverage of $250,000. The Company has not experienced losses on these accounts.	Concentration of Credit Risk Financial instruments that potentially subject the Company to concentrations of credit risk consist of a cash account in a financial institution, which, at times, may exceed the Federal Depository Insurance Coverage of $250,000. The Company has not experienced losses on this account.
Fair Value of Financial Instruments	Fair Value of Financial Instruments Fair value is defined as the price that would be received for sale of an asset or paid to transfer of a liability, in an orderly transaction between market participants at the measurement date. US GAAP establishes a three -tier	Fair Value of Financial Instruments Fair value is defined as the price that would be received for sale of an asset or paid to transfer of a liability, in an orderly transaction between market participants at the measurement date. US GAAP establishes a three -tier
Convertible Notes		Convertible Notes The Company accounts for convertible notes as either equity -classified -classified whether the convertible notes meet all of the requirements for equity classification under ASC 815, including whether the conversion feature are indexed to the Company’s own common shares. The Company has concluded that the convertible notes qualify for equity treatment.
Warrants	Warrants The Company accounts for warrants as either equity -classified -classified For issued or modified warrants that meet all of the criteria for equity classification, the warrants are required to be recorded as a component of additional paid -in -classified -classified -to-fixed	Warrants The Company accounts for warrants as either equity -classified -classified For issued or modified warrants that meet all of the criteria for equity classification, the warrants are required to be recorded as a component of additional paid -in -classified
Forward Purchase Agreement	Forward Purchase Agreement The Company accounts for the forward purchase agreement (“FPA”) as either equity -classified -classified For issued or modified FPA that meets all of the criteria for equity classification, the FPA is required to be recorded as a component of additional paid -in -classified	Forward Purchase Agreement and Non-Redemption Agreement The Company accounts for forward purchase agreement and non -redemption -classified -classified For issued or modified FPA and NRAs that meet all of the criteria for equity classification, the FPA and NRA are required to be recorded as a component of additional paid -in -classified
Recent Accounting Standards	Recent Accounting Standards In December 2023, the FASB issued ASU 2023 -09 -09 -09 -09 In November 2023, the FASB issued Accounting Standards Update (ASU) 2023 -07 Management does not believe that any recently issued, but not yet effective, accounting standards, if currently adopted, would have a material effect on the Company’s financial statements.	Recent Accounting Standards In December 2023, the FASB issued ASU 2023 -09 -09 -09 -09 Management does not believe that any recently issued, but not yet effective, accounting standards, if currently adopted, would have a material effect on the Company’s financial statements.
Segment Reporting	Segment Reporting The Company has determined that the Chief Executive Officer is its Chief Operating Decision Maker (the “CODM”). Operating segments are defined as components of an entity for which separate financial information is available and that is regularly reviewed by the CODM in deciding how to allocate resources to an individual segment and in assessing performance. The Company has determined that it operates in one operating segment and one reportable segment, as the CODM reviews financial information presented on a consolidated basis for purposes of making operating decisions, allocating resources, and evaluating financial performance.
Accounts Receivable, net of Allowance for Credit Losses	Accounts Receivable, net of Allowance for Credit Losses Accounts receivables are stated at the amount the Company expects to collect. The Company recognizes an allowance for credit losses to ensure accounts receivables are not overstated due to un -collectability -time
Other Receivable	Other Receivable As of December 31, 2023, the Company held an other receivable balance of $187,500 from Nubia. This balance originated from cash advances made by G3 on behalf of The Battery Group of G3, in connection with Nubia’s funding requirements for extensions of time in closing the Merger. Pursuant to the Merger Agreement, G3’s Battery Group was responsible for funding 50% of this additional trust funding requirement. As of June 30, 2024, following the elimination of an intercompany amount upon the closing of the Merger, the Company no longer had a balance related to the trust funding requirement. During the first quarter, the Company advanced $302,500 to G3 for transaction costs incurred during the Merger. The outstanding balance of other receivables amounted to $302,500 as of June 30, 2024.
Inventory	Inventory Inventories are stated at the lower of first -in -out -down
Property and Equipment, net	Property and Equipment, net Property and equipment are recorded at cost less accumulated depreciation and amortization. Expenditures for maintenance and repairs, which do not extend the economic useful life of the related assets, are charged to operations as incurred, and expenditures, which extend the economic life, are capitalized. When assets are retired, or otherwise disposed of, the costs and related accumulated depreciation or amortization are removed from the accounts and any gain or loss on disposal is recognized. The Company assesses the carrying value of its property and equipment for impairment each year and when indicators exist that there could be an impairment. Based on its assessments, the Company did not incur any impairment charges for the three and six months ended June 30, 2024 and 2023. The Company depreciates its property and equipment for financial reporting purposes using the straight -line Building 40 years Leasehold improvements 15 years Machinery & equipment 5 years Depreciation expense of property and equipment was $68,416, $125,510, $64,515 and $156,871 for the three and six months ended June 30, 2024 and 2023, respectively.
Patents	Patents The Company capitalizes external costs, such as filing fees and associated attorney fees, incurred to obtain issued patents. The Company’s intangible assets consist of capitalized costs for unissued patents and issued patents. Issued patents are carried at cost less accumulated amortization. Successful patent efforts are amortized over the life of the patent, and unsuccessful efforts are expensed. The issued patents are being amortized over a useful life of 20 years. Amortization of the patent costs commences upon patent issuance. Net unissued and issued patents were $1,081,011 and $857,680 as of June 30, 2024, respectively; and $1,103,792 and $748,857 as of December 31, 2023, respectively. The Company assesses the carrying value of its intangible assets for impairment each year and when indicators exist that there could be an impairment. Based on its assessments, the Company did not incur any impairment charges for the three and six months ended June 30, 2024 and 2023. Amortization expense of patents was $34,495, $71,793, $11,992 and $25,308 for the three and six months ended June 30, 2024 and 2023, respectively.
Translation of Foreign Currencies	Translation of Foreign Currencies The functional currency of Solidion’s Taiwan subsidiary is the New Taiwan Dollar. In accordance with Financial Accounting Standards Board (FASB) Accounting Standards Codification (ASC) 830, Foreign Currency Matters
Revenue Recognition	Revenue Recognition Revenue is recognized when a performance obligation has been satisfied by transferring control of promised products or services to customers in an amount that reflects the consideration the Company expects to receive in exchange for those products. Revenues are recognized at a point in time when control transfers to customers, which is generally determined when title, ownership and risk of loss pass to the customer.
Research and Development	Research and Development All research and development costs are expensed as incurred.
Selling, General and Administrative Expenses	Selling, General and Administrative Expenses Selling, general and administrative expenses represent costs incurred by the Company in managing the business, including salary, benefits, stock -based -research
Stock-Based Compensation	Stock-Based Compensation The Company has an incentive equity plan, (“2023 Equity Incentive Plan”). Under the terms of the plan, Solidion’s employees, consultants and directors, and employees and consultants of its affiliates, may be eligible to receive awards in the form of incentive stock options (“ISOs”) to employees and for the grant of non -statutory The number of stocks of common stock initially reserved for issuance under the incentive plan will be 9,500,000. Stocks subject to stock awards granted under the incentive plan that expire or terminate without being exercised in full, or that are paid out in cash rather than in stocks, will not reduce the number of stocks available for issuance under the incentive plan. The incentive plan also includes an evergreen provision that provides for an automatic annual increase to the number of stocks of common stock available for issuance under the incentive plan on the first day of each fiscal year beginning with the 2024 fiscal year, equal to the least of (i) 9,500,000 stocks of common stock, (ii) 5% of the total number of stocks of common stock outstanding as of the last day of our immediately preceding fiscal year, or (iii) such lesser amount determined by the plan administrator. The Company measures stock options and restricted stock unit awards granted to employees, non -employees Generally, the Company issues stock options and restricted stock units with only service -based -line -based -based The fair value of each stock option grant is estimated on the date of grant using the Black -Scholes -pricing -specific The expected term of all of the Company’s stock options has been determined utilizing the “simplified” method. The risk -free
Other Current Assets	Other Current Assets The composition of other current assets was: June 30, 2024 December 31, 2023 Directors & Officers Insurance 777,135 — Total other assets 777,135 —
Other Assets	Other Assets The composition of other assets was: June 30, 2024 December 31, 2023 Directors & Officers Insurance 778,167 — Total other assets 778,167 —

Summary of Significant Accoun_2

Summary of Significant Accounting Policies (Tables)	6 Months Ended	12 Months Ended
	Jun. 30, 2024	Dec. 31, 2023
Summary of Significant Accounting Policies [Abstract]
Schedule of Class A Common Stock Subject to Possible Redemption Reflected in the Balance Sheet		At December 31, 2023 and December 31, 2022, the Class A common stock subject to possible redemption reflected in the balance sheet is reconciled in the following table: Gross proceeds $ 123,500,000 Less: Proceeds allocated to Public Warrants (3,755,675 ) Class A common stock issuance costs (6,716,427 ) (10,472,102 ) Plus: Class A Common Stock Redeemable Remeasurement Adjustment at IPO 12,942,102 Remeasurement adjustment for the year ended December 31, 2022 1,272,983 Class A common stock subject to possible redemption as of December 31, 2022 127,242,983 Transfer to funds payable to redeemed Class A stockholders (17,834,235 ) Redemptions (89,038,494 ) Remeasurement adjustment for the year ended December 31, 2023 3,972,489 Class A common stock subject to possible redemption as of December 31, 2023 $ 24,342,743
Schedule of Basic and Diluted Net Income (Loss) Per Common Share		The following tables reflects the calculation of basic and diluted net income (loss) per common share (in dollars, except per share amounts): For the Class A Redeemable Common Stock Numerator: Income allocable to Class A Redeemable Common Stock $ 448,713 Denominator: Diluted weighted average shares outstanding 9,846,164 Diluted net income per share, Class A Redeemable Common Stock $ 0.05 Class A and Class B Non-Redeemable Common Stock Numerator: Income allocable to Class A and Class B Non-Redeemable Common Stock $ 145,192 Denominator: Diluted weighted average shares outstanding 3,185,962 Diluted net income per share, Class A and Class B Non-Redeemable Common Stock $ 0.05 Year ended Class A Redeemable Common Stock Numerator: Loss allocable to Class A Redeemable Common Stock $ (13,931,674 ) Denominator: Basic and diluted weighted average shares outstanding 7,654,886 Basic and diluted net loss per share, Class A Redeemable Common Stock $ (1.82 ) Class A and Class B Non-redeemable Common Stock Numerator: Loss allocable to Class A and Class B Non-Redeemable Common Stock $ (5,843,928 ) Denominator: Basic and diluted weighted average shares outstanding 3,211,000 Basic and diluted net loss per share, Class A and Class B Non-Redeemable Common Stock $ (1.82 )
Schedule of Property and Equipment Estimated Useful Lives	The Company depreciates its property and equipment for financial reporting purposes using the straight -line Building 40 years Leasehold improvements 15 years Machinery & equipment 5 years
Schedule of Potentially Dilutive Common Stock Equivalents	The following table presents potentially dilutive common stock equivalents that have been excluded from the calculation of dilutive loss per share as their inclusion would be anti -dilutive June 30, 2024 December 31, 2023 HBC Holdback Shares 200,000 — Warrants – Public 6,175,000 — Warrants – Private 5,405,000 — Warrants – Series A 22,141,701 — Warrants – Series B 5,549,655 — Stock-based compensation – equity awards 300,000 — Forward Purchase Agreement – Additional Shares 8,038,537 — Convertible notes 3,396,261 — HBC Earnout Shares 22,500,000 — Total common stock equivalents excluded from dilutive loss per share 73,706,154 — June 30, 2024 Warrants – Series B 5,549,655 Stock-based compensation – equity awards 300,000 Convertible notes 3,396,261 Total common stock equivalents included in dilutive income per share 9,245,916
Schedule of Composition of Other Current Assets	The composition of other current assets was: June 30, 2024 December 31, 2023 Directors & Officers Insurance 777,135 — Total other assets 777,135 —
Schedule of Composition of Other Assets	The composition of other assets was: June 30, 2024 December 31, 2023 Directors & Officers Insurance 778,167 — Total other assets 778,167 —

Fair Value Measurements (Tables

Fair Value Measurements (Tables)	6 Months Ended	12 Months Ended
	Jun. 30, 2024	Dec. 31, 2023
Fair Value Measurements [Abstract]
Schedule of Company’s Assets and Liabilities	The following table presents information about the Company’s liabilities that are measured at fair value at June 30, 2024 and December 31, 2023, and indicates the fair value hierarchy of the valuation inputs the Company utilized to determine such fair value: Description: Level June 30, December 31, Derivative Liabilities: Forward purchase agreement 3 $ 4,815,800 $ — Warrants – Series A and B 3 $ 12,028,950 $ —	The following table presents information about the Company’s assets and liabilities that are measured at fair value at December 31, 2023 and December 31, 2022, and indicates the fair value hierarchy of the valuation inputs the Company utilized to determine such fair value: Description: Level December 31, December 31, Assets: Cash and investments held in Trust Account 1 $ 42,994,274 $ 127,782,882 Derivative asset 3 $ 28,245,500 $ — Derivative liabilities 3 $ 46,728,596 $ —
Schedule of Fair Value Measurement of FPA and NRA Liability Using the Following Range of Weighted Average Assumptions	The fair value measurement of the FPA at February 2, 2024 and June 30, 2024, was calculated using the following range of weighted average assumptions: June 30, February 2, Risk-free interest rate 4.60 % 4.14 % Stock price $ 0.55 $ 4.53 Expected life 2.4 years 2.8 years Expected volatility of underlying stock 100 % 70.0 % Dividends 0 % 0 %	The fair value measurement of the FPA and the NRA liability at December 31, 2023, was calculated using the following range of weighted average assumptions: December 31, Risk-free interest rate (FPA) 3.85 % Expected life of over-allotment option (FPA) 5.4 years Expected volatility of underlying stock (FPA) 75 % Dividends (FPA) 0 % Probability of merger closing (FPA and NRA) 80 %
Schedule of Fair Value Assumptions of Warrants	The Company utilized a Monte Carlo simulation analysis to determine the fair value of the Series C Warrants and Series D Warrants at the date of issuance (March 15, 2024), which included the following assumptions: Series A Warrants Series B Warrants Expected term (in years) 5.7 years 5.7 years Stock price $ 1.74 $ 1.74 Risk free rate 4.2 % 4.2 % Expected volatility 82.5 % 82.5 % Expected dividend rate $ 0.00 $ 0.00 Exercise Price $ 0.75 $ 0.0001 Series A Warrants Series B Warrants Expected term (in years) 5.4 years 5.4 years Stock price $ 0.55 $ 0.55 Risk free rate 4.2 % 4.2 % Expected volatility 110 % 110 % Expected dividend rate $ 0.00 $ 0.00 Exercise Price $ 0.348 $ 0.0001
Schedule of Recurring Basis Using Significant Unobservable Inputs (Level 3)	The table below provides a summary of the changes in fair value, including net transfers in and/or out, of all financial assets and liabilities measured at fair value on a recurring basis using significant unobservable inputs (Level 3) during the six months ended June 30, 2024. Forward purchase agreement Fair Value Balance, December 31, 2023 $ — Initial measurement, February 2, 2024 20,889,950 Change in fair value (249,350 ) Balance, March 31, 2024 20,640,600 Change in fair value (15,824,800 ) Balance, June 30, 2024 4,815,800 Warrants — Series A and B Fair Value Balance, December 31, 2023 $ — Initial measurement, March 15, 2024 12,739,000 Change in fair value 8,431,850 Balance, March 31, 2024 21,170,850 Change in fair value (9,141,900 ) Balance, June 30, 2024 12,028,950

Income Taxes (Tables)

Income Taxes (Tables)	12 Months Ended
	Dec. 31, 2023
Income Taxes [Abstract]
Schedule of Deferred Tax Assets	The Company’s deferred tax assets are as follows at December 31, 2023 and 2022: December 31, December 31, Deferred tax asset Net operating loss $ — $ — Startup/organizational costs 369,290 147,881 Total deferred tax asset 369,290 147,881 Valuation allowance (369,290 ) (147,881 ) Deferred tax asset, net of allowance $ — $ —
Schedule of Income Tax Provision (Benefit)	The income tax provision (benefit) consists of the following for the year December 31, 2023 and December 31, 2022: December 31, December 31, Federal Current $ 1,579,608 $ 339,899 Deferred — — State and Local Current — — Deferred — — Income tax provision/(benefit) $ 1,579,608 $ 339,899
Schedule of Reconciliation of the Statutory Tax Rate	A reconciliation of the statutory tax rate to the Company’s effective tax rates for the year ended December 31, 2023 and 2022: Year Ended Year Ended Statutory federal income tax rate 21.00 % 21.00 % State taxes, net of federal tax benefit — — Merger costs (2.60 ) — Derivatives (8.46 ) Other (0.04 ) (0.44 ) Change in valuation allowance (1.22 ) 15.84 Income tax provision (benefit) 8.68 % 36.40 %

Restatement of Previously Iss_2

Restatement of Previously Issued Financial Statements (Tables)	6 Months Ended
	Jun. 30, 2024
Restatement of Previously Issued Financial Statements [Abstract]
Schedule of Restatement on each Financial Statement	The following tables summarize the effect of the restatement on each financial statement line item as of the dates, and for the periods, indicated: As Previously Reported Adjustments As Restated Condensed Consolidated and Combined Statement of Operations for the three months ended June 30, 2023 Operating expenses Selling, general and administrative 308,245 43,085 351,330 Total operating expenses 989,891 43,085 1,032,976 Operating loss (989,891 ) (43,085 ) (1,032,976 ) Net Income (loss) $ (989,500 ) $ (43,085 ) $ (1,032,585 ) Condensed Consolidated and Combined Statement of Operations for the six months ended June 30, 2023 Operating expenses Selling, general and administrative 951,386 381,576 1,332,962 Total operating expenses 2,393,517 381,576 2,775,093 Operating loss (2,393,217 ) (381,576 ) (2,774,793 ) Net Income (loss) (2,392,551 ) (381,576 ) (2,774,127 ) Basic and diluted net income (loss) per share of common stock $ (0.03 ) $ (0.01 ) $ (0.04 ) As Previously Reported Adjustments As Restated Condensed Consolidated and Combined Statement of Cash Flows for the six months ended June 30, 2023 Cash Flows From Operating Activities: Net loss $ (2,392,551 ) $ (381,576 ) $ (2,774,127 ) Adjustments to reconcile net income (loss) to net cash used in operating activities: Changes in operating assets and liabilities: Due to related party — 444,076 444,076 Net Cash Used In Operating Activities (2,212,897 ) 62,500 (2,150,397 ) Cash Flows From Investing Activities: Capitalized patent costs (32,065 ) (30,170 ) (62,235 ) Net Cash Used In Investing Activities (32,065 ) (30,170 ) (62,235 ) Cash Flows From Financing Activities: Capital contributions from related party 1,624,425 (32,330 ) 1,592,095 Net Cash Provided By Financing Activities 1,624,425 (32,330 ) 1,592,095 Net change in cash $ (620,537 ) $ — $ (620,537 ) Condensed Consolidated and Combined Statement of Changes in Stockholders’ (Deficit) Equity for the three months ended June 30, 2023 Contributions and net transfers with related parties 226,698 (40,833 ) 185,865 Net loss (989,500 ) (43,085 ) (1,032,585 ) Stockholders’ Equity (Deficit), Balance at June 30, 2023 $ 3,865,588 $ (28,056 ) $ 3,837,532

Recapitalization (Tables)

Recapitalization (Tables)	6 Months Ended
	Jun. 30, 2024
Recapitalization [Abstract]
Schedule of Reconciles the Elements of the Merger	The following table reconciles the elements of the Merger to the condensed consolidated and combined statements of cash flows and the condensed consolidated and combined statements of changes in stockholders’ equity (deficit) for the period ended June 30, 2024: Cash received from NUBI Trust 25,160,047 Less: discount payment related to Non Redemption Agreement (13,937,997 ) Less: reimbursement for consideration shares related to the FPA (2,193,800 ) Less: reimbursement for Recycled Shares related to the FPA (80,241 ) Less: transaction expenses paid in connection with the Merger (8,948,009 ) Net cash received from NUBI Trust — Add: cash from NUBI operating account 17,555 Add: prepaid expenses 165,407 Less: derivative liabilities (20,889,950 ) Less: other liabilities (4,086,172 ) Reverse recapitalization, net (24,793,160 )
Schedule of Consummation of the Merger	The number of shares of common stock issued immediately following the consummation of the Merger were: Nubia common stock, outstanding prior to the closing of the Merger 6,004,741 Shares issued to Nubia convertible noteholders 5,962,325 Predecessor HBC Shares 69,800,000 Common stock immediately after the closing of the Merger 81,767,066
Schedule of the Number of Predecessor HBC Shares	The number of Predecessor HBC shares was determined as follows: Predecessor HBC Shares Shares issued to shareholders of Predecessor HBC Common stock 1,000 69,800,000

Description of Organization, _2

Description of Organization, Business Operations and Going Concern (Details) - USD ($)				3 Months Ended		6 Months Ended		12 Months Ended
	Mar. 13, 2024	Dec. 14, 2023	Mar. 15, 2022	Jun. 30, 2024	Jun. 30, 2023	Jun. 30, 2024	Jun. 30, 2023	Dec. 31, 2023	Dec. 31, 2022	Mar. 13, 2023
Description of Organization, Business Operations and Going Concern (Details) [Line Items]
Aggregate consideration shares (in Shares)								123,500
Merger agreement, description								(i)     5,000,000 Earnout Shares if, over any ten (10) trading days within any thirty (30) trading day period from and after the date that is thirty (30) days following the closing date of the Transactions (the “Closing Date”) until the second anniversary of the Closing Date, the VWAP of the shares of Solidion’s Class A common stock is greater than or equal to $12.50 per share (subject to any adjustment pursuant to the Merger Agreement);(ii)    7,500,000 Earnout Shares if, over any ten (10) trading days within any thirty (30) trading day period from and after the date that is one hundred eighty (180) days following the Closing Date until the date that is forty-two (42) months following the Closing Date, the VWAP of the shares of Solidion’s Class A common stock is greater than or equal to $15.00 per share (subject to any adjustment pursuant to the Merger Agreement); and(iii)   10,000,000 Earnout Shares if over any ten (10) trading days within any thirty (30) trading day period from and after the date that is one hundred eighty (180) days following the Closing Date until the fourth anniversary of the Closing Date, the VWAP of the shares of Solidion’s Class A common stock is greater than or equal to $25.00 per share (subject to any adjustment pursuant to the Merger Agreement).
Generating gross proceeds	$ 260,803
Sale of private placement warrant (in Shares)						200,000
Percentage of fair market value								80%
Contributed amount										$ 1,235,000
Price of public share (in Dollars per share)										$ 0.1
Additional contributed amount								$ 125,000
Special meeting extension								$ 750,000
Aggregate of common stock (in Shares)								8,430,383
Cash withdrawal from trust account								$ 89,038,494
Equity adjustment								900,000
Redeem an aggregate (in Shares)		1,625,876
Redeeming stockholders		$ 17,834,235						17,834,235
Net loss								5,300,000
Net cash used in operating activities						$ (3,541,372)	$ (2,150,397)
Cash and cash equivalents								1,000
Percentage of excise tax									1%
Excise tax								900,000
Holdback shares (in Shares)							22,500,000
Net loss				$ 22,018,416	$ (1,032,585)	(7,747,847)	$ (2,774,127)	(19,775,602)	$ 593,905
Change in the fair value of derivative liabilities				(24,966,700)		(16,784,200)		18,483,096
Issuance of common stock and warrants						17,820,998
Cash and cash equivalents				$ 256,504	$ 1,038	$ 256,504	$ 1,038	$ 780	$ 621,575
Merger Agreement [Member]
Description of Organization, Business Operations and Going Concern (Details) [Line Items]
Merger agreement, description						(i)     5,000,000 Earnout Shares if, over any ten (10) trading days within any thirty (30) trading day period from and after the date that is thirty (30) days following the closing date of the Transactions (the “Closing Date”) until the second anniversary of the Closing Date, the VWAP of the shares of Solidion’s Class A common stock is greater than or equal to $12.50 per share (subject to any adjustment pursuant to the Merger Agreement);(ii)    7,500,000 Earnout Shares if, over any ten (10) trading days within any thirty (30) trading day period from and after the date that is one hundred eighty (180) days following the Closing Date until the date that is forty-two (42) months following the Closing Date, the VWAP of the shares of Solidion’s Class A common stock is greater than or equal to $15.00 per share (subject to any adjustment pursuant to the Merger Agreement); and(iii)   10,000,000 Earnout Shares if over any ten (10) trading days within any thirty (30) trading day period from and after the date that is one hundred eighty (180) days following the Closing Date until the fourth anniversary of the Closing Date, the VWAP of the shares of Solidion’s Class A common stock is greater than or equal to $25.00 per share (subject to any adjustment pursuant to the Merger Agreement).
Holdback shares (in Shares)						200,000
Private Placement [Member]
Description of Organization, Business Operations and Going Concern (Details) [Line Items]
Aggregate warrant shares (in Shares)								5,000,000
Generating gross proceeds								$ 5,000,000
Private Placement Warrants [Member]
Description of Organization, Business Operations and Going Concern (Details) [Line Items]
Aggregate consideration shares (in Shares)									5,405,000
Aggregate warrant shares (in Shares)								5,000,000
Price per warrant shares (in Dollars per share)								$ 1
Generating gross proceeds								$ 5,000,000
Sale of private placement warrant (in Shares)								5,405,000
Common Stock [Member] | Merger Agreement [Member]
Description of Organization, Business Operations and Going Concern (Details) [Line Items]
Aggregate consideration shares (in Shares)						70,000,000
HBC [Member]
Description of Organization, Business Operations and Going Concern (Details) [Line Items]
Net cash used in operating activities								$ 4,068,302
Net loss								$ (5,324,624)
Business Combination [Member]
Description of Organization, Business Operations and Going Concern (Details) [Line Items]
Ownership interest to be acquired on post-transaction company								50%
Closing Merger Consideration Shares [Member]
Description of Organization, Business Operations and Going Concern (Details) [Line Items]
Aggregate consideration shares (in Shares)								70,000,000
Additional shares (in Shares)								22,500,000
Class A common stock subject to possible redemption [Member
Description of Organization, Business Operations and Going Concern (Details) [Line Items]
Generating gross proceeds									$ 123,500,000
Generating gross proceeds									$ 3,755,675
Redeeming stockholders		$ 17,834,235						$ 17,834,235
Initial Public Offering [Member]
Description of Organization, Business Operations and Going Concern (Details) [Line Items]
Aggregate consideration shares (in Shares)			11,000,000
Generating gross proceeds			$ 110,000,000
Sale of per unit (in Dollars per share)								$ 10.2
Over-Allotment Option [Member]
Description of Organization, Business Operations and Going Concern (Details) [Line Items]
Aggregate consideration shares (in Shares)			1,350,000					12,350,000
Generating gross proceeds			$ 13,500,000
Aggregate warrant shares (in Shares)			405,000
Offering price per unit (in Dollars per share)			$ 10
Price per unit (in Dollars per share)								$ 10
Over-Allotment Option [Member] | Private Placement Warrants [Member]
Description of Organization, Business Operations and Going Concern (Details) [Line Items]
Aggregate warrant shares (in Shares)			405,000
Price per warrant shares (in Dollars per share)			$ 1
Generating gross proceeds			$ 405,000
Offering price per unit (in Dollars per share)								$ 1
Public Shares [Member]
Description of Organization, Business Operations and Going Concern (Details) [Line Items]
Public share redemption percentage								100%
Going Concern Consideration [Member]
Description of Organization, Business Operations and Going Concern (Details) [Line Items]
Net cash used in operating activities								$ 4,100,000

Summary of Significant Accoun_3

Summary of Significant Accounting Policies (Details)				3 Months Ended		6 Months Ended		12 Months Ended
	Mar. 13, 2024 USD ($)	Feb. 01, 2024 USD ($)	Dec. 14, 2023 USD ($) shares	Jun. 30, 2024 USD ($) shares	Jun. 30, 2023 USD ($)	Jun. 30, 2024 USD ($) shares	Jun. 30, 2023 USD ($)	Dec. 31, 2023 USD ($) shares	Dec. 31, 2022 USD ($) shares	Mar. 31, 2024 USD ($)
Summary of Significant Accounting Policies [Line Items]
Interest earned								$ 187,000
Other costs	$ 522,867
Deferred shares (in Shares) | shares								4,322,500
Fair value of share issued								$ 776,815
Redemption amount								24,300,000	$ 127,200,000
Additional paid-in capital				$ 79,610,239		$ 79,610,239		28,850,985
Accumulated deficit				(97,699,353)		(97,699,353)		(25,445,506)
Interest to pay distribution expenses								100,000
Redeem an aggregate (in Shares) | shares			1,625,876
Redeeming stockholders			$ 17,834,235					17,834,235
Excise tax percentage									1%
Tax liability								900,000
Shares of common stock (in Shares) | shares			1,625,876
Federal depository insurance coverage				250,000		$ 250,000		250,000
Number of operating segment						1
Number of reportable segment						1
Other receivables								187,500
Percentage of additional trust funding requirement						50%
Depreciation expense of property and equipment				$ 68,416	$ 64,515	$ 125,510	$ 156,871
Patents useful life				20 years		20 years
Net unissued						$ 1,081,011		776,815	$ 776,815
Issued patents						857,680
Amortization expense of patents				$ 34,495	11,992	$ 71,793	25,308
Common stock initially reserved for issuance (in Shares) | shares				9,500,000		9,500,000
Stocks of common stock (in Shares) | shares				9,500,000		9,500,000
Percentage of number of stocks of common stock outstanding						5%
Patents [Member]
Summary of Significant Accounting Policies [Line Items]
Patents useful life				5 years		5 years
Net unissued								1,103,792
Issued patents								748,857
Amortization expense of patents				$ 34,495	$ 11,992	$ 71,793	$ 25,308
Global Graphene Group [Member]
Summary of Significant Accounting Policies [Line Items]
Other receivables				302,500		302,500
Transaction costs				$ 302,500		$ 302,500
Subsequent Event [Member]
Summary of Significant Accounting Policies [Line Items]
Tax obligation value										$ 82,000
Underwriter fees		$ 2,200,000
Class A Redeemable Common Stock [Member]
Summary of Significant Accounting Policies [Line Items]
Additional paid-in capital								4,800,000
Accumulated deficit									$ 12,900,000
Class A Common Stock [Member]
Summary of Significant Accounting Policies [Line Items]
Redeeming stockholders			$ 17,834,235					17,834,235
Aggregate purchase of common stock (in Shares) | shares									11,580,000
IPO [Member]
Summary of Significant Accounting Policies [Line Items]
Offering costs								6,951,081
Other costs								597,334
Underwriter fees								5,557,500
Over-Allotment Option [Member]
Summary of Significant Accounting Policies [Line Items]
Offering cost								$ 19,432

Summary of Significant Accoun_4

Summary of Significant Accounting Policies (Details) - Schedule of Class A Common Stock Subject to Possible Redemption Reflected in the Balance Sheet - Class A Common Stock [Member] - USD ($)	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022
Schedule of the Class A Common Stock Reflected in the Condensed Balance Sheets is Reconciled [Abstract]
Gross proceeds		$ 123,500,000
Proceeds allocated to Public Warrants		(3,755,675)
Class A common stock issuance costs		(6,716,427)
Total		(10,472,102)
Class A Common Stock Redeemable Remeasurement Adjustment at IPO		12,942,102
Remeasurement adjustment for the year ended December 31, 2022		1,272,983
Class A common stock subject to possible redemption as of December 31, 2022		$ 127,242,983
Class A common stock subject to possible redemption, beginning	$ 24,342,743
Transfer to funds payable to redeemed Class A stockholders	(17,834,235)
Redemptions	(89,038,494)
Remeasurement adjustment for the year ended December 31, 2023	$ 3,972,489

Summary of Significant Accoun_5

Summary of Significant Accounting Policies (Details) - Schedule of Basic and Diluted Net Income (Loss) Per Common Share - USD ($)	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022
Class A Redeemable Common Stock [Member]
Schedule of Basic and Diluted Net Income Per Share of Common Stock [Abstract]
Numerator: Income (loss) allocable	$ (13,931,674)	$ 448,713
Basic and diluted weighted average shares outstanding	7,654,886	9,846,164
Basic net income (loss) per share	$ (1.82)	$ 0.05
Diluted weighted average shares outstanding	7,654,886	9,846,164
Diluted net income per share		$ 0.05
Class A and Class B Non-Redeemable Common Stock [Member]
Schedule of Basic and Diluted Net Income Per Share of Common Stock [Abstract]
Numerator: Income (loss) allocable	$ (5,843,928)	$ 145,192
Basic and diluted weighted average shares outstanding	3,211,000	3,117,537
Basic net income (loss) per share	$ (1.82)	$ 0.05
Diluted weighted average shares outstanding	3,211,000	3,185,962
Diluted net income per share		$ 0.05

Summary of Significant Accoun_6

Summary of Significant Accounting Policies (Details) - Schedule of Basic and Diluted Net Income (Loss) Per Common Share (Parentheticals) - $ / shares	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022
Class A Redeemable Common Stock [Member]
Schedule of Basic and Diluted Net Income Per Share of Common Stock [Abstract]
Diluted weighted average shares outstanding	7,654,886	9,846,164
Diluted net income (loss) per share	$ (1.82)	$ 0.05
Class A and Class B Non-Redeemable Common Stock [Member]
Schedule of Basic and Diluted Net Income Per Share of Common Stock [Abstract]
Diluted weighted average shares outstanding	3,211,000	3,185,962
Diluted net income (loss) per share	$ (1.82)	$ 0.05

Initial Public Offering (Detail

Initial Public Offering (Details) - USD ($)					6 Months Ended
	Jun. 11, 2024	Mar. 22, 2024	Jan. 17, 2024	Mar. 15, 2022	Jun. 30, 2024	Dec. 31, 2023
Initial Public Offering [Line Items]
Additional units	9,543,002	8,038,537	5,838,537		8,996,779
Public warrants [Member]
Initial Public Offering [Line Items]
Price per share (in Dollars per share)					$ 0.01
Warrant [Member]
Initial Public Offering [Line Items]
Price per share (in Dollars per share)					9.2
Private Placement Warrants [Member]
Initial Public Offering [Line Items]
Number of shares issuable per warrant						1
Class A Common Stock [Member]
Initial Public Offering [Line Items]
Offering price per unit (in Dollars per share)					$ 18
Class A Common Stock [Member] | Warrant [Member]
Initial Public Offering [Line Items]
Number of shares issuable per warrant						1
IPO [Member] | Public warrants [Member]
Initial Public Offering [Line Items]
Number of shares issued						11,000,000
IPO [Member] | Warrant [Member]
Initial Public Offering [Line Items]
Offering price per unit (in Dollars per share)						$ 10
IPO [Member] | Class A Common Stock [Member] | Warrant [Member]
Initial Public Offering [Line Items]
Price per share (in Dollars per share)						11.5
Over-Allotment Option [Member]
Initial Public Offering [Line Items]
Offering price per unit (in Dollars per share)				$ 10
Additional units				1,350,000
Generating gross proceeds (in Dollars)				$ 13,500,000
Over-Allotment Option [Member] | Private Placement Warrants [Member]
Initial Public Offering [Line Items]
Offering price per unit (in Dollars per share)						$ 1

Private Placements (Details)

Private Placements (Details) - USD ($)		12 Months Ended
	Mar. 15, 2022	Dec. 31, 2023
Private Placement Warrants [Member]
Private Placements (Details) [Line Items]
Sale of private placement warrants		5,000,000
Price of warrant		$ 1
Generating gross proceeds		$ 5,000,000
Number of shares issuable per warrant		1
Warrant [Member]
Private Placements (Details) [Line Items]
Exercise price of warrants		$ 11.5
Over-Allotment Option [Member] | Private Placement Warrants [Member]
Private Placements (Details) [Line Items]
Sale of private placement warrants	405,000
Price of warrant	$ 1
Generating gross proceeds	$ 405,000

Related Parties (Details)

Related Parties (Details) - USD ($)

3 Months Ended

5 Months Ended

6 Months Ended

9 Months Ended

12 Months Ended

Apr. 29, 2024

Dec. 13, 2023

Aug. 15, 2023

Jul. 14, 2023

Mar. 15, 2022

Mar. 10, 2022

Aug. 17, 2021

Jun. 30, 2024

Mar. 31, 2024

Jun. 30, 2024

Jun. 30, 2024

Jun. 30, 2023

Sep. 30, 2023

Dec. 31, 2023

Dec. 31, 2022

Jan. 29, 2024

Jun. 15, 2023

May 17, 2023

May 20, 2022

Jul. 27, 2021

Related Parties [Line Items]

Number of shares issued (in Shares)

200,000

Aggregate purchase price

$ 906,000

Aggregate to founder shares (in Shares)

3,162,500

Shares subject to forfeiture (in Shares)

75,000

Outstanding amount

$ 1,297,500

$ 125,341

Working capital amount

$ 905,000

905,000

Convertible notes from related parties outstanding

905,000

0

Advances from Target

$ 62,500

Additional advanced

$ 62,500

$ 62,500

Related parties expenses paid

332,500

2,841

Cash payment

$ 7,250,000

Expenses per month

10,000

Expenses related

125,000

95,000

General and administrative services outstanding

79,481

$ 0

Business combination interest

1,500,000

Capital contribution

487,273

$ 1,592,095

Other receivables

$ 187,500

Additional trust funding requirement percentage

50%

Expenses amount

$ 76,521

Amount outstanding

13,000

Payment

$ 669,985

Repaid due to related parties

911,091

Shares issue (in Shares)

123,500

Fair value

$ 906,000

Holdback shares (in Shares)

200,000

Private Placement Warrants [Member]

Related Parties [Line Items]

Number of shares issued (in Shares)

5,405,000

Shares issue (in Shares)

5,405,000

Unsecured Promissory Note [Member]

Related Parties [Line Items]

Aggregate principal amount

$ 1,000,000

$ 300,000

Conversion price (in Dollars per share)

$ 1

$ 1

Nubia [Member]

Related Parties [Line Items]

Transaction costs

$ 302,500

Sponsor [Member]

Related Parties [Line Items]

Percentage of shares holding after IPO

20%

Related Party [Member]

Related Parties [Line Items]

Advances from Related Party

$ 332,500

Related Party [Member] | Private Placement Warrants [Member]

Related Parties [Line Items]

Warrant per share (in Dollars per share)

$ 1

Global Graphene Group [Member]

Related Parties [Line Items]

Other receivables

$ 302,500

$ 302,500

$ 302,500

Amount outstanding

879,985

Mach FM [Member]

Related Parties [Line Items]

Amount outstanding

88,979

Founder Shares [Member] | Sponsor [Member]

Related Parties [Line Items]

Exceed per share (in Dollars per share)

$ 12

Merger Agreement [Member]

Related Parties [Line Items]

Deferred underwriting commission

$ 4,322,500

Related Party [Member]

Related Parties [Line Items]

Repaid due to related parties

$ 669,985

879,985

Related Party [Member] | Global Graphene Group [Member]

Related Parties [Line Items]

Amount outstanding

0

Related Party [Member] | Mach FM [Member]

Related Parties [Line Items]

Amount outstanding

$ 87,873

Tax Lien [Member]

Related Parties [Line Items]

Shares issue (in Shares)

200,000

Subsequent Event [Member]

Related Parties [Line Items]

Conversion price (in Dollars per share)

$ 1

Previously Reported [Member]

Related Parties [Line Items]

Advance outstanding amount

$ 187,500

Class B Common Stock [Member] | Founder Shares [Member] | Sponsor [Member]

Related Parties [Line Items]

Number of shares issued (in Shares)

2,875,000

Aggregate purchase price

$ 25,000

Over-Allotment Option [Member]

Related Parties [Line Items]

Exceed per share (in Dollars per share)

$ 10

Shares issue (in Shares)

1,350,000

12,350,000

Over-Allotment Option [Member] | Private Placement Warrants [Member]

Related Parties [Line Items]

Exceed per share (in Dollars per share)

$ 1

Over-Allotment Option [Member] | Founder Shares [Member]

Related Parties [Line Items]

Shares subject to forfeiture (in Shares)

412,500

Commitments and Contingencies (

Commitments and Contingencies (Details) - USD ($)		6 Months Ended		12 Months Ended
	Mar. 15, 2022	Jun. 30, 2024	Jun. 30, 2023	Dec. 31, 2023	Dec. 31, 2022
Commitments and Contingencies [Line Items]
Aggregate consideration shares (in Shares)				123,500
Underwriting cash discount per unit (in Dollars per share)				$ 0.1
Additional deferred fee				$ 4,322,500
Cash payment to sponsor				7,250,000
Change in fair value					$ (19,432)
Stock issuance cost				$ 776,815
Inclusive of interest balance		$ 1,950,000
Shares not issued (in Shares)			22,500,000
Fair value		$ 906,000
Fair value holdback shares (in Shares)		200,000
HBC holdback shares [Member]
Commitments and Contingencies [Line Items]
Aggregate consideration shares (in Shares)		200,000
Shares not issued (in Shares)		200,000
HBC shareholders [Member]
Commitments and Contingencies [Line Items]
Additional shares of common stock (in Shares)		22,500,000
Class A Common Stock [Member]
Commitments and Contingencies [Line Items]
Receive shares (in Shares)				123,500
Price per share (in Dollars per share)		$ 18
Over-Allotment Option [Member]
Commitments and Contingencies [Line Items]
Aggregate consideration shares (in Shares)	1,350,000			12,350,000
Underwriting discount paid upon closing of initial public offering				$ 1,235,000
Deferred fee				$ 0.35
Price per share (in Dollars per share)	$ 10
Gross proceeds	$ 13,500,000
Change in fair value	$ 19,432
Over-Allotment Option [Member] | Indemnification Agreement [Member]
Commitments and Contingencies [Line Items]
Aggregate consideration shares (in Shares)				1,650,000

Stockholders_ Equity (Deficit)

Stockholders’ Equity (Deficit) (Details) - USD ($)		6 Months Ended		12 Months Ended
	Mar. 13, 2024	Jun. 30, 2024	Jun. 30, 2023	Dec. 31, 2023	Dec. 31, 2022
Stockholders’ Equity (Deficit) [Line Items]
Preferred stock, shares authorized		2,000,000		2,000,000
Preferred stock, par value (in Dollars per share)		$ 0.0001		$ 0.0001
Preferred stock, shares issued
Preferred stock, shares outstanding
Common stock authorized		300,000,000		300,000,000
Common stock, par value (in Dollars per share)		$ 0.0001		$ 0.0001
Common stock, voting rights		one
Common stock, shares issued		87,100,341		69,800,000
Common stock, shares outstanding		87,100,341		69,800,000
Converted basis, percentage				20%
Share price (in Dollars per share)		$ 0.55		$ 18
Proceeds from Issuance of Private Placement (in Dollars)	$ 3,850,000	$ (262,064)
Other expenses (in Dollars)	522,867
Issuance of warrants (in Dollars)	260,803
Prefund purchase price (in Dollars per share)		$ 0.0001
Sale of units		Each Unit consists of (i) one share of Solidion Common Stock, (ii) two Series C Warrants (“Series C Warrants”) each to purchase one share of Common Stock, and (iii) one Series B warrant (“Series D Warrants”) to purchase such number of shares of Common Stock as determined on the reset date (as defined in the Subscription Agreement), and in accordance with the terms therein.
Warrant [Member]
Stockholders’ Equity (Deficit) [Line Items]
Warrants outstanding				11,580,000
Public warrants, term				5 years
Private Warrants [Member]
Stockholders’ Equity (Deficit) [Line Items]
Warrants outstanding				5,405,000
Public warrants [Member]
Stockholders’ Equity (Deficit) [Line Items]
Warrants outstanding				6,175,000
Redemption of warrant price per share (in Dollars per share)				$ 0.01
Previously Reported [Member]
Stockholders’ Equity (Deficit) [Line Items]
Preferred stock, shares authorized				1,000,000	1,000,000
Preferred stock, par value (in Dollars per share)				$ 0.0001	$ 0.0001
Preferred stock, shares issued
Preferred stock, shares outstanding
Proceeds from Issuance of Private Placement (in Dollars)					$ 5,405,000
Class A Common Stock [Member]
Stockholders’ Equity (Deficit) [Line Items]
Common stock, shares outstanding				123,500	123,500
Redemption of warrant common stock equal or exceed price per share (in Dollars per share)				$ 18
Class A Common Stock [Member] | Previously Reported [Member]
Stockholders’ Equity (Deficit) [Line Items]
Common stock authorized				100,000,000	100,000,000
Common stock, par value (in Dollars per share)				$ 0.0001	$ 0.0001
Common stock, voting rights				one
Common stock, shares outstanding				2,293,741	12,350,000
Common stock, shares issued				123,500	123,500
Common stock, shares outstanding				123,500	123,500
Class A Common Stock [Member] | Equity [Member]
Stockholders’ Equity (Deficit) [Line Items]
Common stock, shares issued				123,500	123,500
Class A Common Stock [Member] | Previously Reported [Member]
Stockholders’ Equity (Deficit) [Line Items]
Common stock, shares outstanding				2,293,741	12,350,000
Class B Common Stock [Member] | Previously Reported [Member]
Stockholders’ Equity (Deficit) [Line Items]
Common stock authorized				10,000,000	10,000,000
Common stock, par value (in Dollars per share)				$ 0.0001	$ 0.0001
Common stock, voting rights				one
Common stock, shares issued				3,087,500	3,087,500
Common stock, shares outstanding				3,087,500	3,087,500
Class B Common Stock [Member] | Founder Shares [Member]
Stockholders’ Equity (Deficit) [Line Items]
Founder shares, percentage				20%
Common Stock [Member]
Stockholders’ Equity (Deficit) [Line Items]
Common stock, shares outstanding		87,100,341
Over-Allotment Option [Member]
Stockholders’ Equity (Deficit) [Line Items]
Shares subject to forfeiture				75,000
Over-Allotment Option [Member] | Class B Common Stock [Member]
Stockholders’ Equity (Deficit) [Line Items]
Common stock, shares outstanding				3,087,500
Shares subject to forfeiture				412,500
Over-Allotment Option [Member] | Class B Common Stock [Member] | Previously Reported [Member]
Stockholders’ Equity (Deficit) [Line Items]
Common stock, shares issued				3,087,500	3,087,500
Common stock, shares outstanding					3,087,500
Private Placement [Member]
Stockholders’ Equity (Deficit) [Line Items]
Share price (in Dollars per share)		$ 0.75
Issuance of private placement common stock (in Dollars)	$ 262,064
Prefunded units		5,133,332
Prefund purchase price (in Dollars per share)		$ 0.75

Forward Purchase Agreement an_2

Forward Purchase Agreement and Non Redemption Agreement (Details) - USD ($)							3 Months Ended	6 Months Ended
	Jun. 11, 2024	Mar. 22, 2024	Feb. 29, 2024	Feb. 02, 2024	Jan. 17, 2024	Dec. 13, 2023	Jun. 30, 2024	Jun. 30, 2024	Jun. 28, 2024	Dec. 31, 2023
Forward Purchase Agreement and Non Redemption Agreement [Line Items]
Ordinary shares, par value (in Dollars per share)							$ 0.0001	$ 0.0001		$ 0.0001
Derivative liability (in Dollars)							$ 16,844,750	$ 16,844,750
Redemption price (in Dollars per share)							$ 18	$ 18
Cash payment				7,352
Trust account (in Dollars)				$ 80,241
Additional shares	9,543,002	8,038,537			5,838,537			8,996,779
Proceeds from liability (in Dollars)	$ 245,051							$ 216,967
Liability (in Dollars)	5,403,534						$ 21,268	21,268
Net liability (in Dollars)	$ 5,158,483						$ 4,815,800	$ 4,815,800
Aggregate issued shares								200,000
Price per unit (in Dollars per share)							$ 0.55	$ 0.55		$ 18
VWAP amount (in Dollars per share)									$ 0.4347
Warrants reset per share (in Dollars per share)								$ 0.3478
Issuance of common shares								199,943
Prefunded Warrant [Member]
Forward Purchase Agreement and Non Redemption Agreement [Line Items]
Exercise price (in Dollars per share)							0.0001	$ 0.0001
Series C Warrant [Member]
Forward Purchase Agreement and Non Redemption Agreement [Line Items]
Exercise price (in Dollars per share)							$ 0.75	$ 0.75
Share of common stock							10,266,664	10,266,664
Series B Warrants [Member]
Forward Purchase Agreement and Non Redemption Agreement [Line Items]
Exercise price (in Dollars per share)							$ 0.0001	$ 0.0001
Warrant reset shares								5,749,598
Issuance of common shares								199,943
Series D Warrant [Member]
Forward Purchase Agreement and Non Redemption Agreement [Line Items]
Share of common stock							25,666,660	25,666,660
Series A Warrants [Member]
Forward Purchase Agreement and Non Redemption Agreement [Line Items]
Warrant reset shares								22,141,701
Issuance of common shares								0
Forward Purchase Agreement [Member]
Forward Purchase Agreement and Non Redemption Agreement [Line Items]
Purchase price percentage						9.90%		9.90%
Shares outstanding, percentage						9.90%	9.90%	9.90%
Prepayment shortfall for purchase agreement						0.50%	0.50%	0.50%
Proceeds from sale equal to prepayment shortfall percentage						100%	100%	100%
Payment of cash (in Dollars)						$ 200,000		$ 200,000
Derivative liability (in Dollars)										$ 35,576,596
Reimbursement amount (in Dollars)			$ 2,193,800
Reimbursement consideration shares			200,000
Additional shares	9,543,002							8,996,779
Proceeds from liability (in Dollars)								$ 216,967
Liability (in Dollars)							$ 5,032,777	5,032,777
Net liability (in Dollars)							$ 4,815,800	$ 4,815,800
Non-Redemption Agreement [Member]
Forward Purchase Agreement and Non Redemption Agreement [Line Items]
Derivative liability (in Dollars)										$ 11,152,000
Issued and outstanding shares percentage						9.99%		9.99%
Redemption price (in Dollars per share)				$ 4		$ 4
Common Stock [Member]
Forward Purchase Agreement and Non Redemption Agreement [Line Items]
Ordinary shares, par value (in Dollars per share)							$ 0.0001	$ 0.0001
Price per unit (in Dollars per share)							$ 0.15	$ 0.15
Issuance of common shares							199,943
NUBI Shares [Member] | Forward Purchase Agreement [Member]
Forward Purchase Agreement and Non Redemption Agreement [Line Items]
Ownership limitation percentage						9.90%	9.90%	9.90%
Class A Ordinary Shares [Member]
Forward Purchase Agreement and Non Redemption Agreement [Line Items]
Redemption price (in Dollars per share)							$ 18	$ 18
Value per unit (in Dollars per share)							18	18
Class A Ordinary Shares [Member] | Forward Purchase Agreement [Member]
Forward Purchase Agreement and Non Redemption Agreement [Line Items]
Ordinary shares, par value (in Dollars per share)						$ 0.0001	0.0001	$ 0.0001
Private Placement [Member]
Forward Purchase Agreement and Non Redemption Agreement [Line Items]
Gross proceeds (in Dollars)								$ 3,850,000
Aggregate issued shares								5,133,332
Price per unit (in Dollars per share)							0.75	$ 0.75
Value per unit (in Dollars per share)							$ 0.0001	$ 0.0001

Fair Value Measurements (Detail

Fair Value Measurements (Details) - USD ($)				3 Months Ended	6 Months Ended	12 Months Ended
	Jun. 11, 2024	Mar. 22, 2024	Jan. 17, 2024	Jun. 30, 2024	Jun. 30, 2024	Dec. 31, 2023	Dec. 31, 2022
Fair Value Measurements [Line Items]
Derivative liabilities				$ 16,844,750	$ 16,844,750
Representative Shares (in Shares)						123,500
Grant of fair value per share (in Dollars per share)						$ 6.29
Aggregate value					$ 1,081,011	$ 776,815	$ 776,815
Additional Shares (in Shares)	9,543,002	8,038,537	5,838,537		8,996,779
Proceeds from liability	$ 245,051				$ 216,967
Liability	5,403,534			21,268	21,268
Net liability	$ 5,158,483			4,815,800	4,815,800
Gain (loss) from the change in fair value of derivatives				$ 0	$ 17,820,998
Stock price (in Dollars per share)				$ 0.55	$ 0.55	$ 18
Risk free rate					4.60%
Volatility rate					100%
Dividends yield rate					0%
Duration of years					2 years 4 months 24 days
Series C Warrant [Member]
Fair Value Measurements [Line Items]
Fair value of warrants				$ 9,139,200	$ 9,139,200
Exercise warrants shares (in Shares)				10,266,664	10,266,664
Series D Warrant [Member]
Fair Value Measurements [Line Items]
Fair value of warrants				$ 2,889,750	$ 2,889,750
Exercise warrants shares (in Shares)				25,666,660	25,666,660
Warrant [Member]
Fair Value Measurements [Line Items]
Gain (loss) from the change in fair value of derivatives				$ 9,141,900	$ 710,050
Forward Purchase Agreement [Member]
Fair Value Measurements [Line Items]
Derivative liabilities						$ 35,576,596
Additional Shares (in Shares)	9,543,002				8,996,779
Proceeds from liability					$ 216,967
Liability				5,032,777	5,032,777
Net liability				4,815,800	4,815,800
Non-Redemption Agreement [Member]
Fair Value Measurements [Line Items]
Derivative liabilities						$ 11,152,000
Forward Purchase Agreement [Member]
Fair Value Measurements [Line Items]
Liability				$ 5,032,777	$ 5,032,777
Common Stock [Member] | Series C Warrant [Member]
Fair Value Measurements [Line Items]
Exercise warrants shares (in Shares)				0	0
Common Stock [Member] | Series D Warrant [Member]
Fair Value Measurements [Line Items]
Exercise warrants shares (in Shares)				199,943	199,943
Earnout Shares [Member]
Fair Value Measurements [Line Items]
Stock price (in Dollars per share)				$ 4.53	$ 4.53
Risk free rate					3.98%
Volatility rate					85%
Dividends yield rate					0%
Duration of years					4 years

Fair Value Measurements (Deta_2

Fair Value Measurements (Details) - Schedule of Company’s Assets and Liabilities - USD ($)	Dec. 31, 2023	Dec. 31, 2022
Level 1 [Member]
Fair Value Measurements (Details) - Schedule of Company’s Assets and Liabilities [Line Items]
Cash and investments held in Trust Account	$ 42,994,274	$ 127,782,882
Level 3 [Member]
Fair Value Measurements (Details) - Schedule of Company’s Assets and Liabilities [Line Items]
Derivative asset	28,245,500
Level 3 [Member]
Fair Value Measurements (Details) - Schedule of Company’s Assets and Liabilities [Line Items]
Derivative liabilities	$ 46,728,596

Fair Value Measurements (Deta_3

Fair Value Measurements (Details) - Schedule of Fair Value Measurement of FPA and NRA Liability Using the Following Range of Weighted Average Assumptions	Dec. 31, 2023
Risk-free interest rate (FPA) [Member]
Schedule of Fair Value Measurement of FPA and NRA Liability [Line Items]
Fair value measurement liability	3.85
Expected life of over-allotment option (FPA) [Member]
Schedule of Fair Value Measurement of FPA and NRA Liability [Line Items]
Fair value measurement liability	5.4
Expected volatility of underlying stock (FPA) [Member]
Schedule of Fair Value Measurement of FPA and NRA Liability [Line Items]
Fair value measurement liability	75
Dividends (FPA) [Member]
Schedule of Fair Value Measurement of FPA and NRA Liability [Line Items]
Fair value measurement liability	0
Probability of merger closing (FPA and NRA) [Member]
Schedule of Fair Value Measurement of FPA and NRA Liability [Line Items]
Fair value measurement liability	80

Income Taxes (Details)

Income Taxes (Details) - USD ($)	3 Months Ended		6 Months Ended		12 Months Ended
	Jun. 30, 2024	Jun. 30, 2023	Jun. 30, 2024	Jun. 30, 2023	Dec. 31, 2023	Dec. 31, 2022
Income Taxes [Abstract]
Valuation allowance					$ 221,409	$ 147,481
Income tax expense					(1,579,608)	(339,899)
Effective tax rate	0%	0%	0%	0%
Deferred tax assets

Income Taxes (Details) - Schedu

Income Taxes (Details) - Schedule of Deferred Tax Assets - USD ($)	Jun. 30, 2024	Dec. 31, 2023	Jun. 30, 2023	Dec. 31, 2022
Deferred tax asset
Net operating loss
Startup/organizational costs		369,290		147,881
Total deferred tax asset		369,290		147,881
Valuation allowance		(369,290)		(147,881)
Deferred tax asset, net of allowance

Income Taxes (Details) - Sche_2

Income Taxes (Details) - Schedule of Income Tax Provision (Benefit) - USD ($)	3 Months Ended		6 Months Ended		12 Months Ended
	Jun. 30, 2024	Jun. 30, 2023	Jun. 30, 2024	Jun. 30, 2023	Dec. 31, 2023	Dec. 31, 2022
Federal
Current					$ 1,579,608	$ 339,899
Deferred
State and Local
Current
Deferred
Income tax provision/(benefit)					$ 1,579,608	$ 339,899

Income Taxes (Details) - Sche_3

Income Taxes (Details) - Schedule of Reconciliation of the Statutory Tax Rate	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022
Schedule of Reconciliation of the Statutory Tax Rate [Abstract]
Statutory federal income tax rate	21%	21%
State taxes, net of federal tax benefit
Merger costs	(2.60%)
Derivatives	(8.46%)
Other	(0.04%)	(0.44%)
Change in valuation allowance	(1.22%)	15.84%
Income tax provision (benefit)	8.68%	36.40%

Subsequent Events (Details)

Subsequent Events (Details) - USD ($)				6 Months Ended		12 Months Ended
	Mar. 13, 2024	Feb. 01, 2024	Dec. 14, 2023	Jun. 30, 2024	Jun. 30, 2023	Dec. 31, 2023	Apr. 01, 2024	Jan. 29, 2024
Subsequent Events [Line Items]
Stockholders elected to redeem common stock			1,625,876
Funds due and payable (in Dollars)			$ 17,834,235			$ 17,834,235
Aggregate gross proceeds (in Dollars)	$ 3,850,000			$ (262,064)
Aggregate units						123,500
Price per unit (in Dollars per share)				$ 0.0001		$ 0.0001
Subsequent Event [Member]
Subsequent Events [Line Items]
Conversion price per share (in Dollars per share)								$ 1
Underwriters' fees (in Dollars)		$ 2,200,000
Principal amount (in Dollars)							$ 183,333
Aggregate gross proceeds (in Dollars)	$ 3,850,000
Price per unit (in Dollars per share)						$ 0.0001
Number of shares						1
Subsequent Event [Member] | Series A Warrant [Member]
Subsequent Events [Line Items]
Number of shares						2
Subsequent Event [Member] | Series B Warrant [Member]
Subsequent Events [Line Items]
Number of shares						1
Solidion Common Stock [Member] | Subsequent Event [Member]
Subsequent Events [Line Items]
Number of shares						1
Common Stock [Member]
Subsequent Events [Line Items]
Price per unit (in Dollars per share)				$ 0.0001
Number of shares				87,100,341	69,800,000
Common Stock [Member] | Subsequent Event [Member]
Subsequent Events [Line Items]
Number of shares						1
Common Stock [Member] | Subsequent Event [Member] | Series A Warrant [Member]
Subsequent Events [Line Items]
Number of shares						1
Private Placement [Member] | Subsequent Event [Member]
Subsequent Events [Line Items]
Aggregate units						5,133,332
Purchase price per unit (in Dollars per share)						$ 0.75

Restatement of Previously Iss_3

Restatement of Previously Issued Financial Statements (Details) - Schedule of Restatement on each Financial Statement - USD ($)	3 Months Ended			6 Months Ended		12 Months Ended
	Jun. 30, 2024	Jun. 30, 2023	Mar. 31, 2023	Jun. 30, 2024	Jun. 30, 2023	Dec. 31, 2023	Dec. 31, 2022
Operating expenses
Selling, general and administrative		$ 351,330			$ 1,332,962
Total operating expenses	$ 2,933,309	1,032,976		$ 6,692,645	2,775,093	$ 3,509,621	$ 904,193
Operating loss	(2,933,309)	(1,032,976)		(6,692,645)	(2,774,793)
Net Income (loss)	$ 22,018,416	$ (1,032,585)		$ (7,747,847)	$ (2,774,127)	(19,775,602)	593,905
Basic net income (loss) per share of common stock (in Dollars per share)	$ 0.25	$ (0.01)		$ (0.09)	$ (0.04)
Cash Flows From Operating Activities:
Net loss	$ 22,018,416	$ (1,032,585)		$ (7,747,847)	$ (2,774,127)	(19,775,602)	593,905
Due to related party					444,076
Net Cash Used In Operating Activities				(3,541,372)	(2,150,397)
Cash Flows From Investing Activities:
Capitalized patent costs				(157,834)	(62,235)
Net Cash Used In Investing Activities				(157,834)	(62,235)
Cash Flows From Financing Activities:
Capital contributions from related party				487,273	1,592,095
Net Cash Provided By Financing Activities				3,954,930	1,592,095
Net change in cash				255,724	(620,537)
Contributions and net transfers with related parties		185,865
Net loss	22,018,416	(1,032,585)		(7,747,847)	(2,774,127)	(19,775,602)	593,905
Balance ending	$ (18,160,646)	3,837,532		$ (18,160,646)	3,837,532	(28,533,250)	(3,894,774)
As Previously Reported [Member]
Operating expenses
Net Income (loss)						(19,775,602)	593,905
Cash Flows From Operating Activities:
Net loss						(19,775,602)	593,905
Net Cash Used In Operating Activities						(2,661,093)	(725,102)
Cash Flows From Investing Activities:
Net Cash Used In Investing Activities						88,576,752	(125,970,000)
Cash Flows From Financing Activities:
Net Cash Provided By Financing Activities						(86,441,335)	127,240,757
Net change in cash						(525,676)	545,655
Net loss						(19,775,602)	593,905
Balance ending						3,412,459	5,983,426
Adjustments [Member]
Cash Flows From Financing Activities:
Contributions and net transfers with related parties			$ 442,368
Balance ending			$ 4,684,252			$ 3,412,459	$ 5,983,426
Restatement [Member] | As Previously Reported [Member]
Operating expenses
Selling, general and administrative		308,245			951,386
Total operating expenses		989,891			2,393,517
Operating loss		(989,891)			(2,393,217)
Net Income (loss)		(989,500)			$ (2,392,551)
Basic net income (loss) per share of common stock (in Dollars per share)					$ (0.03)
Cash Flows From Operating Activities:
Net loss		(989,500)			$ (2,392,551)
Due to related party
Net Cash Used In Operating Activities					(2,212,897)
Cash Flows From Investing Activities:
Capitalized patent costs					(32,065)
Net Cash Used In Investing Activities					(32,065)
Cash Flows From Financing Activities:
Capital contributions from related party					1,624,425
Net Cash Provided By Financing Activities					1,624,425
Net change in cash					(620,537)
Contributions and net transfers with related parties		226,698
Net loss		(989,500)			(2,392,551)
Balance ending		3,865,588			3,865,588
Restatement [Member] | Adjustments [Member]
Operating expenses
Selling, general and administrative		43,085			381,576
Total operating expenses		43,085			381,576
Operating loss		(43,085)			(381,576)
Net Income (loss)		(43,085)			$ (381,576)
Basic net income (loss) per share of common stock (in Dollars per share)					$ (0.01)
Cash Flows From Operating Activities:
Net loss		(43,085)			$ (381,576)
Due to related party					444,076
Net Cash Used In Operating Activities					62,500
Cash Flows From Investing Activities:
Capitalized patent costs					(30,170)
Net Cash Used In Investing Activities					(30,170)
Cash Flows From Financing Activities:
Capital contributions from related party					(32,330)
Net Cash Provided By Financing Activities					(32,330)
Net change in cash
Contributions and net transfers with related parties		(40,833)
Net loss		(43,085)			(381,576)
Balance ending		$ (28,056)			$ (28,056)

Restatement of Previously Iss_4

Restatement of Previously Issued Financial Statements (Details) - Schedule of Restatement on each Financial Statement (Parentheticals) - $ / shares	3 Months Ended		6 Months Ended
	Jun. 30, 2024	Jun. 30, 2023	Jun. 30, 2024	Jun. 30, 2023
Condensed Financial Statements, Captions [Line Items]
Diluted net income (loss) per share of common stock	$ 0.23	$ (0.01)	$ (0.09)	$ (0.04)
Restatement [Member] | As Previously Reported [Member]
Condensed Financial Statements, Captions [Line Items]
Diluted net income (loss) per share of common stock				(0.03)
Restatement [Member] | Adjustments [Member]
Condensed Financial Statements, Captions [Line Items]
Diluted net income (loss) per share of common stock				$ (0.01)

Summary of Significant Accoun_7

Summary of Significant Accounting Policies (Details) - Schedule of Property and Equipment Estimated Useful Lives	Jun. 30, 2024
Building [Member]
Schedule of Property and Equipment Estimated Useful Lives [Line Items]
Estimated useful lives	40 years
Leasehold improvements [Member]
Schedule of Property and Equipment Estimated Useful Lives [Line Items]
Estimated useful lives	15 years
Machinery & equipment [Member]
Schedule of Property and Equipment Estimated Useful Lives [Line Items]
Estimated useful lives	5 years

Summary of Significant Accoun_8

Summary of Significant Accounting Policies (Details) - Schedule of Potentially Dilutive Common Stock Equivalents - shares	6 Months Ended	12 Months Ended
	Jun. 30, 2024	Dec. 31, 2023
HBC holdback shares [Member]
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Total common stock equivalents excluded from dilutive loss per share	200,000
Warrants - Public [Member]
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Total common stock equivalents excluded from dilutive loss per share	6,175,000
Warrants - Private [Member]
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Total common stock equivalents excluded from dilutive loss per share	5,405,000
Warrants - Series A [Member]
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Total common stock equivalents excluded from dilutive loss per share	22,141,701
Warrants - Series B [Member]
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Total common stock equivalents excluded from dilutive loss per share	5,549,655
Total common stock equivalents included in dilutive income per share	5,549,655
Share-Based Payment Arrangement [Member]
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Total common stock equivalents excluded from dilutive loss per share	300,000
Total common stock equivalents included in dilutive income per share	300,000
Forward Purchase Agreement – Additional Shares [Member]
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Total common stock equivalents excluded from dilutive loss per share	8,038,537
Convertible notes [Member]
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Total common stock equivalents excluded from dilutive loss per share	3,396,261
Total common stock equivalents included in dilutive income per share	3,396,261
HBC Earnout Shares [Member]
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Total common stock equivalents excluded from dilutive loss per share	22,500,000
Anti-dilutive [Member]
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Total common stock equivalents excluded from dilutive loss per share	73,706,154
Dilutive [Member]
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Total common stock equivalents included in dilutive income per share	9,245,916

Summary of Significant Accoun_9

Summary of Significant Accounting Policies (Details) - Schedule of Composition of Other Current Assets - USD ($)	Jun. 30, 2024	Dec. 31, 2023
Schedule of Composition of Other Current Assets [Line Items]
Total other assets	$ 777,135
Directors & Officers Insurance [Member]
Schedule of Composition of Other Current Assets [Line Items]
Total other assets	$ 777,135

Summary of Significant Accou_10

Summary of Significant Accounting Policies (Details) - Schedule of Composition of Other Assets - USD ($)	Jun. 30, 2024	Dec. 31, 2023
Schedule of Composition of Other Assets [Line Items]
Total other assets	$ 778,167
Directors & Officers Insurance [Member]
Schedule of Composition of Other Assets [Line Items]
Total other assets	$ 778,167

Recapitalization (Details)

Recapitalization (Details) - USD ($)	6 Months Ended	12 Months Ended
	Jun. 30, 2024	Dec. 31, 2023	Dec. 31, 2022
Recapitalization [Line Items]
Net proceeds from transaction cost (in Dollars)	$ 17,555
Aggregate units		123,500
Risk free rate	4.60%
Volatility	100%
Dividends yield	0%
Duration	2 years 4 months 24 days
Earnout shares	0
HBC Earnout Arrangement [Member]
Recapitalization [Line Items]
Stock price (in Dollars per share)	$ 4.53
Risk free rate	3.98%
Volatility	85%
Dividends yield	0%
Duration	4 years
Public Warrants [Member]
Recapitalization [Line Items]
Aggregate units			6,175,000
Private Placement Warrants [Member]
Recapitalization [Line Items]
Aggregate units			5,405,000
HBC holdback shares [Member]
Recapitalization [Line Items]
Aggregate units			200,000
Shares issued	200,000
HBC shareholders [Member]
Recapitalization [Line Items]
Aggregate units	22,500,000

Recapitalization (Details) - Sc

Recapitalization (Details) - Schedule of Reconciles the Elements of the Merger - Merger [Member]	6 Months Ended
	Jun. 30, 2024 USD ($)
Schedule of Reconciles the Elements of the Merger [Line Items]
Cash received from NUBI Trust	$ 25,160,047
Less: discount payment related to Non Redemption Agreement	(13,937,997)
Less: reimbursement for consideration shares related to the FPA	(2,193,800)
Less: reimbursement for Recycled Shares related to the FPA	(80,241)
Less: transaction expenses paid in connection with the Merger	(8,948,009)
Net cash received from NUBI Trust
Add: cash from NUBI operating account	17,555
Add: prepaid expenses	165,407
Less: derivative liabilities	(20,889,950)
Less: other liabilities	(4,086,172)
Reverse recapitalization, net	$ (24,793,160)

Recapitalization (Details) - _2

Recapitalization (Details) - Schedule of Consummation of the Merger - Merger [Member]	Jun. 30, 2024 shares
Schedule of Consummation of the Merger [Line Items]
Common stock issued immediately after the Merger	81,767,066
Nubia common stock, outstanding prior to the closing of the Merger [Member]
Schedule of Consummation of the Merger [Line Items]
Common stock issued immediately after the Merger	6,004,741
Shares issued to Nubia convertible noteholders [Member]
Schedule of Consummation of the Merger [Line Items]
Common stock issued immediately after the Merger	5,962,325
Predecessor HBC Shares [Member]
Schedule of Consummation of the Merger [Line Items]
Common stock issued immediately after the Merger	69,800,000

Recapitalization (Details) - _3

Recapitalization (Details) - Schedule of the Number of Predecessor HBC Shares	Jun. 30, 2024 shares
Predecessor HBC Shares [Member]
Schedule of the Number of Predecessor HBC Shares [Line Items]
Common stock	1,000
Shares issued to shareholders of Predecessor HBC [Member]
Schedule of the Number of Predecessor HBC Shares [Line Items]
Common stock	69,800,000

Patents (Details)

Patents (Details) - USD ($)	3 Months Ended		6 Months Ended
	Jun. 30, 2024	Jun. 30, 2023	Jun. 30, 2024	Jun. 30, 2023	Dec. 31, 2023
Patents [Line Items]
Net accumulated amortization	$ 1,938,690		$ 1,938,690		$ 1,852,649
Amortization expense for the patents	$ 34,495	$ 11,992	$ 71,793	$ 25,308
Amortization expense over period	20 years		20 years
Patents [Member]
Patents [Line Items]
Amortization expense for the patents	$ 34,495	$ 11,992	$ 71,793	$ 25,308
Amortization expense over period	5 years		5 years
Future amortization expense for the patents			$ 148,000

Foreign Operations (Details)

Foreign Operations (Details) - USD ($)	3 Months Ended		6 Months Ended		12 Months Ended
	Jun. 30, 2024	Jun. 30, 2023	Jun. 30, 2024	Jun. 30, 2023	Dec. 31, 2023	Dec. 31, 2022	Jun. 11, 2024
Foreign Operations [Line Items]
Total assets	$ 34,057		$ 34,057
Total liabilities	21,268		21,268				$ 5,403,534
Revenues recognized				$ 300
Total expenses foreign subsidiary	2,933,309	1,032,976	6,692,645	2,775,093	$ 3,509,621	$ 904,193
Foreign Subsidiary [Member]
Foreign Operations [Line Items]
Total assets					24,132
Total liabilities					62,753
Property and equipment total	10,250		10,250		$ 14,500
Revenues recognized
Total expenses foreign subsidiary	$ 56,337	$ 60,908	$ 97,756	$ 140,447

Warrants (Details)

Warrants (Details) - USD ($)	3 Months Ended		6 Months Ended		12 Months Ended
	Jun. 30, 2024	Jun. 30, 2023	Jun. 30, 2024	Jun. 30, 2023	Dec. 31, 2023	Dec. 31, 2022
Warrants (Details) [Line Items]
Redemption trigger price	$ 18		$ 18
Redeemed common stock percentage	100%		100%
Consideration receivable percentage	70%		70%
Equity proceeds percentage			60%
Percentage of market value			180%
Issuance of warrants			$ 17,820,998
Fair value of warrants	(24,966,700)		(16,784,200)		$ 18,483,096
Fair value gain	$ 9,141,900		$ 710,050
Issuance common shares			199,943
IPO Warrants [Member]
Warrants (Details) [Line Items]
Sale of stock price per share	$ 11.5		$ 11.5
Public warrants expire term	5 years		5 years
Warrant exercise price per share	$ 11.5		$ 11.5
Public warrants [Member]
Warrants (Details) [Line Items]
Warrant exercise price per share	0.01		0.01
Warrant [Member]
Warrants (Details) [Line Items]
Public warrants expire term					5 years
Warrant exercise price per share	9.2		$ 9.2
Percentage of market value			115%
Series C Warrant [Member]
Warrants (Details) [Line Items]
Warrant exercise price per share	$ 0.75		$ 0.75
Issuance of warrants			$ 12,656,550
Proceeds from private placement			3,850,000
Issuance of warrants			17,820,998
Fair value of warrants			$ 9,139,200
Warrants exercised	0		0
Series D Warrant [Member]
Warrants (Details) [Line Items]
Issuance of warrants			$ 82,450
Fair value of warrants			$ 2,889,750
Warrants exercised	333,333		333,333
Minimum [Member]
Warrants (Details) [Line Items]
Common stock outstanding percentage	4.90%		4.90%
Maximum [Member]
Warrants (Details) [Line Items]
Common stock outstanding percentage	9.80%		9.80%
Class A Common Stock [Member]
Warrants (Details) [Line Items]
Sale of stock price per share	$ 18		$ 18
Redemption trigger price	18		18
Class A Common Stock [Member] | Business Combination [Member]
Warrants (Details) [Line Items]
Newly issued price per share	$ 9.2		$ 9.2

Debt (Details)

Debt (Details) - USD ($) shares in Millions			6 Months Ended	12 Months Ended
	Apr. 29, 2024	Feb. 01, 2024	Jun. 30, 2024	Dec. 31, 2023	Mar. 01, 2025
Debt [Line Items]
Convertible Notes			$ 527,500
Convertible Notes outstanding			527,500	0
Short-term notes payable outstanding			2,858,769
Benesch Friedlander Coplan & Aronoff LLP [Member]
Debt [Line Items]
Excuted amount of promissory note	$ 670,000
Loeb and Loeb LLP [Member]
Debt [Line Items]
Short-term notes payable outstanding				$ 0
Promissory Note [Member]
Debt [Line Items]
Interest rate		24%
Interest rate per annum	7%
Promissory Note [Member] | EF Hutton [Member]
Debt [Line Items]
Executed a promissory note		$ 2,200,000
Promissory Note [Member] | Loeb and Loeb [Member]
Debt [Line Items]
Executed a promissory note		$ 540,000
Loeb and Loeb LLP [Member]
Debt [Line Items]
Interest rate			23.50%
Total interest payments			$ 127,000
Aronoff LLP [Member]
Debt [Line Items]
Maturity date	Nov. 01, 2024
Convertible Notes [Member]
Debt [Line Items]
Convertible notes shares (in Shares)			3.3
Forecast [Member] | Promissory Note [Member]
Debt [Line Items]
Principal amount of note payable					$ 183,333

Stock-Based Compensation (Detai

Stock-Based Compensation (Details)	3 Months Ended	6 Months Ended
	Jun. 30, 2024 USD ($)	Jun. 30, 2024 USD ($) $ / shares shares
Stock-Based Compensation [Line Items]
Compensation expense		$ 1,359,000
Stock price targets over the term		6 years
Estimated fair value	$ 4,800,000	$ 4,800,000
Expense related	$ 452,000	$ 452,000
Cash bonus percentage		2.50%
Cash bonus		$ 20,000,000
Executive [Member]
Stock-Based Compensation [Line Items]
Granted shares (in Shares) | shares		6,000,000
Executive Officer [Member]
Stock-Based Compensation [Line Items]
Cash bonus		$ 10,000,000
Minimum [Member]
Stock-Based Compensation [Line Items]
Stock price target, range per share (in Dollars per share) | $ / shares		$ 30
Maximum [Member]
Stock-Based Compensation [Line Items]
Stock price target, range per share (in Dollars per share) | $ / shares		$ 300

Fair Value Measurements (Deta_4

Fair Value Measurements (Details) - Schedule of Company’s Liabilities that are Measured at Fair Value - Level 3 [Member] - USD ($)	Jun. 30, 2024	Dec. 31, 2023
Forward purchase agreement [Member]
Schedule of Company’s Liabilities that are Measured at Fair Value [Line Items]
Derivative Liabilities	$ 4,815,800
Warrants – Series A and B [Member]
Schedule of Company’s Liabilities that are Measured at Fair Value [Line Items]
Derivative Liabilities	$ 12,028,950

Fair Value Measurements (Deta_5

Fair Value Measurements (Details) - Schedule of Fair Value Measurement of FPA - $ / shares	6 Months Ended
	Jun. 30, 2024	Dec. 31, 2023
Schedule of Fair Value Measurement of FPA [Abstract]
Risk-free interest rate	4.60%
Stock price (in Dollars per share)	$ 0.55	$ 18
Expected life	2 years 4 months 24 days
Expected volatility of underlying stock	100%
Dividends	0%

Fair Value Measurements (Deta_6

Fair Value Measurements (Details) - Schedule of Fair Value Assumptions of Warrants	Jun. 30, 2024	Mar. 15, 2024
Expected term (in years) | Series C Warrant [Member]
Schedule of Fair Value Assumptions of Warrants [Line Items]
Fair value measurement input	5.4	5.7
Expected term (in years) | Series D Warrant [Member]
Schedule of Fair Value Assumptions of Warrants [Line Items]
Fair value measurement input	5.4	5.7
Stock price | Series C Warrant [Member]
Schedule of Fair Value Assumptions of Warrants [Line Items]
Fair value measurement input	0.55	1.74
Stock price | Series D Warrant [Member]
Schedule of Fair Value Assumptions of Warrants [Line Items]
Fair value measurement input	0.55	1.74
Risk free rate | Series C Warrant [Member]
Schedule of Fair Value Assumptions of Warrants [Line Items]
Fair value measurement input	4.2	4.2
Risk free rate | Series D Warrant [Member]
Schedule of Fair Value Assumptions of Warrants [Line Items]
Fair value measurement input	4.2	4.2
Expected volatility | Series C Warrant [Member]
Schedule of Fair Value Assumptions of Warrants [Line Items]
Fair value measurement input	110	82.5
Expected volatility | Series D Warrant [Member]
Schedule of Fair Value Assumptions of Warrants [Line Items]
Fair value measurement input	110	82.5
Expected dividend rate | Series C Warrant [Member]
Schedule of Fair Value Assumptions of Warrants [Line Items]
Fair value measurement input	0	0
Expected dividend rate | Series D Warrant [Member]
Schedule of Fair Value Assumptions of Warrants [Line Items]
Fair value measurement input	0	0
Exercise Price | Series C Warrant [Member]
Schedule of Fair Value Assumptions of Warrants [Line Items]
Fair value measurement input	0.348	0.75
Exercise Price | Series D Warrant [Member]
Schedule of Fair Value Assumptions of Warrants [Line Items]
Fair value measurement input	0.0001	0.0001

Fair Value Measurements (Deta_7

Fair Value Measurements (Details) - Schedule of Recurring Basis Using Significant Unobservable Inputs (Level 3) - Level 3 [Member] - USD ($)	3 Months Ended
	Jun. 30, 2024	Mar. 31, 2024
Forward purchase agreement [Member]
Schedule of Recurring Basis Using Significant Unobservable Inputs (Level 3) [Line Items]
Balance at beginning	$ 20,640,600
Initial measurement		20,889,950
Change in fair value	(15,824,800)	(249,350)
Balance at ending	4,815,800	20,640,600
Warrants – Series A and B [Member]
Schedule of Recurring Basis Using Significant Unobservable Inputs (Level 3) [Line Items]
Balance at beginning	21,170,850
Initial measurement		12,739,000
Change in fair value	(9,141,900)	8,431,850
Balance at ending	$ 12,028,950	$ 21,170,850